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The mitochondrial free radical theory of ageing (mFRTA) proposes that loss of mitochondrial 
DNA (mtDNA) integrity as result of damage by endogenous reactive oxygen species (ROS) is 
a major cause of age-dependent mitochondrial degeneration. I have developed a sensitive S-
XL-qRT-PCR DNA damage assay that can measure DNA damage in Caenorhabditis elegans 
(C. elegans), particularly mtDNA. I found that mtDNA damage in C,elegans is usually low, in 
the order of less than one lesion per molecule of mtDNA. This low level of mtDNA damage is 
probably not sufficient to interfere significantly with mitochondrial function to play a part in 
reducing the lifespan of the nematodes. Pharmacological interventions using a mitochondrial 
targeted antioxidant, MitoQ do not alter the mtDNA damage of a transgenic C. elegans model 
of Alzheimer disease despite an increase in the lifespan and healthspan of the nematodes. In 
fact, I found that the protective effect in lifespan and healthspan may be caused by highly 
specific protective effects on the ETC and mitochondrial membrane. This further supports the 
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1. Introduction  
1.1. The demography of ageing populations 
The world population is rapidly ageing. Population ageing is defined as a process that changes 
the global age distribution of the population toward older ages, increasing the proportion of the 
elderly in the total population. Since the beginning of recorded history, the number of children 
under the age of 5 has always outnumbered people aged 65 and above. However, this situation 
will be reversed for the first time in human history, by the year 2050, when the elderly 
population is projected to exceed the young. A direct consequence of the ongoing dramatic 
decline in birth rates, coupled with increases in life expectancy, population ageing will continue 
to accelerate over the next few decades. In the year 1950, the total population of people aged 
65 and older was approximately 131 million, representing only 5% of the global population. In 
a report published by the World Health Organization (WHO), the number of people aged 65 
and above is projected to increase from 524 million to almost 1.5 billion between the years 
2010 and 2050 [1]. In most countries, the oldest group among the elderly population, 
constituting people aged 80 and above, is growing faster than any other age group. The 
proportion of this age group at the total global population is projected to increase from 1 % in 
the year 1950 to 4 % by the year 2050. Although this age group still constitutes only a small 
proportion of the total population, the rapid growth of this age group has important implication 
to society, related to demand for long term care. Generally, the rapid increase in the number of 
people aged 65 and above will have profound impact on global economic, social and political 
conditions [1] as they have different needs and productive capacities [2] than those people from 
the younger age group.  
Over the last half of 20th century, the total fertility rate (the average number of children that 
would be born to a woman over her lifetime) has fallen drastically, from 5.0 to 2.7 children per 
woman. The global fertility rate has significantly declined, but differing patterns of fertility 
behavior in different countries have caused the decline to be varied widely. In the more 
developed countries, such as Europe, Japan and Singapore, the fertility rate has fallen well 
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below the replacement level of 2.1 [3, 4]. As for the developing countries, the drop in the 
fertility rate started later compared to developed countries but proceed faster. The total fertility 
rate dropped by 60 % between the year 1950 and the year 2005 in developing countries [5].  
According to a report by Sarah Harper published in the year 2005, Asia and Latin America are 
also experiencing a steady fall in fertility rate with birthrate as low as 1.4 in Hong Kong, 1.5 in 
Singapore, 1.8 in Korea, 2.1 in Chile and 2.3 in Brazil [3]. The decline in the fertility rate is 
still ongoing, for instance, Singapore’s total fertility rate in the year 2012 had fallen to below 
1.2 children per woman [6].  
Under current mortality conditions of 7.99 deaths per 1000 person each year for all age groups 
in the world population, more people are expected to survive to old age. About 75 % of 
newborns will live to age 60 and about 30 % will survive till age 80. Overall, the global life 
expectancy, which is defined as the average number of years a new born is expected to live, has 
improved with the global increased of life expectancy at birth by almost 20 years from the year 
1950 to 2005 [5]. Life expectancy is an indicator of the condition of life and health status of a 
population. The higher the life expectancy, the better the condition of a country [2, 7]. While 
life expectancy rate is improved in almost every country, the improvement in the life 
expectancy at birth in the developing countries over the last half-century is still higher (23.1 
years) than developed countries (9.4 years). However, this steady increase in life expectancy 
still favors developed countries as individual born in developed countries are expected to 
outlive individuals in less developed countries by almost 12 years according to current mortality 
conditions [5]. Thus, with the increase in life expectancy, about 88 % of newborns are expected 
to survive till age 60 and more than half to age 80 by the year 2050 [5]. According to a WHO 
report in the year 2011, Singapore has the fourth-best life expectancy in the world. People living 
in Singapore have average life expectancy of 82 years, ranking Singapore after Japan, 
Switzerland and Australia. Improvement in the average life expectancy can be considered one 
of the society’s greatest achievements and is due to medical advances, better nutrition, health-
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care, education and economic development. However, together with lower birth rate, the 
resulting population ageing poses new challenge.  
1.1.1. The challenge of global ageing  
The shift in the distribution of global age structure poses social, political and economic 
challenges to individuals, families and societies. Population ageing is likely to burden health 
systems because age is the single biggest risk factor for many diseases including cancer, 
diabetes, cardiovascular disease, stroke and neurodegenerative diseases [8]. For instance, 
Alzheimer disease (AD) is a progressive, age-related neurodegenerative disease and is the most 
common form of dementia [9, 10]. AD is an increasingly serious public health challenge, 
especially in countries with large ageing populations. Currently, the total number of people with 
AD is estimated to be 34 million people worldwide and this figure is expected to triple over the 
next 40 years [10].  
One of the major concerns that is often mentioned is the rise of health care cost as populations 
age. For example, in the United States, healthcare cost grew faster than the economy as a whole 
from the year 1980 to the year 2004 [11]. The healthcare expenses for the whole US populations 
increased from USD$255 billion in the year 1980 to USD$1.9 trillion in the year 2004 [11]. 
The costs of caring and managing elderly suffering from health problems or disabilities will 
continue to increase with the growing numbers of aged-people. For instance, the prevalence of 
AD is very low at younger ages and high in elderly people. In the year 2010, less than 3 % of 
people aged 65 to 69 suffer from dementia worldwide, but almost 30 % of elderly aged 85 and 
above suffered from some form of dementia [12]. The cost of care for AD is daunting. In the 
2010 World Alzheimer report, the annual global cost of caregiving for dementia was estimated 
to exceed USD$600 billion in the year 2010 [12, 13]. In the United States, approximately 5.4 
million Americans are suffering from AD and the cost of caring for AD patients in this alone is 
estimated to exceed USD$200 billion annually. If no disease-modifying therapies are developed, 
this cost is projected to increase to USD$1.2 trillion in the year 2050 [14].  
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In addition to cost, the demographic transformation to ageing population will tend to lower 
labour force participation, thus affect the economic growth [2]. Traditionally, people in the 
working ages of 15 to 64 are expected to provide support to those in the dependent ages of 15 
and below or 65 and above. This is known as potential support ratio, which is an indicator of 
productive working-age people for every older person in the population. The global potential 
support ratio is projected to drop drastically, by more than 50 % over the next 50 years. By the 
year 2050, the global potential support ratio is expected to decline to 4.1 from the numerical 
value of 9.1 in the year 2000, with the highest percentage decrease in the developing countries 
[5]. For instance, a report released by National Population and Talent Division of Singapore 
stated that due to low fertility rate of only 1.2 in Singapore, the potential support ratio in 
Singapore dropped drastically from 13.5 in the year 1970 to 4.8 today. In another 15 years, this 
ratio is expected to drop more than 50 % to 2.1 [15]. The widespread decrease of the potential 
support ratio increases the economic burden of working individuals in order to maintain stable 
flow of benefits and supports to the elderly population.  
Population ageing is a powerful and transforming demographic force. With the increasing 
number of people entering older ages combined with steady improvement in human life 
expectancy, the understanding of the mechanism underlying ageing and age-related diseases is 
becoming more important as the need to develop interventions that can delay ageing, improve 
lifespan and healthspan. Thus ageing research is needed to elucidate the nature of ageing and 
age-related changes in humans as well as diseases and conditions associated with growing old. 
This effort is important to find ways of preventing or ameliorating such age-related diseases 
with the aim of promoting healthy and active years late in life.  
1.2. Ageing  
Ageing is a time-related progressive accumulation of detrimental changes that are associated 
with increasing susceptibility to disease and death [16].  
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The American gerontologist, Bernard Strehler [17] suggested four criteria to define age-related 
changes (ageing) which includes [17, 18]:  
1. Ageing is a universal phenomenon that all individuals share. It is associated with 
natural age-dependent changes that must occur in different degrees in all individuals of 
a species.  
2. Ageing is an intrinsic process which means the causes of normal age-related changes 
must be endogenous and must not depend on extrinsic factors. This is a criterion 
suggested to distinguish universal ageing and intrinsic ageing as certain age-related 
changes may be universal but a consequence of a modifiable, environmental effect on 
living systems. For instance, genetic damage due to cosmic radiation is universal but 
not intrinsic damage to the system. 
3. Ageing must be progressive, usually considered as a process rather than sudden event.  
This process is a gradual age changes occur with time throughout the lifespan of an 
organism and the age-related changes start to occur in individuals even when they were 
young.  
4. Ageing is the accumulation of various deleterious process which affects the functions 
of cells, tissues, organs and ultimately the organisms. This is because most age 
dependent deleterious effects, particularly the decline in functional capacity is reflected 
in an increased in mortality rate. However, not all age-related changes are deleterious, 
some age-correlated changes like development process and adaptive process that 
results in improvement of an organism’s survival capacity are not consider ageing, 
these are part of developmental process rather that ageing.  
In general, ageing is associated with a decline in efficiency of physiological processes which 
include biological function on molecular, cellular and tissue level [19]. These physiological 
processes reduce the efficiency of body metabolism, resulting in the disruption of body 
functional processes and ultimately death. Characteristic signs of ageing in human include a 
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gradual decline in height and weight due to loss of muscle and bone mass, a lower metabolic 
rate, a decline in memory, vision, as well as an increase in the susceptibility to disease.  
1.3. Theories of Ageing  
Almost every important discovery of molecular biology has stimulated the development of 
different theories of ageing [20]. The study of the ultimate causes of ageing and the mechanisms 
by which we age has generated more than 300 scientific theories of ageing and the number 
continues to grow [21]. However, these different theories of ageing are not mutually exclusive, 
but they may overlap at some level and may in fact be complementary to other theories [20, 
22]. Theories of ageing can be classified into evolutionary theories of ageing and 
causality/molecular theories of ageing [23]. Evolutionary theories of ageing try to address how 
ageing evolves and why ageing occurs whereas causality/molecular theories of ageing explain 
how ageing and death occur on a molecular level [23, 24].  
1.3.1. Evolutionary theories of ageing  
The evolution of ageing theories aim to understand why ageing evolves and why different 
biological species age at different rates [25]. The evolutionary theories of ageing describe 
ageing through the interaction of two important processes; natural selection and mutation [26]. 
In a given environment, every trait can be classified into neutral, beneficial or detrimental 
according to its fitness value. This value describes the ability of an individual to survive and 
reproduce. Over several generations, genes that improve organism’s survival due to forces of 
extrinsic mortality (e.g. starvation, environmental variations, predation and disease) and genes 
that enhance reproductive capacity are selected for [27-29]. For instance, genes that are able to 
enhance rapid development and reproduction are selected for in organisms living in 
environments with high extrinsic mortality; whereas for organisms living in environments with 
low extrinsic mortality, genes that increase the longevity and reproductive fitness are favored 
[22]. Therefore, these genes become dominant within the population. Supporting this theory is 
the study by Austad conducted in the year 1993 where he compared the lifespan of opossums 
living in environments subject to predators or free of predators. Consistent with the 
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evolutionary theory of ageing, the protected opossums aged more slowly and thus had a longer 
life expectancy [22, 30]. 
Evolutionary explanations of aging are classified into [20, 26]: (a) mutation accumulation 
theory, (b) antagonistic pleiotropy theory and (c) disposable soma theory.  
1.3.1.1. Mutation accumulation theory  
The mutation accumulation theory of ageing is based on Medawar’s insight (1952) that the 
decline in the force of selection means that there is no mechanism to prevent the accumulation 
of late-acting mutations that are not deleterious to reproductive success in the population [20, 
31]. This theory emphasizes that these detrimental, late-acting mutations are not selected 
against by natural selection at young age, hence, these genes would accumulate and lead to 
pathology and death at old age [20, 26, 32].  For example, a mutant gene that kills young people 
will be strongly selected against and have little chance to reproduce, therefore being eliminated 
from the population. This can be explained using the example of a rare, fatal genetic disease, 
progeria. Patients with progeria, particularly young children develop symptoms of premature 
ageing. They only live for about 12 years, consequently, they have no chance to reproduce and 
to pass their mutant genes to next generations [33]. In contrast, patients with Huntington’s 
disease (an inherited neurodegenerative genetic disorder that causes damage to brain cells 
leading to cognitive decline and dementia) usually develop physical symptoms of this disease 
between 30 to 40 years of age. People carrying the mutation for this late-onset disease can 
therefore reproduce before the illness occurs, thereby allowing the mutation to escape natural 
selection and pass the gene to their next generations [34]. 
Although both Progeria and Huntington’s are considered relatively rare genetic disorders, 
Progeria is an extremely rare genetic disease with an incidence rate of about 1 in every 8 million 
people worldwide [35]. By contrast, the gene for Huntington’s disease appears more frequently 
than Progeria at approximately 1 in 20,000 people worldwide [36, 37]. Overall, the mutation 
accumulation theory of ageing suggests that, since there is little force of selection on late acting 
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genes through possible accumulation with late acting detrimental effects, a very large number 
of genes might be distributed through the genome contributing to disease and ageing [25, 26].   
1.3.1.2. Antagonistic pleiotropy theory of ageing 
Pleiotropy is a situation in which a single gene influences multiple phenotypic traits. 
Antagonistic pleiotropy describes a situation in which the expression of one pleiotropic gene 
provides both beneficial and detrimental effects to the organisms. In the year 1957, George 
Williams further developed Medawar’s theory by considering pleiotropic genes and suggested 
the antagonistic pleiotropy theory of ageing. This theory proposes that organismal age because 
of combined effect of many genes that offer beneficial effects early in life but have adverse 
(antagonistic) pleiotropic effects in late life. [38]. The antagonistic pleiotropy theory assumes 
that natural selection favored pleiotropic genes that have beneficial effects on reproduction or 
physical fitness early in life and that these genes will therefore be selected for, regardless of the 
various accompanying detrimental side effects in later life [24]. Support for the antagonistic 
pleitropy theory of ageing has been found in the experiment on natural populations of Poecilia 
reticulata guppies [39]. In one study, guppies derived from more dangerous environments with 
high extrinsic mortality rate were introduced into an environment with low extrinsic mortality 
rate. The pattern of senescence of these two groups of guppies was compared. The introduced 
guppies still had higher reproduction capacity and experienced senescence earlier than those 
from natural low extrinsic mortality rate environments. This early onset of senescence may 
involve the immune system and this may be part of the trade-offs to have significance 
detrimental impact on fitness and lifespan. There is, however, a second study that does not 
support the classical antagonistic pleitropy theory of ageing. In this study, guppies from more 
dangerous environments with high extrinsic mortality rate have lower rate of ageing and do not 
experience senescence earlier than those from natural low extrinsic mortality rate environments 
but this population of guppies experienced a more rapid deterioration in physical performance 
(eg. Swimming performance) [40].  
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1.3.1.3.Disposable Soma theory of ageing  
Proposed by Thomas Kirkwood in the year 1977 [41], the disposable soma theory of ageing 
can be considered as an extension of the antagonistic pleitropy theory of ageing, suggesting the 
relationship between reproduction and lifespan. The key idea is that organisms have to ration 
resources between maintenance of the soma and reproduction [41, 42]. Kirkwood states that all 
living organisms have limited energy resources [38] and that ageing might be due to progressive 
accumulation of unrepaired damage over time, resulting from the trade-off between the 
metabolic cost of reproduction and body maintenance.  When resources are limited, 
evolutionary forces tend to allocate resources to reproduction and thus there are fewer resources 
for somatic maintenance (in other words longevity). This is a successful strategy because the 
chance of an organism dying young in the wild is high and it is not sensible to invest resources 
in maintenance to result in organisms’ survival much beyond their essential lifespans, which is 
the natural lifespan of a species [43]. Resources allocation is important because the germ line 
(reproductive cells) must be maintained throughout the generations, whereas the soma serves 
only a single generation [25]. Supporting evidence for this antagonistic pleitropy theory 
including the disposable soma theory of ageing comes from studies in both Drosophila and 
C.elegans where longevity often inversely correlates with reproductive capacity [44, 45].  
Overall, evolution acts to maximise reproductive fitness and selects for a longevity that is 
beneficial to reproductive success for continuation of generations. Therefore, evolutionary 
theories of ageing try to address the observation that ageing is a phenomena that takes place in 
protected environment in which the survival of an organism beyond its essential lifespan is 
possible and likely [46].  
It is important to note that evolutionary theories of ageing explain why ageing occurs (how 
particular traits that affect ageing might accumulate in the population) while mechanistic 
theories which will be discussed later, explaining how ageing occurs (molecular mechanism 
underlying the process of ageing). These two types of ageing theories are complementary in the 
explanation of the normal ageing process.  
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1.3.2. Damage-accumulation theories of ageing 
Numerous molecular or mechanistic theories of ageing have been proposed. As early as the 
year 1900s, Max Rubner found that large animals tend to live longer than small animals and 
that those small animals had higher metabolic rates [47, 48]. Based on his observations, he 
suggested a relationship between metabolic rate, body size and longevity. Later in the year 1928, 
Raymond Pearl further expanded on this inverse relationship between metabolism and lifespan, 
formulating the rate of living hypothesis of ageing [49]. He observed that Drosophila cultured 
at different temperatures have different metabolic rates and thus have different lifespans. Based 
on this observation, he proposed metabolism causes ageing and therefore metabolic rate 
determines ageing rate (Figure 1.1). This implies that the higher the metabolic rate (energy 
consumption), the faster the biochemical processes underlying life and thus the faster an 
organism ages. In other words, animals are born with finite lifetime metabolic capacity [47, 50]. 
Over time, evidence to support this living theory became less convincing. For example, the rate 
of living theory does not explain why birds and bats live longer than mice although they have 
relatively high metabolic rates [43]. Furthermore, regular exercise, which increases the 
metabolic rate, does not result in higher mortality in mammals [51, 52]. Also not in agreement 
with this theory are some caloric restriction studies in rodents, suggesting that limited calorie 
intake can increase lifespan without reducing metabolic rate as compared to control animals 
[53]. These are only some examples which make clear that energy metabolism alone could not 
explain lifespan [54]. While the rate-of living theory is no longer accepted nowadays, it directed 
ageing research to focus on oxygen metabolism [43, 55, 56] as oxygen is the main requirement 
during aerobic metabolism. The free-radical theory of ageing (FRTA), which will be discussed 
in the next section, was later developed by Denham Harman in the year 1956 [57]. The FRTA 
provided a link between metabolism and ageing [47, 58] and is a possible explanation that might 
account for the observations of Max Rubner and Raymond Pearl.  
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The FRTA is one of the more popular and well-studied ageing theories today. It proposes that 
ageing results from the progressive accumulation of free radical-mediated damage, causing 
random deleterious damage to macromolecules in vivo and that this damage is ultimately the 
cause of age-dependent diseases and death [8, 57, 59]. Biological macromolecules such as, 
proteins, lipids and nucleic acids are susceptible to free radicals attack, and the extent of free 
radical-mediated damage is dependent on genetic and environmental factors [57, 60]. Harman  
 
postulated his theory based on the observations that irradiation generates free radicals and that 
high reactivity free radicals are also produced in living systems under normal conditions. These 
observations are supported from the study using paramagnetic resonance absorption method 
which demonstrated the discovery of unpaired electrons (free radicals) in biological system 
[61].  The FRTA suggests that the amount of free radicals increases with high metabolic rate 
[57] and free radicals matter to ageing. In support of this theory, increased molecular damage 
 
                     Adapted from J. Loeb and J. H. Northrop, 1917 
Figure 1.1. The effect of temperature on the metabolic rate of Drosophila. Animals 
cultured at higher temperature have higher metabolic rate. The faster the energy consumption, 




with advancing age was indeed found in various laboratory animal models including C.elegans, 
flies and mice [57, 62-65]. Harman’s FRTA did not gain much attention initially. However, his 
theory started to gain support and acceptance when McCord and Fridovich discovered SOD 
enzymes that degrade superoxide in the year 1969 [66].  
Harman initially suggested free radicals production during normal metabolism without 
specifying their source, later in the year 1972, he refined the FRTA by proposing that 
mitochondria may be the source and target of free radical reactions [67, 68]. This version of the 
FRTA is commonly known as mitochondrial free radical theory of ageing (mFRTA) [69]. The 
mFRTA postulates accumulation of partially unrepaired mitochondrial damage produced as by-
products during normal metabolism as the driving force of the ageing process [67, 69, 70]. 
Harman’s mFRTA received further support when Britton Chance observed the generation of 
hydrogen peroxide (H2O2) in isolated mitochondria in the year 1973 [71], which provides 
evidence about the role of free radicals in living systems. 
The mFTRA is based on several concepts [72-77]: 
(a) Mitochondrial reactive oxygen species (ROS) increase with age  
(b) Mitochondrial ROS-scavenging enzymes’ activity decreases with age  
(c) mtDNA mutation accumulates with age  
(d) mtDNA mutation impairs mitochondrial ETC function, further elevates mitochondrial 
ROS production, thereby facilitates mutation accumulation and increases 
macromolecules damaged.  
Over the years, there was a great deal of experimental evidence that has accumulated to support 
as well as challenge aspects of the mFRTA. For instance, mitochondria of old animals are 
indeed less efficient than the young animals which might be attributed to increased 
mitochondrial ROS generation in older animals. Old animals also generally have higher 
markers of oxidative damage with increased protein, lipid and nucleic acid oxidation [62, 75-
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77].  There is evidence for age-associated accumulation of mitochondrial mutation such as point 
mutation and deletion. For example, Corral-Debrinski et al. showed increased mitochondrial 
deletions with advanced age in different regions of human brain [78]. Furthermore, the mtDNA 
of old rhesus monkey also accumulates high levels of deletions in skeletal muscles. Some 
experimental data that support this theory come from studies of lifespan in different species, 
such as nematodes, flies and mice [62, 79-87].  These studies demonstrated that longer-lived 
species typically have lower mitochondrial ROS production thus lower oxidative damage to 
macromolecules. However, this is not always the case and some studies have failed to support 
the mFRTA. C.elegans lacking mitochondrial SOD (MnSOD) did not experience reduced 
lifespan or increased accumulation of oxidative damage [62, 63, 88]. Similarly, the longest 
living rodent, the naked-mole rat, is able to live longer with extended health span compared to 
normal mice, even though it accumulates high level oxidative damage  at young age [89].  
1.4. Reactive Oxygen Species  
A free radical is an atom, molecule or ion that contains one or more unpaired electrons [8]. Free 
radicals can have positive, negative or neutral charge. Free radicals can be formed by either 
donating or accepting one electron from a non-radical species, forming radical cation  (equation 
1) or radical anion (equation 2) respectively [8]. In addition to these two chemical processes, 
formation of free radicals may also involve a process known as homolytic bond fission. This 
process involves the breaking of a covalent bond and one electron from the covalent bond 
remains on each atom after the homolytic cleavage (equation 3). The dissociation of the 
covalent bond requires a significant amount of energy such as energy provided by heat, 
ultraviolet light or ionizing radiation [8]. Generally, free radicals are short-lived, unstable and 
have high tendency to react with other molecules. 
Equation 1 :   A - e¯           A˙+ 
Equation 2:   B + e¯           B˙  ¯
Equation 3:   A : B            A˙ + B˙ 
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Reactive oxygen species (ROS) are chemically reactive molecules (including free radicals) that 
contain at least one atom of oxygen. All oxygen radicals are ROS but not all ROS are oxygen 
radicals [8]. Some of the examples of oxygen radicals are superoxide anion (O2˙¯) and hydroxyl 
radical (OH˙).  In contrast, examples of non-radical derivatives of oxygen which are also 
considered as ROS are hydrogen peroxide (H2O2), peroxynitrite (ONOOˉ) and hypochlorite 
(OCl ˉ) [8, 90].  
ROS can be generated in living systems by either exogenous or endogenous sources. Exogenous 
ROS sources includes ultraviolet (UV), ionizing radiation, chemical pollutants and some 
medications. Endogenous ROS are generated intracellularly through multiple mechanisms, the 
major process being oxidative phosphorylation.  
The process of ROS production and detoxification is generally tightly regulated, ROS can be 
beneficial and detrimental to living systems depending on nature, locations and concentrations 
of the ROS. There is a large body of evidence that demonstrate the use of free radicals in various 
physiological functions that benefit the living systems [91], such as in the cellular signaling 
functions and defense against infectious agents [92]. ROS, maintained at proper (low or 
moderate) cellular concentration can be beneficial to living systems, including physiological 
roles in cell signaling as second messenger molecules [93]. However, excessive ROS 
production or deficiency of antioxidant enzymes, is known to be harmful to the living systems. 
ROS at high concentration can be detrimental to cell structures, damage biological 
macromolecules including proteins, lipids and nucleic acids and therefore disrupt cellular 
function [91, 92]. Nitric oxide (NO˙), a gaseous free radical and signaling molecules, is an 
example of ROS that is both beneficial and detrimental. NO˙ plays an important role in 
biological processes, particularly in blood vessel homeostasis to inhibit vascular smooth muscle 
growth [94, 95]. NO˙ also plays a role in cell signaling, it acts as secondary messenger in 
neurons and macrophages [93].  In contrast to the useful functions, excess NO˙ can contribute 
to cell injury [93].  
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A disturbance in the balance between ROS production and detoxification in biological systems 
is termed oxidative stress. Oxidative stress has been implicated in the development of several 
human diseases including some neurodegenerative diseases, cancer and cardiovascular disease.  
1.5. Mitochondria  
ROS are metabolic by-products which are constantly generated as part of normal aerobic life 
and mitochondria are known to be the main producer of ROS in animals [96, 97]. Mitochondria 
are often called “cellular power plants” because they play a prominent role in producing the 
majority of adenosine triphosphate (ATP) via oxidative phosphorylation [98]. In addition to 
energy generation, mitochondria are also involved in apoptosis [99], ion homeostasis [100], and 
other biochemical metabolic pathways include calcium signaling [101] and steroid synthesis 
[102].  
Mitochondria are highly organized structures, bound by two phospholipid bilayers, the inner 
and outer membrane, leading to the formation of two compartments, the matrix and the 
intermembrane space (Figure 1.2) [103]. These inner and outer membranes are quite distinct in 
appearance and function, with different enzymes and reactions confined to different membranes 
and compartments [104]. The outer  mitochondrial membrane encloses the entire organelle and 
contains porins, which are the integral proteins that form channels to allow ions and large 
molecules  through the outer mitochondrial membrane [105]. Unlike the outer mitochondrial 
membrane, the inner mitochondrial membrane does not contain porins and therefore is 
impermeable to ions and most metabolites. However, there are numerous specific transporters 
in the inner mitochondrial membrane that facilitate metabolic communication with other cell 
compartments. Mitochondria are also highly mobile organelles. They form dynamic networks 
that continuously undergo fusion and fission events [103, 106]. Mitochondrial fusion and 
fission are important for modulating cellular redox status, maintaining mtDNA integrity, 
mitochondrial networks and function [107]. In addition, mitochondrial fusion and fission events 
also play important roles in several disease-related processes such as apoptosis and mitophagy 
[106, 108] . For instance, studies have shown that Alzheimer disease (AD) patients have 
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imbalance in the expression of mitochondrial fusion and fission proteins resulting in 




Cellular respiration takes place in three stages: glycolysis, tricarboxylic acid (TCA) cycle and 
oxidative phosphorylation (Figure 1.3). Nutrients such as glucose can be broken down into 
pyruvate during glycolysis in the cytoplasm. Pyruvate is transported to the mitochondria where 
it is converted into acetyl coenzyme A (acetyl-CoA). Subsequently, acetyl-CoA enters the TCA 
cycle and is further oxidized to carbon dioxide, this process produces nicotinamide adenine 
dinucleotide (NADH) and flavin adenine dinucleotide (FADH2). NADH and FADH2 are 
energy-rich molecules that act as a source of electrons for the oxidative phosphorylation (Figure 
1.4). 
Figure 1.2. Structure of a mitochondrion. Mitochondria are membrane bound organelles that 
are surrounded by two membranes, the outer and inner mitochondrial membrane. In electro 
micrograph, the mitochondrion is oval in shape and has an average size ranging from 0.5 to 1.0 
µm. The number of mitochondria per cell varies widely, depending on the metabolic 





Oxidative phosphorylation is the metabolic process by which respiratory enzymes in the 
mitochondrial inner membrane use energy released by the oxidation of nutrients to generate 
ATP. The prominent role of mitochondria in ATP production is due to the presence of five 
distinct insoluble integral membrane protein complexes which are embedded in the inner 
mitochondrial membrane (Figure 1.4). These mitochondrial respiratory chain complexes are 
the main enzymatic machinery of the oxidative phosphorylation [111].  
 
Figure 1.3. An overview of cellular respiration. Cellular respiration is carried out in three 
stages: glycolysis, TCA cycle and oxidative phosphorylation. The first stage in cellular 
respiration is the biochemical process called glycolysis, occurring in cytoplasm. Glycolysis 
converts glucose to pyruvate, generates ATP and NADH. Pyruvate generated during glycolysis 
is then transported to mitochondria and converted to acetyl-CoA. The second biochemical 
pathway is known as TCA cycle, where the acetyl-CoA enters TCA cycle, converts into CO2, 
generating ATP, NADH and FADH2. TCA cycle occurs at the matrix of the mitochondria. The 
third stage of the cellular respiration is the oxidative phosphorylation, takes place in inner 
mitochondrial membrane. Oxidative phosphorylation is the metabolic pathway in which ATP 




The ETC complexes are:  
1. Complex I: NADH dehydrogenase or NADH- ubiquinone oxidoreductase, is the first 
enzyme of the respiratory chain. It catalyzes NADH oxidation by transferring electrons 
from NADH to ubiquinone (a lipid-soluble carrier). NADH is oxidized by reducing 
flavin mononucleotide to FMNH2. Electrons are then transferred from FMNH2 to Fe-
S cluster to ubiquinone. During the transfer of the electrons, protons are transported 
across the inner mitochondrial membrane, contributing to the proton-motive force.  
2. Complex II: succinate dehydrogenase or succinate ubiquinone oxidoreductase. 
Additional electrons are transferred from complex II to ubiquinone.  The electrons 
transfer originates from complex II by oxidation of succinate to fumarate while passing 
electrons on to FAD which then is reduced to FADH2. FADH2 then passes its electrons 
to Fe-S clusters and then to ubiquinone. Unlike complex I, no proton-motive force is 
generated.   
3. Complex III: cytochrome c reductase, bc1 complex or ubiquinone-cytochrome c  
oxidoreductase. Complex III catalyzes the reduction of cytochrome c by transferring 
electrons that were accepted from complex I and II from ubiquinone to cytochrome c 
(a water-soluble electron carrier). During this process, proton motive force is generated.  
4. Complex IV: cytochrome c oxidase (COX) or reduced cytochrome c: oxygen 
oxidoreductase. Complex IV is the terminal enzyme of the respiratory chain. In 
complex IV, electrons were transferred from cytochrome c to complex IV and were 
then transferred to molecular oxygen one at a time to produce water molecules.   
5. Complex V: ATP synthase or proton-translocating ATP synthase. Complex V is 
responsible for ATP production from ADP and inorganic phosphate, driven by the 
transmembrane electrochemical proton potential difference generated by the transfer 









In general, electrons  enter the ETC via complex I and II respectively [98]. In a stepwise pattern, 
the electrons from both complex I and II are then carried by the electron carriers, ubiquinone 
or coenzyme-Q to complex III. The electrons are then transferred from complex III to 
cytochrome c, located within the intermembrane space. In complex IV, electrons from the 
cytochrome c are transferred to oxygen, the terminal electron acceptor where oxygen is reduced 
and water formed as the product.  
The flow of electrons by the ETC complexes results in a net efflux of protons through complex 
I, III and IV from the mitochondrial matrix into the mitochondrial inter-membrane space 
creating an electrochemical proton gradient.  This electrochemical proton gradient is used to 
drive ATP synthesis from adenosine diphosphate (ADP) and inorganic phosphate through the 
Figure 1.4. A schematic of mitochondrial ETC complexes. Oxidative 
phosphorylation is the last step of cellular respiration and depends on electron transfer 
on ETC complexes. The mitochondrial ETC complexes consists of five complexes, 
namely complex I to IV. 
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enzymatic activity of ATP synthase. Since the mitochondrial inner membrane is impermeable 
to ions, the protons can only reenter the matrix through special proton channel protein, complex 
V [112]. The PMF drives the passage of protons back into the mitochondrial matrix through 
complex V, thus driving the synthesis of ATP from ADP and phosphate.    
1.5.1. Mitochondria as a cellular source of ROS production  
ROS can be generated at numerous sites within the cell with mitochondria being the major 
cellular source of ROS [113]. A main factor that controls mitochondrial ROS production is the 
redox state of the mitochondrial ETC [114]. During the final reaction of oxidative 
phosphorylation, the final electron acceptor, oxygen, is reduced to water (Equation 4).  
However some electrons from the ETC can leak to oxygen prematurely, causing electron 
reduction of molecular oxygen to generate superoxide (Equation 5), which is a charged, 
relatively unstable intermediate [96]. Superoxide is the precursor of most ROS and a mediator 
in oxidative chain reactions in ETC [8, 58, 74, 115]. ROS are mainly generated in this way 
within ETC complex I and III [116, 117]. Complex I produces the most superoxide radicals 
compared to other complexes in the mitochondrial ETC and that superoxide produced is being 
released to the matrix side of the Inner mitochondrial membrane (Figure 4) [118-120]. There is 
evidence that there are two distinct superoxide production sites from complex I, (i) the flavin 
from flavin mononucleotide moiety and (ii) QH˙ in the ubiquinone binding site [115, 121]. 
Whereas, complex III releases superoxide to both the mitochondrial matrix and intermembrane 
space (Figure 4) [122] . Rich and Bonner first suggested that Qo semiquinone which is situated 
next to intermembrane space is the site of superoxide production in complex III [115, 121, 123-
125] .  
Superoxide is the first radical produced in mitochondria. It is generally membrane impermeable 
and is converted to hydrogen peroxide (H2O2) (Equation 6) by metal dependent enzyme 
superoxide dismutase (SOD) (manganese SOD (MnSOD) in the mitochondrial matrix or 
Copper Zinc SOD (CuZnSOD) in all cell compartments except the mitochondrial matrix [121, 
126]. Unlike superoxide, the uncharged H2O2 is a compound of relatively poor reactivity, more 
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stable than superoxide and can diffuse through the mitochondrial membranes. H2O2 is, in turn, 
broken down into water [121] (Equation 7) by glutathione peroxidase (GPx), peroxiredoxins 
(Prdx), glutathione (GSH) and thioredoxin-2 (Trx) in the mitochondrial matrix or is removed 
by catalase in the cytosol and peroxisomes [127]. However, in the presence of transition metals 
such as iron, H2O2 can undergo Fenton reaction and generate the extremely reactive hydroxyl 
radical (OH·) (Equation 8). There are two other important radical species, nitric oxide (NO·) 
and peroxynitrite (ONOOˉ).  Superoxide can react with NO· to generate ONOOˉ which is 
subsequently converted to other reactive radicals includes nitrogen dioxide (NO2·) and 
OH· [58].  
Equation 4:    O2 + 4H++ 4e  ¯            2H2O 
Equation 5:    O2 + e  ¯            O2•  ¯
Equation 6:    O2•  ¯+ e  ¯+ 2H+           H2O2   
Equation 7:    2H2O2             2H2O  + O2 
Equation 8:    H2O2 + Fe2+             HO•  + OH  ¯+ Fe3+ 
ROS can damage lipids, proteins and nucleic acids. Furthermore, the products of oxidation of 
these macromolecules can cause secondary damage to proteins which causes proteins to 
degrade and lose their catalytic function [128]. The significance of ROS production in 
mitochondria is demonstrated in the studies using MnSOD knockout mice and flies where 
failing to remove the mitochondrial ROS reduces the lifespan of the mice [129, 130]. Unlike 
MnSOD knockout mice and flies, MnSOD deletion in nematodes did not altered lifespan or 
increase oxidative damage [62, 63, 88]. However, there is evidence that knocking out MnSOD 
in nematodes inhibited the mitochondrial ETC [62, 63] which is thought to be a compensatory 
mechanism. Nevertheless, mitochondrial-generated ROS can be considered as a major source 
of cellular damage.  
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1.5.2. Mitochondria as target of ROS  
As the main site of oxidative phosphorylation, mitochondria are exposed to relatively high 
concentration of ROS and may therefore susceptible to ROS-mediated damage [96, 124]. 
Although H2O2 can diffuse through the mitochondrial membrane, other ROS such as O2• a¯re 
not membrane permeable, and probably react with macromolecules inside the mitochondria. 
ROS produced outside mitochondria by other cellular sources may also be targeted to 
mitochondria [124, 131], thus causing additional mitochondrial damage. Such cellular locations 
include the endoplasmic reticulum [132], cytosol [133], peroxisome [134], plasma membrane 
[135] and extracellular space [136]. ROS can react with and are able to cause damage to a wide 
range of biomolecules such as lipids, proteins and nucleic acids.  
1.5.2.1. Oxidative damage to mitochondrial lipids  
Mitochondrial lipid peroxidation refers to ROS attack on mitochondrial lipid, particularly on 
free lipids or lipids in the mitochondrial membrane [58]. Lipid peroxidation might be 
particularly harmful to mitochondria because mitochondria contain cardiolipin as a major and 
important component of mitochondrial inner membrane. Cardiolipin is exclusively found in the 
inner mitochondrial membrane [137, 138] and is vulnerable to peroxidation because of its high 
degree of polyunsaturated fatty acids [137]. Lipid peroxidation generates lipid radicals, which 
can further react with oxygen or other lipids forming lipid peroxidation products such as 4-
hydroxy-2-nonenal (HNE) and malondialdehyde [58, 139]. Lipid peroxidation therefore can 
progress in a chain reaction and these lipid peroxidation products can subsequently cause 
cellular damage by reacting with other lipids, proteins and nucleic acids. Peroxidation of lipids 
can also alter membrane fluidity and permeability, thus directly affecting the ETC function 
[140, 141]. The product of oxidized lipids, HNE can induce mitochondrial uncoupling proteins, 
causing protons leak across mitochondrial membrane [142].  
1.5.2.2. Oxidative damage to mitochondrial proteins  
Proteins can also be damaged by oxidative conditions either by direct oxidation of amino acids 
in the protein sequence or as a secondary consequence of lipid peroxidation, for example, HNE 
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can introduce carbonyl groups to the protein  [76, 124, 143]. Mitochondrial proteins are highly 
susceptible to oxidative damage such as carbonylation and nitration [144]. Mitochondrial 
protein oxidation may modify amino acid residues, altering mitochondrial ETC metabolic 
enzymes functions including ATP synthase, pyruvate decarboxylase complex activity, NADH 
dehydrogenase and aconitase activity [139, 144-146]. Consistent with a role of ROS in ageing, 
increased oxidized proteins in human [147, 148], mice [149] and C. elegans [62, 150] show a 
positive correlation with age. This is consistent with the notion that accumulation of oxidized 
protein may play a part in ageing.  
1.5.2.3. Oxidative damage to mitochondrial DNA (mtDNA)  
DNA damage appears ubiquitous in biological systems and is often proposed to be a main 
mechanism of ageing [151]. DNA damage is important because other macromolecules such as 
proteins and RNA can be replaced if damaged thus blocking the progressive accumulation of 
damage of these macromolecules over a lifetime [152]. Genetic defects in DNA are particularly 
harmful to organisms as they may lead to mutation, modify gene expression and replication, 
and in the case of mtDNA cause impairment of mitochondrial function, eventually leading to 
metabolic dysfunction and degenerative diseases including neurodegeneration [153-156].  
1.5.3. Mitochondrial genome  
Mitochondria are of particular interest because they are the only organelles in animals that have 
their own genetic information (DNA) [127]. MtDNA was discovered in the year 1963 by Margit 
M. K. Nass and Sylvan Nass using electron microscopy [157]. Besides having their own 
genome, mitochondria also have their own ribosomes and transfer ribonucleic acids (tRNA), 
independent of the nucleus. MtDNA molecules are typically 13 to 18 kb in length [112, 154, 
158, 159]. For instance, C. elegans mitochondrial genome is 13,794 nucleotides in length, 
encoding 12 polypeptides of the mitochondrial respiratory chain complexes, 2 ribosomal RNAs 
(12S rRNA and 16S rRNA) as structural part of mitochondrial ribosomes and 22 transfer RNA 
essential for mitochondrial translation [160, 161]. They have a closed circular double stranded 
DNA structure, organized into DNA-protein structures known as nucleoids. These nucleoids 
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reside within the mitochondrial matrix and attach to the mitochondrial inner membrane [158, 
159]. Despite having their own DNA, about 98% of the mitochondrial proteins are nuclear 
encoded, synthesized in the cytosol and translocated into the mitochondria by mitochondria-
import peptides [103]. The number of mitochondria as well as the mtDNA content in each cell 
varies, depending on the type of cell and the metabolic activities of the tissues [158, 162]. For 
instance, muscle tissue has relatively high number of mitochondria due to its high energy 
requirements [163]. In C. elegans, mtDNA content varies with developmental stage. Adult C. 
elegans have much higher mtDNA content than both embryos and larvae because during 
development mitochondrial copy number increases significantly and oocytes also contain 
24,000 copies of mtDNA [160, 161]. However, we have found that the mtDNA copy number 
declines as the nematodes age [62].  
1.5.4. mtDNA damage induced by ROS  
MtDNA is under constant attack by ROS and is exposed to oxidative damage leading to genetic 
defects. Not all ROS can damage DNA and different ROS cause various types of mutagenic or 
lethal lesions to DNA [8]. Examples of the main types of DNA damage including alkylation 
damage, hydrolytic damage, formation of adducts, DNA stand breaks and oxidation damage, 
especially 8-hydroxy-2' -deoxyguanosine (8OHdG) [152].       
1.5.4.1. Alkylation damage  
DNA alkylation damage occurs when an alkylating agent such as Methyl methanesulfonate and 
10-decarbamoyl mitomycin C, covalently modifies DNA by transferring an alkyl group to a 
DNA base. Alkylating agents are therefore mutagenic and cytotoxic. There are two types of 
alkylating agents: exogenous and endogenous. Exogenous agents such as anticancer 
compounds and endogenous agents for instance S-adenosylmethionine are alkyl donors that 
can cause DNA lesions at DNA heterocyclic bases or the DNA backbone [164, 165].  
1.5.4.2. Hydrolytic damage  
The covalent structure of DNA, in particular the glycosidic bond that holds the nucleobases to 
the sugar phosphate backbone is relatively unstable and is subjected to spontaneous hydrolytic 
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damage by water molecules [166, 167]. Hydrolysis of glycosidic bond results in the loss of 
purine or pyrimidine bases forming abasic (apurinic or apyrimidic respectively) sites[168]. The 
process of breaking the chemical bond connecting the purine base (adenine or guanine) from 
the deoxyribose phosphate backbone leaving an apurinic, site is known as depurination while 
the loss of pyrimidine base (cytosine and thymine) from DNA forming apyrimidic site is known 
as depyrimidination. Depurination and depyrimidination are potentially lethal to the cells as 
unrepaired abasic sites can inhibit transcription.  
1.5.4.3. Formation of bulky adducts  
DNA adducts are altered forms of DNA that occur when DNA is covalently bonded to 
carcinogenic chemicals from endogenous or exogenous sources [168]. In humans, DNA 
adducts are caused by natural hormone including estrogen or other endogenous sources such as 
malondialdehyde or HNE which are naturally occurring products of lipid peroxidation [169, 
170]. Covalent binding of exogenous sources to DNA molecule includes acetaldehyde /tobacco 
smoke and cisplatin/chemotherapy drugs, which can form DNA adducts thus damaging the 
DNA [171].  
1.5.4.4. DNA stand breaks  
DNA strand breaks refer to single- or double-strand DNA cleavage in DNA double helix. 
Single-strand breaks occur when both the nucleotide base and deoxyribose backbone are lost 
from DNA structure. Such DNA strand breaks can arise either directly from the attack by ROS 
or indirectly during the process of repair of other DNA lesions [172]. In contrast, double-strand 
breaks form when the phosphate backbones of both complementary DNA strands are cleaved 
simultaneously. They can be formed as a consequence of the unrepaired DNA structure during 
the formation of single-strand breaks. DNA strand breaks can also be caused by exogenous 
factors such as exposure to irradiation [173]. DNA double-strand breaks are proposed to be one 
of the most toxic lesions in DNA. A single double-strand break can be sufficient to kill a cell 
and cause genomic instability [174]. 
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1.5.4.5. Formation of pyrimidine dimers  
Pyrimidine dimers are molecular lesions that are characterized by the covalent cross-linkages 
of two neighbouring pyrimidine residues within a strand of DNA [175]. UV radiation induces 
the formation of two types of photoproducts, namely cyclobutane pyrimidine dimers (CPDs) 
and 6-4 photoproducts (6-4 PPs) [175, 176]. 6-4 PPs are less common but more mutagenic than 
CPDs. Both lesions can distort the DNA structure, disrupt polymerases and thereby impeding 
transcription and replication.  
1.5.4.6. Oxidation of bases  
The continuously generation of ROS as by-products of normal metabolism is one cause of DNA 
oxidation and could be one of the leading contributors to DNA damage under normal conditions. 
DNA oxidation can occur at either sugar units, phosphates and nucleobases [177, 178]. 
Oxidative DNA damage to sugar units generates carbon-centered sugar radicals that further 
react with oxygen and cause the DNA to lose nucleobases or formation of DNA strand breaks 
[178].  ROS attack can also occur at both purine or pyrimidine. For instance, oxidative damage 
of DNA bases at guanine residue [179] can lead to the formation of 8-oxo-7,8-dihydroguanine 
(8-OxoG). Cyclopurine and cyclopyrimidine are formed when both sugar and base of DNA are 
attacked by ROS, this is mainly caused by ionizing radiation or cancer drugs [180, 181].  
Oxidised DNA loses genetic integrity, which can directly or indirectly inhibit normal biological 
functions. Oxidative damage to DNA is associated with ageing [62] and age-dependent diseases 
such as AD [182, 183] and Parkinson’s diseases [184].  
1.6. Ways to cause DNA damage 
1.6.1. Damage by endogenous ROS  
Many types of ROS are produced in vivo during normal metabolism. Of the ROS, the highly 
reactive OH• is considered the main contributor to ROS-mediated damage and can easily react 
with DNA to generate oxidized bases and abasic sites. OH• can also indirectly generate other 
DNA damage products include DNA–DNA intra-strand adducts, DNA strand breaks and 
DNA–protein cross-links [185].  
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1.6.2. Damage from gamma radiation   
Gamma (γ) radiation refers to short wavelength and high frequency electromagnetic radiation 
that has high energy and high penetrating power. γ radiation is harmful to living systems as it 
can readily penetrate most materials. Examples of γ emitters include iodine-131, cesium-137 
and cobalt-60. γ radiation has been shown to cause mtDNA damage. Exposure to γ generates 
ROS with OH• being the major and most damaging product [186, 187]. γ radiation creates a 
variety of DNA damage including generation of single- and double- strand breaks, abasic sites, 
oxidized bases and DNA-proteins crosslinks [188-190]. These DNA lesions can cause 
chromosomal abbreviations, deletions and mutation, which ultimately leads to genome 
instability and cell death [190].   
1.6.3. Damage from Ultraviolet light  
Ultraviolet (UV) light is part of the electromagnetic radiation that has shorter wavelength and 
higher frequency than visible light, thus it is more energetic and damaging. UV light is emitted 
by the sun or specialized lights such as mercury lamps and to some degree by fluorescent lights. 
Based on the amount of energy and wavelength, UV light can be divided into subtypes, of 
which the most common are ultraviolet A (UVA), ultraviolet B (UVB) and ultraviolet C (UVC). 
The shorter the wavelength, the more harmful UV light is to living systems [191]. UVA has a 
longer wavelength (320-400nm) and lower penetrating power. UVA hardly has enough energy 
to cause DNA damage directly [175]. However, UVB, which is in the middle range of UV 
wavelength (280-320nm), carries more energy and is able to cause DNA lesions directly. UVC 
(200-280nm) is blocked by the ozone layer and cannot penetrate through the atmosphere [192]. 
However, UVC is the most energetic and most harmful UV light. UV radiation can cause the 
formation of CPDs predominantly and 6-4 PPs to a lesser extent [193, 194]. Indirectly, exposure 
to UV irradiation can also stimulate intracellular production of ROS, therefore generating more 
DNA damage including 8-OxoG, strand breaks, DNA-protein crosslinks [191, 195, 196].  
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1.6.4. Damage by ROS generating chemicals : paraquat and Juglone  
Both paraquat and juglone are commonly used ROS generating chemicals that are thought to 
be reduced upon entering the cells and therefore produce more ROS from oxygen [63, 197, 
198]. Their main molecular mechanism of toxicity as an electron acceptor is based on redox 
cycling and intracellular oxidative stress generation. Paraquat is a widely used herbicide [198]. 
Several studies have reported paraquat toxicity oxidative stress, modifying DNA bases 
(increase in 8-OxoG formation) and forming DNA strand breaks [198]. Juglone is a natural 
toxic compound that can be found in one type of plant known as Black Walnut [199]. It is being 
used as dye and is also under study as anti-cancer compound [200]. The generation of ROS by 
both paraquat and juglone can trigger DNA damage and act as potential inhibitors of ETC [198, 
201].  
1.7. Age-related mtDNA damage and mitochondrial diseases 
The mFRTA proposed that accumulation of mitochondrial damage is the cause of ageing. 
However, there are many types of macromolecular damage and there is no consensus regarding 
which type of damage, if any, plays the central causal role in driving ageing. I will discuss the 
mtDNA damage in greater detail as this is the focus of my research. There is a large body of 
evidence suggesting that cellular DNA is constantly exposed to endogenous and exogenous 
DNA-damaging agents, and  accumulation of genetic damage has long been suggested to cause 
ageing and mitochondrial diseases [152, 202-204]. The relevance of mtDNA to ageing has been 
suggested by Miquel et al. where they proposed that free radical attack on mtDNA and the inner 
mitochondrial membrane plays a key role in cellular senescence [67]. Numerous studies have 
since demonstrated accumulation of mtDNA damage in an age-dependent manner, for example 
in human brain tissue [205], skeletal muscle [206] and cardiac muscle [207]. In addition, 
oxidative mtDNA lesions were also observed to accumulate in rat and mice [208, 209], 
Drosophila [210] and C.elegans [62]. Some animal models with accelerated mtDNA damage 
accumulation showed premature ageing phenotypes or shorter lifespan. Mice overexpressing 
catalase targeted to mitochondria have less oxidative damage to mtDNA and longer lifespan 
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[211]. These animal studies support the idea that DNA damage or DNA damage consequences 
are involved in ageing [212]. However, in the case of C. elegans, knocking out mitochondrial 
SOD or even sod-2 and sod-3 double knock out mutant, devoid of all mitochondrial SOD 
activity, does not result in the expected lifespan shortening, despite increases in oxidised protein 
[62, 63, 88, 213, 214]. However, to date, no mtDNA damage data was reported in these MnSOD 
mutant nematodes. In another example, deletion of C. elegans peroxisomal catalase shortens 
the lifespan yet the animals surprisingly experience lower oxidative damage to protein [215].  
Animal studies have thus produced conflicting results. Further insight into the importance of 
oxidative damage; particularly mtDNA damage is needed in order to test if mtDNA damage is 
a determinant of ageing.  
Accumulation of mtDNA damage has also been suggested to contribute to the development and 
progression of several diseases such as Alzheimer disease [216, 217], Parkinson’s disease [218], 
diabetes [219], cancer [220] and Huntington’s disease [221]. AD, is the most common age-
dependent neurodegenerative disease [10, 222]. The “Amyloid hypothesis” states that 
accumulation of Aβ is integral to AD pathogenesis. It is believed that the presence of Aβ plays 
a key role in the synaptic damage and neuronal loss that characterises AD [223, 224]. Oxidative 
stress is closely associated with Aβ accumulation and is believed to play a crucial role in AD 
pathogenesis [90, 225-227]. In 1994, Butterfield et al. showed that Aβ peptides can initiate 
neuronal lipid peroxidation [227, 228]. AD patients also suffer from increased levels of lipid 
peroxidation [229], increased formation of advanced glycation end products [230], elevated 
protein nitration [231] and increased levels of oxidative DNA damage markers [205]. 
Apart from directly promoting oxidative damage, there is evidence that Aβ targets the 
mitochondria, causing impairment of ETC complexes, resulting in elevation of ROS production 
[232, 233]. Interestingly, several studies have reported that Aβ is actively imported into 
mitochondria through cellular trafficking systems [232]. Manczak and co-workers showed that 
Aβ readily penetrates the mitochondria and localises to mitoplasts [233], where the ETC 
complexes reside. This localisation is in line with the finding that Aβ inhibits, in particular 
complex IV of the ETC [234, 235]. Indeed, early signs of AD include decreased respiratory 
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chain enzyme activity and reduced mitochondrial membrane potential [236, 237]. In addition, 
Aβ may contribute even further to mitochondrial dysfunction through disruption of 
mitochondrial fusion and fission processes, leading to mitochondrial fragmentation [109]. 
Again, several studies have demonstrated the accumulation of mtDNA damage to be associated 
with age-related mitochondrial diseases [226, 238], therefore, accurate measurement of mtDNA 
damage level is important in the study of ageing.  
1.8. Measurement of Oxidative DNA damage  
Over the years, several techniques have been developed to measure oxidative damage to DNA 
in purified DNA, cultured cells and tissues. Common techniques include [239-241]: 
a) Analytical methods such as high-performance liquid chromatography-electrochemical 
detection (HPLC-ECD), gas chromatography–mass spectrometry (GC-MS), liquid 
chromatography/tandem mass spectrometry (LC-MS/ MS) and liquid 
chromatography/mass spectrometry (LC- MS)  
b) Immunology methods  
c) Fluorescence-based approaches such as Comet assay and Pico green double-stranded 
DNA assay 
d) Radiolabelled probe such as 32P-postlabeling assay 
e) Quantitative PCR-based technique  
In general, each technique has specific advantages and limitations. The analytical methods such 
as HPLC and GCMS are specific to the type of oxidized DNA products that can be detected 
and they may also provide structural information of the DNA adducts. However, one limitation 




Another example, the comet assay, is a sensitive assay that can measure a wide range of DNA 
damage products [243]. However, due to the small size of mtDNA molecules, this assay cannot 
measure DNA damage in mtDNA.   
The radiolabelled probe assay is well known for its high sensitivity. DNA damage 
determination can be carried out by administering a radiolabelled compound to laboratory 
animals and measuring the isotopes ratio.  This assay can detect a broad range of DNA adducts 
and requires only a small amount of DNA sample [241, 244].  
Lastly, the quantitative PCR based methods are highly sensitive and gene-specific assay that 
can be simultaneously used to measure DNA damage in both mitochondria and nuclei. There 
are various PCR-based assays that have been used to study the oxidative DNA damage 
including single-strand ligation PCR strand-specific QPCR, and ligation-mediated PCR [245]. 
I have successfully developed a novel sequence specific DNA damage method based on the 
PCR based techniques. I will discuss this method in greater detail in chapter 3.   
1.8.1. Purpose of developing a sequence-specific DNA damage assay  
The purpose of developing sequence-specific DNA damage assay to detect damaged DNA in 
C. elegans is because  
i. C. elegans are relatively small in size. Therefore, it is difficult to use HPLC method 
that requires relatively large quantities of starting material [242]. 
ii. Only 1 % of the DNA in C. elegans consists of mtDNA. Some assay such as the 
comet assay cannot be used to detect DNA damage in mitochondria as mtDNA 
molecules are too small to be detected and will diffuse away even before 
electrophoresis starts [246]. Physicochemical methods are not suitable for 
mitochondrial ageing in C. elegans as extraction of large enough mtDNA is a 
challenge and also the difficulties in purification of mtDNA from total DNA. 
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1.8.2. PCR-based assays 
The PCR–based assays have been widely used to detect and measure DNA damage and repair, 
such as gene-specific quantitative PCR (qPCR) [245], long qPCR [241], ligation- mediated 
PCR [247], Fpg-qRT-PCR [248], radiolabelled-qPCR [249] and strand-specific qPCR [250]. 
However, some of these methods cannot detect the amplification and the DNA molecules in 
real time. Furthermore, many of these methods are semi-quantitative and only give relative 
comparison of DNA damage level. Although some of the assays can be used quantitatively, 
careful calibration and standardization is required. Moreover, some of these PCR techniques 
required multiple post-PCR processing steps such as quantifying PCR products using 
PicoGreen fluorescent dye [251], using alkaline elution and measurement of DNA fractions by 
fluorometry [245]. Furthermore, PCR products can also be quantified by radiolabelling the PCR 
products and quantification of DNA by gel densitometry [249] or using PCR methods to 
quantify mitochondrial copy number [241] of the PCR  products.  However,multiple pre- or 
post- PCR processing steps are time consuming and tend to reduce signal to background noise 
ratio as multiple processing steps increase the sources of variation that collectively contribute 
to the increased in noise signal. Therefore, careful optimization of these multi-step procedures 
needed to ensure a reliable experimental data.  
1.8.3. Sequence-specific quantitative real time PCR (qRT-PCR) 
Many PCR based DNA damage assays amplify short DNA target. I have compared several 
variations of sequence-specific qRT-PCR based DNA damage assays and optimised a qRT-
PCR based DNA damage assay using amplification of short and long DNA targets to quantify 
DNA damage in C. elegans which I will discuss in greater detail in chapter 3.   
1.9. Animal models of ageing research  
Over the years, scientific advances have provided foundations to generate useful animal models 
to study the ageing process. Various animals have been used to study ageing in the laboratory, 
ranging from birds, mice, flies and worms [252]. The use of animals in ageing research allows 
us to address those conserved (public) mechanisms that apply throughout the animal kingdom 
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[253]. In addition, this approach is the only way to address aspects of human ageing (for 
practical and ethical reasons) that are difficult to study directly in human beings.  For instance, 
longitudinal investigations of ageing usually require monitoring of a group of individuals from 
birth till death. Such ageing research in human beings will take many years, but in worms it 
only takes less than a month. Moreover, laboratory animals allow us to clone many genetically 
identical animals and subject these animals to controlled conditions [252, 254]. However, 
laboratory animals are different from human in many ways. The relevance of laboratory animals 
to the understanding of ageing in human depends on whether the specific functions and 
biological systems studied are appropriate models for human ageing. Some common (public) 
ageing mechanisms might be involved in animals across different phyla although some 
mechanisms are species-specific (private) [255, 256]. Studying ageing in animals from different 
phyla provides insight into how the common mechanisms, such as public ageing mechanisms 
are and in any can be translated into an understanding of human ageing [253, 255]. In my 
projects, I used C. elegans as the model of my research studies for investigating the role of 
DNA damage in ageing.  
1.9.1. C. elegans as a model organism for ageing research 
C. elegans is a small (about 1 mm in length and 80 µm in width) and transparent nematode that 
feeds on bacteria and lives in temperate soil environments. Most C. elegans exist as 
hermaphrodites and only a small percentage occur as male C. elegans. Hermaphrodite C. 
elegans cannot cross-fertilize. One of the advantages of C. elegans in ageing research is their 
short lifespan (mean lifespan of 20 days when cultured at 20 °C), developing rapidly (from egg 
to adult in about 2.5 days) and reproducing through self-fertilization of hermaphrodites 
producing about 300 cloned offspring [257]. Moreover, maintaining C. elegans in the 
laboratory is relatively easy and inexpensive, which further facilitates large scale production, 
genetic manipulation and experimental treatments of nematodes in short period of times. C. 
elegans has a number of features that make it an attractive model for ageing research. It is a 
multicellular organism that goes through complex developmental processes; therefore, it may 
34 
 
resemble more complicated organisms in fundamental ways. Hermaphrodite C. elegans 
contains a constant 959 somatic cells while male C. elegans comprises 1031 somatic cells. It 
has 302 neuronal cells that make it one of the simplest organisms with a nervous system [258]. 
The C. elegans genome carries homologs of about 60-80% of human genes [259], making it an 
attractive organism for modeling human ageing and human diseases [257]. age-1 is the first 
lifespan-extending gene ever identified and was first found in C. elegans [260]. The 
identification of such single gene mutations that can extend lifespan dramatically has shed light 
on fundamental questions relative to ageing. The identification of a single gene mutation, for 
instance, makes it clear that ageing rate is not a consequence of the combination of a large 
number of independent biochemical mechanisms controlled by many genes, as often thought 
previously [252].  
Many human disease genes have orthologs in the genome of C. elegans. Coupled with the 
availability of complete sequences of both genomes, this facilitates investigation of human 
genetic and age-related diseases, including those genes associated with Alzheimer disease [261], 
Parkinson’s disease [262] and Huntington disease [263]. For instance, C. elegans has been 
widely used as the model organism to study AD. One of the pathological hallmarks of AD is 
the accumulation of beta-amyloid (Aβ) peptide that is formed by sequential cleavage of large 
amyloid precursor protein (APP) [264]. It is believed that Aβ plays a key role in the synaptic 
damage and neuronal loss that characterises AD [223, 224]. C. elegans has apl-1, a single gene 
that is related to human APP. Interestingly, overexpression or loss of function of this apl-1 gene 
has deleterious effect on the nematode [265], although C. elegans does not contain β-secretase 
that cleaves APP and produce Aβ peptides [266]. In addition, transgenic C.elegans models of 
AD, overexpressing human Aβ have also been engineered and model the pathological processes 
of AD [261].  
1.10. Pharmacological interventions to modulate DNA damage  
One of the proposed public mechanisms of ageing is the mitochondrial deterioration caused by 
accumulation of ROS-mediated mitochondrial damage [8, 57, 69]. Therefore, there is a 
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considerable interest to develop mitochondrial pharmacological intervention strategies to 
reduce mitochondrial oxidative damage. The main approach is to target compounds to 
mitochondria, in the hope that this may increase lifespan, improve healthspan, decrease 
mitochondrial damage and prevent or delay age-dependent deterioration in mitochondrial 
function and onset of mitochondrial diseases. Targeting compound to mitochondria is 
facilitated by large mitochondrial membrane potential and mitochondrial protein import 
machinery, which can be used to deliver compounds to mitochondria [267].  
 1.10.1. Mitochondria-targeted antioxidants, MitoQ 
Small molecules such as vitamin E, vitamin C and ubiquinone have limited therapeutic success 
as mitochondrial therapies, probably because these compounds are widely distributed within 
the body with only a small percentage of these small molecules are taken up by mitochondria 
[267-270]. However, compound can be targeted specifically to mitochondria. For example, the 
mitochondria-targeted antioxidant, MitoQ (mitoquinone mesylate: [10-(4, 5-dimethoxy-2-
methyl-3, 6-dioxo-1, 4-cycloheexadienlyl) Decyltri-phenylphosphonium methanesulfonate]) 
[271]. MitoQ is a mitochondria-targeted ubiquinol, produced by covalently attaching a 
ubiquinone moiety to the lipophilic decyltriphenylphosphonium (dTPP) cation through a 10-
carbon aliphatic carbon chain (Figure 1.5) [271]. MitoQ selectively absorbs and concentrates 
several hundred-fold in the mitochondrial matrix due to the large mitochondrial membrane 
potential [271-274]. The ubiquinone moiety of MitoQ is then inserted into the lipid bilayer of 
the mitochondrial matrix and rapidly reduced by complex II to ubiquinol, which acts as the 
active antioxidant. This ubiquinol moiety is continuously recycled to the active antioxidant by 
the respiratory chain [271, 275]. MitoQ has been specifically designed with the aim of 
protecting the  mitochondrial membrane against lipid peroxidation [276]. MitoQ is one of the 
best characterised mitochondria-targeted antioxidants and even has been reported to prevent 
cognitive decline and early neuropathology in one study using a transgenic mouse model of AD 
[272]. Exploration of the effects of MitoQ on ROS production and ROS-mediated damage in 
nematodes may provide insight into possible further pharmacological interventions to 
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Figure 1.5.  The chemical structure of MitoQ (top) and dTPP (bottom). MitoQ has two 
main complenents, the ubiquinone derivative that is responsible for the antioxidant capability 




1.11. Hypothesis and objectives  
It is often suggested that the accumulation of free-radical mediated oxidative damage to 
macromolecules, particularly to mtDNA, might be the major cause of ageing.  Therefore, I 
hypothesized that if mtDNA damage is related to ageing, then long-lived species or strains 
should suffer from less mtDNA damage than short-lived species or stains. To test this 
hypothesis, I decided to quantify the levels of mtDNA damage in various strains of C. elegans.  
However, to date, there is no mtDNA damage assay that can reliably measure the level of 
damaged mtDNA in C. elegans. I therefore, developed, tested and optimized a DNA damage 
assay that can measure damaged DNA in mitochondria of C. elegans. With the new method, I 
further investigated and elucidated the role of mtDNA in ageing of C. elegans. Based on the 
above hypothesis, genetic, physical or pharmacological interventions were also performed, 
testing interventions that might modify oxidative damage to mtDNA and thus should modulate 












2. Materials and Methods  
2.1. C. elegans strains used and general maintenance of the nematodes 
In this study, the Bristol N2 (wild type), JK1107 (glp-1), CL2006 (unc-54/Aβ1-42), GA480 
(sod-2/sod-3), OK2040 (mpst-1) and TK22 (mev-1) of C. elegans strains were used. All strains 
(unless otherwise stated) were maintained and cultivated at 20 °C in appropriate incubators on 
nematode growth medium (NGM) agar plates seeded with Escherichia coli (E. coli) strain 
OP50-1 which is a Streptomycin resistant strain of OP50. The JK1107 (glp-1) strain is a 
temperature sensitive mutant that is fertile at 17 ˚C but sterile at 25.5 ˚C, therefore, this strain 
were maintained at 17 °C and cultivated at 25.5 °C on NGM agar plates to prevent progeny. 
All nematode strains as well as the E. coli strain used in this study were obtained from the 
Caenorhabditis Genetics Centre (University of Minnesota, Minneapolis, MN). 
2.2. Preparation of bacterial food source (Escherichia coli (E. coli) OP50-1 strain)  
Using sterile technique, single colonies of E. coli OP50-1 were picked from steak plate agar 
supplemented with Luria-Bertani (LB) agar (5 g Bacto-tryptone, 2.5 g Bacto-yeast, 2.5 g NaCl, 
7.5 g agar and 500 ml of MiliQ water, pH 7.5, sterilized by autoclaving) into 5 ml of LB broth 
(10 g Bacto-tryptone, 5 g Bacto-yeast, 5 g NaCl and 1 L MiliQ water, pH to 7.0, sterilized by 
autoclaving) supplemented with the 5 µl filter sterilized 200 mg/ml streptomycin and grown 
overnight at 37 °C at 220 rpm to generate a starter culture. The starter culture was transferred 
into 1 L LB broth supplemented with 10 ml filter sterilized 200 mg/ml streptomycin and grown 
overnight at 37 °C at 220 rpm. The E. coli were harvested by centrifugation at 5000 g for 10 
min at 4 °C. The E. coli pellets were then re-suspended using sterile M9 buffer (3 g KH2PO4, 6 
g Na2HPO4, 5 g NaCl, 1 ml 1 M MgSO4 and I L MiliQ water, sterilized by autoclaving) and 
concentrated to 1010 cells/ml (at 600 nm, the concentration of bacterial cells at OD600 = 1 is 5 x 
108 cells/ml). The concentrated E. coli solution is then aliquoted, stored at -80 °C freezer and 
can be used to seed the NGM agar plates.  
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2.3. Preparation of NGM petri plates  
Preparation of NGM agar plates was as previously described in [278, 279] and has to be done 
aseptically in a laminar flow cabinet after sterilizing the NGM agar mix.  Briefly, NGM was 
prepared by mixing 1.5 g NaCl, 8.5 g Bacto agar, 1.25 g peptone and 487.5 ml MiliQ water in 
a 500 ml duran bottle. The agar was then autoclaved to melt it and to sterilize it. After 
autoclaving, the agar was cooled to 55 °C in a pre-heated water bath, after which, 500 μl filter 
sterilized 1M CaCl2, 500 μl filter sterilized 1M MgSO4, 500 μl filter sterilized 5 mg/ml 
cholesterol (dissolved in ethanol), 500 μl filter sterilized 200 mg/ml streptomycin, and 12.5 ml 
filter sterilized 1M KPO4 were added and then mixed by swirling. Using sterile procedures, the 
NGM mix solution was dispensed into petri plates using disposable serological pipettes and left 
to solidify. A constant amount of agar was dispensed into each petri plate to reduce the need 
for refocusing the microscope when viewing the worms from one plate to another plate [278, 
279]. NGM agar plates were then seeded with appropriate volume of E. coli OP50-1 liquid 
culture depending on the intended used, the bacterial lawns were then left to dry and store at 4 ° 
C for up to one month.  
2.4. Maintaining age-synchronized animals  
For all experiments, synchronous culture of worms were obtained by hypochlorite treatment of 
gravid nematodes to collect the eggs as described in [278]. I used small scale and large scale 
worm synchronization methods for the egg preparation.  
To prepare small amount of synchronous worms, small scale egg preparation method was used. 
Briefly, the worms on a 94 mm petri plate were washed off the plate with sterile M9 buffer. 
The liquid was collected and 1 ml of liquid was aliquoted into 1.5 ml micro-centrifuge tube. 
Household bleach (5 % solution of sodium hypochlorite) and 5 N NaOH were prepared in ratio 
of 2:1. 430 µl of the freshly prepared bleach and NaOH mix solution was then added into each 
micro-centrifuge tube. The micro-centrifuge tubes containing worms and eggs were vortexed 
for 20 s every 2 min for a total of 10min. The sample was checked under the microscope. The 
incubation in the bleach and NaOH mix can be terminated once all the worms are lysed and the 
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incubation time cannot be more than 10 min. The sample was then subjected to centrifugation 
at 1500 g for 1 min to pellet the released eggs. The egg pellet was washed with 1 ml M9 buffer. 
The washing step was repeated for 3 times. Lastly, the eggs were allowed to hatch and grow on 
NGM plates without any addition of treatment compounds unless otherwise stated. 
To prepare large amount of worms, large scale hypochlorite treatment of gravid nematodes 
protocol was used. Briefly, worms were washed off the plates with M9 buffer, the liquid was 
collected in 15 ml of centrifuge tube and M9 buffer was added to top up the volume to 7ml. 2 
ml of Household bleach (5% solution of sodium hypochlorite) and 1 ml of 5 N NaOH was 
added to the nematodes solution and incubated for up to 10 min at room temperature. The 
mixture was vortexed for 20 s every 2 min. Once all the nematodes were lysed after checking 
under the microscope, the mixture was centrifuged at 2500 g for 1 min at room temperature. 
The pellet containing eggs was washed with 10 ml of M9 buffer and the washing step was 
repeated three times. Lastly, the pellet was re-suspended in 500 µl to 1 ml of M9 buffer and 
eggs were transferred to clean NGM plates seeded with bacterial lawn. The eggs were allowed 
to hatch and grow on NGM plates until further analysis.  
2.5. Preparation and treatment of nematodes with compounds 
2.5.1. MitoQ and dTPP 
Stock solutions of MitoQ and dTPP were prepared by dissolving in deionized water and 
filtered-sterilized before adding into NGM agar or E.coli OP50-1 to the desired final 
concentrations of 0.1, 1 and 5 µM.  Synchronized young adults of transgenic CL 2006 animals 
(Day 4 post-hatching) were transferred and cultured on NGM plates with and without addition 
of treatment compounds till harvesting. 
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2.6. DNA damage induced by gamma and ultraviolet radiation  
2.6.1. Gamma irradiation of worms  
Worms on NGM plates with food were irradiated in Cobalt-60 gamma-ray irradiator with total 
doses of 20 and 40 kRad. Worms were immediately (within an hour) collected and used for the 
appropriate assays after exposing the animals to the desired gamma radiation doses.  
2.6.2. UV irradiation of worms  
Worms were washed off the plates and washed three times with M9 buffer to remove excess 
bacteria. Worm pellets without bacteria were transferred to fresh NGM agar plates without food 
and were evenly spread across the plates to prevent overlapping of worms. CL-1000 ultraviolet 
crosslinker with an emission peak at 254 nm was used to irradiate the nematodes. Worms on 
NGM agar plates without the plates cover were exposed to 400 J/m2 UVC source. Immediately 
after UVC exposure, worms were washed off the plates and immediately (within an hour) 
collected for the appropriate assays.  
2.7. Comet assay  
C. elegans embryonic cells were prepared from eggs isolated from young gravid adults as 
described in [280-282]. Briefly, large quantities of gravid adult worms were used and worms 
were lysed using 5 ml egg isolation solution consisting of 1 ml fresh Chlorox, 0.25 ml 10 N 
NaOH, and 3.75 ml sterile MilliQ water.  The lysis reactions were stopped when 80 % of the 
worms were lysed by adding the egg buffer (118 mM NaCl, 48 mM KCl, 2 mM CaCl2, 2mM 
MgCl2, 25 mM Hepes, pH 7.3, 340 mOsm). The eggs were pelleted by centrifugation at 350 g 
for 5 min, supernatant were discarded and fresh egg buffer was added.  The washing steps were 
repeated for three times. The egg pellet was separated from worms’ debris by flotation on a 
sucrose cushion consisting 2 ml of sterile egg buffer and 2 ml of 60 % sucrose. The suspension 
was centrifuged at 350 g for 3 min. Eggs were then transferred to a sterile 15 ml centrifuge tube 
and washed three times with sterile egg buffer to remove the sucrose.  
42 
 
To prepare the dissociated embryonic cells, 100 µl of 1 U/ml Chitinase in egg buffer were added 
to the egg pellet. The resuspended egg pellet was incubated at room temperature with gentle 
rocking for 20 to 80 min until about 80 % of the egg shells were digested. The egg shell 
digestion reaction was stopped by adding 800 µl of L-15 cell culture medium without phenol 
red (containing 10% (v/v) heat-inactivated fetal bovine serum, 50 U/ml penicillin and 50 mg/ml 
streptomycin). The digested eggs were centrifuged at 900 g for 3 min at 4 °C, supernatant was 
discarded and 800 µl of fresh L-15 cell culture medium was added. Gentle repeated pipetting 
at the side of the Eppendorf tube was done to dissociate the embryonic cells until single cell 
suspension was obtained. The dissociated cell suspension was centrifuged at 900 g for 3 min at 
4 °C and the pellet was resuspended in 500 µ of fresh L-15 cell culture medium. The cell 
suspension was then filtered using an 18 gauge needle to remove the hatched larvae. The cells 
were then centrifuged at 900 g for 3 min at 4 °C and resuspended in appropriate volume of L-
15 cell culture medium depending on the cells density. The cell suspension was plated onto 
four-well Lab-Tek  II - CC2 chamber slide (Nunc, Thermo Fisher Scientific Inc) and kept in a 
humidified incubator at 22 °C overnight for cell differentiation.   
After 24 hours, the degree of DNA damage was determined using the alkaline comet assay 
according to [282, 283]. Microscope slides were precoated with a layer of 1 % normal melting 
temperature agarose and air-dried at room temperature.  The agarose precoated microscope 
slides were then stored with desiccant. 100 µl of 0.5 % low melting point agarose were added 
onto the center of the precoated microscope slide. Immediately, microscope slides with the 
cultured embryonic cells were left to cool. The microscope slide with cells was slipped out and 
cells were left in agarose. 1.2 ml of 1 % low melting point agarose was added on top of the first 
layer of agarose. The microscope slides were allowed to solidify for 2 min on an ice-cooled 
tray. After the agarose has gelled, the microscope slides were immersed in a covered container 
containing ice-cold alkaline lysing solution (1.2 M NaCl, 100 mM EDTA, 0.1 % sodium 
dodecyl sulfate (SDS), 0.26 M NaOH, pH > 13) for at least one hour or overnight at 4 °C in the 
dark. After lysis, the microscope slides were removed from lysing solution and were place in a 
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horizontal gel electrophoresis chamber filled with electrophoretic buffer (300 mM of NaOH 
and 1 mM of EDTA, pH>13) for one hour at room temperature. Electrophoresis was conducted 
at 25 V and 300 mA for 10 min in a chamber cooled on ice. Following electrophoresis at 4 °C, 
the slides were rinsed twice with neutralization solution (400 mM Tris, pH 7.5) and dried at 
room temperature. Prior to scoring, the slides were then stained with 300 µl of 10000 x diluted 
SYBR Green I (Molecular Probes, Invitrogen Inc) and placed at 4 °C until slides analysis. To 
observe the comets, the microscope slides were examined using confocal fluorescence 
microscope (LSM 510 Carl Zeiss, Jena, Germany). At least 300 randomly selected cells were 
analyzed and the extent of DNA migration was determined using image analysis software, 
CometScore (TriTek Corp, USA).  
2.8. mtDNA copy number    
MtDNA copy number as was quantified as previously described in [161, 284]. Briefly, 
individual worms were picked from the stock plate into PCR tubes containing 50 µl of ice-cold 
worm lysis buffer (50 mM KCl, 2.5 mM MgCl2, 10 mM Tris-HCl, 0.01 % Gelatin, 0.45 % 
Tween-20, 0.45 % Nonidet P-40, 100 µg/ml freshly added Proteinase K).  The worms were 
subjected to three times of freeze-thaw cycles at -80 °C. The worms were then incubated at 
60°C for 1 hour and followed by 10 min incubation at 95°C to inactivate the Proteinase K. 
Samples were stored at -80 °C until further analysis.  
mtDNA copy number of individual nematodes was determined by quantitative real-time PCR 
(qRT-PCR) amplifying a 71 bp region of the mitochondrial genome using the worm lysate as 
the source of DNA template and the mtDNA (short fragment) primers and probe (F1: 5’- GAG 
CGT CAT TTA TTG GGA AGA AGA-3’ (nucleotides 1838-1861 mtDNA); R1:5’- TGT GCT 
AAT CCC ATA AAT GTA ACC TT-3’ (nucleotides 1883-1908 mtDNA)  and P1:5’- FAM-
AAA ATC GTC TAG GGC CCA C-3’(nucleotides 1863-1881 mtDNA)). The probe was 
labeled with a specific reporter (FAM-labeled) and has non-fluorescent quencher (MGB Probes) 
(Applied Biosystems).  This assay was performed using a reference sample of known copy 
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number (quantified by serial dilution generating actual rather than relative copy numbers). A 
serial of ten-fold dilutions of the worm lysate of the reference sample were used.      
qRT-PCR amplification was performed in 20 µl reactions containing 1 µl of worm extract, 10 
µl of 10X TaqMan Universal PCR Master Mix (Applied Biosystems),  0.18 µl of 100 µM each 
primers,  1 µl of 20 µM probe and 7.64 µl of nuclease free water.  PCR was carried out in 
StepOne Plus™ Real-Time PCR System, under the following cycling conditions: 2 min at 50 ° 
C, 10 min at 95 °C, 50 cycles of 15 s at 95 °C and 60 s at 60°C. Fluorescence intensity data 
were collected at the annealing stage (60 °C). At least three non-template-controls were 
included with each experiment. The copy number of the samples was determined by comparing 
the amplification Ct value of the samples to the Ct value of the reference sample with known 
copy number.  
2.9. Mitochondrial DNA extraction for qRT-PCR 
mtDNA was extracted as previously described in [150] with several modifications. To isolate 
mtDNA, relatively large batches (about 5,000 to 10,000) of nematodes were used. Briefly, 
worms were washed off the plates with ice-cold S-basal buffer (100.1 mM NaCl, 5.7 mM 
K2HPO4, 44.1 mM KH2PO4, 0.01 mM cholesterol) for three-times. The worms were then 
washed twice with ice-cold isolation buffer (210 mM mannitol, 70 mM sucrose, 0.1 mM EDTA, 
5 mM Tris-HCl, pH 7.4). Animals were collected and homogenized in isolation buffer using a 
Teflon-glass homogenizer. Debris and nuclei were removed from the homogenate by 
differential centrifugation at 600 g for 10 min at 4 °C. The pellet was discarded and supernatant 
containing mitochondria was further centrifuged at 7200 g for 10 min at 4 °C to obtain 
mitochondrial pellet. The pellet was resuspended in Tris-EDTA buffer (50 mM Tris-HCl, 0.1 
mM EDTA, pH 7.4). DNA from crude mitochondria was purified using Prepman Ultra Sample 
Preparation Reagent (Applied Biosystems), according to the manufacturer’s protocol.  
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2.10. Amplification factor determination  
Amplification factor was determined for each primer sets used for mtDNA damage assay. Ten-
fold serial dilutions of mtDNA extract ranging from no dilution to 106 X dilutions were used to 
construct the standard curve for amplification factor determination.   
For short PCR fragments (up to 300 bp), the qRT-PCR was performed using FAM-labelled dye 
in StepOne Plus™ Real-Time PCR system. The qRT-PCR amplification was performed in a 25 
µl reaction similar to the reactions set up and PCR cycling conditions for S-qRT-PCR that 
mentioned below.  
For long PCR fragments, the qRT-PCR was performed using SYBR Green I nucleic acid gel 
stain dye in StepOne Plus™ Real-Time PCR system. The qRT-PCR amplification was 
performed in a 25 µl reaction similar to the reactions set up and PCR cycling conditions for S-
qRT-PCR that mentioned below. 
The difference in the ΔCt was used to construct the standard curve which was used for 
determination of amplification factor for the respective primers set used.  
2.11. Formamidopyrimidine DNA glycosylase (Fpg) Fpg-qRT-PCR assay 
Following mtDNA extraction and purification, mtDNA was diluted five-fold with nuclease free 
water. For Fpg digest and undigested sample, 20 µl of diluted mtDNA was digested with 0.5 µl 
of 8 U/µl Fpg enzyme (New England Biolabs), incubated in 4 µl of 10 X NE buffer 1, 0.4 µl of 
1 mg/ml bovine serum albumin (BSA, New England Biolabs) in a total volume of 40 µl. A 
mock (omitting enzyme) digest sample, same volume (20 µl) of diluted mtDNA was incubated 
with 4 µl of 10 X NE buffer 1 and 0.4 µl of 1 mg/ml BSA without the addition of Fpg enzyme 
in a total volume of 40 µl reaction. The Fpg digest and mock digest sample with the exception 
of undigested sample, were incubated at 37 ˚C for 2 h, followed by “boosting” with additional 
4 µl of 1.2 U/µl Fpg enzyme in 1X NE Buffer 1 for another 2 h at 37 ˚C. For mock digest 
sample, 4 µl of 1 X NE buffer 1 was added during the “boosting” instead of Fpg enzyme. 
Undigested mtDNA sample was incubated at 4 ˚C throughout. Fpg enzyme was then heat 
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inactivated at 60 ˚C for 10 min. This was carried out in parallel for each sample. All samples 
were then cooled at 4 °C for 5 minutes and immediately used for qRT-PCR or stored at –20 ˚C 
until further analysis.  
qRT-PCR reaction was performed on ABI StepOne Plus™ Real-Time PCR System in 
MicroAmp optical 96-well reaction plates. The qRT-PCR was conducted using double strand 
DNA binding dye (SYBR Green I nucleic acid gel stain, Life Technologies, Thermofisher 
Scientific Inc). qRT-PCR amplification was performed in 25 µl reactions containing : 4.1 µl of 
nuclease-free water (Promega, Fitchburg, Wisconsin, USA), 7.5 µl of 3.3 X XL Buffer II, 2 µl 
of GeneAmp 10 mM dNTP Blend , 1 µl of 10 µM each primer (1st BASE, Singapore), 0.4 µl 
of 25 mM Mg(OAc)2 Solution, 2.5 µl of 1 mg/ml BSA (New England Biolabs), 4 µl of 0.25 
U/µl rTth XL DNA polymerase , 0.5 µl of 10 X SYBR Green I nucleic acid gel stain and 2 µl 
sample (fpg ,mock digest or undigested mtDNA) or nuclease-free water  for Non-template-
control.  
The qRT-PCR was assessed in a 6.3 kbp region of the mitochondrial genome with primer 
sequences based on [285]. Long fragment primers: forward primer: (5’-3’) TCG CTT TTA 
TTA CTC TAT ATG AGC G (nucleotides 1818-1842 mtDNA) whereas, reverse primer: (5’-
3’) TCA GTT ACC AAA ACC ACC GAT T (nucleotides 8111-8090 mtDNA). The qRT-PCR 
cycling profile was an initial denaturation at 94 °C for 2 min, followed by 60 cycles at 93 °C 
for 10 s, 62 °C for 10 min, and 68 °C for 30 s, ending with a final extension at 68 °C for 30 min. 
Fluorescence intensity data were collected at the annealing stage (60 °C). At least three well 
replicates were performed for the qRT-PCR amplification.  
2.12. Sequence-specific mitochondrial DNA damage (S-XL-qRT-PCR)  
Following mtDNA extraction and purification, mtDNA of one of the samples (reference sample) 
was used to quantify the mtDNA copy number using the mtDNA copy number quantification 
method as mentioned above.  
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After determining the mtDNA copy number of the reference sample, mtDNA damage was 
assesed using two independent qRT-PCRs: S-qRT-PCR and XL-qRT-PCR, which were 
performed on the same day.   
For S-qRT-PCR, PCR reaction was performed on ABI StepOne Plus™ Real-Time PCR System 
in MicroAmp optical 96-well reaction plates. The qRT-PCR was conducted using short 
fragment primers and FAM-labelled Taqman probe as mentioned above in a 71 bp 
mitochondrial region. qRT-PCR amplification was performed in 25 µl reactions containing: 
9.79 µl of nuclease-free water (Promega, Fitchburg, Wisconsin, USA), 12.5 µl of 10X TaqMan 
Universal PCR Master Mix (Applied Biosystems), 0.23 µl of 100 µM each primers, 1.25 µl of 
5 µM probe and 1 µl of mtDNA extract.  At least three wells were run for each sample and 
reference sample. Non-template control (nuclease free water only to replace the mtDNA extract) 
was added into each PCR reaction. PCR was carried out under the following cycling conditions: 
2 min at 50 °C, 10 min at 95 °C, 50 cycles of 15 s at 95 °C and 60 s at 60°C. Fluorescence 
intensity data was collected at the annealing stage (60 °C).  
For XL-qRT-PCR, qRT-PCR was performed using GeneAMP XL PCR kit (applied Biosystems) 
based on the protocol in [62].  The PCR reaction was also performed on the same ABI StepOne 
Plus™ Real-Time PCR System in MicroAmp optical 96-well reaction plates. The qRT-PCR 
was conducted using long fragment primers and SYBR Green I nucleic acid gel stain as 
mentioned above in a 6.3 kbp mitochondrial region. qRT-PCR amplification was performed in 
25 µl reactions containing: 4.3 µl of nuclease-free water (Promega, Fitchburg, Wisconsin, 
USA), 7.5 µl of 3.3 X XL Buffer II, 2 µl of GeneAmp 10 mM dNTP Blend , 1 µl of 10 µM 
each primer (1st BASE, Singapore), 1.2 µl of 25 mM Mg(OAc)2 Solution, 2.5 µl of 1 mg/ml 
BSA (New England Biolabs), 4 µl of 0.25 U/µl rTth XL DNA polymerase , 0.5 µl of 10 X 
SYBR Green I nucleic acid gel stain and 1 µl mtDNA sample or nuclease-free water  for Non-
template-control.  At least three wells were run for each sample and reference sample. Non-
template control (water only to replace the mtDNA extract) was added into each PCR reaction. 
PCR was carried out under the following cycling conditions: 2 min at 94 °C, followed by 60 
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cycles of 10 s at 93 °C , 10 min at 62 °C, and 30 s at 68 °C, ending with a final extension of 30 
min at 68 °C. Fluorescence intensity data was collected at the annealing stage (60 °C). 
mtDNA copy number for each sample in both PCRs, S-qRT-PCR and XL-qRT-PCR was 
determined based on the mtDNA copy number of the reference sample. The mtDNA copy 
number was then used for the quantification of mtDNA lesions for the particular samples.  
2.13. Blinded lifespan study  
Lifespan and healthspan of C. elegans were performed under blinded conditions to eliminate 
the effect of experimental bias [286]. A total initial population of 200 worms was tested for 
each treatment condition. Using a platinum wire worm pick, Day 3 (post-hatching) age-
synchronised nematodes were picked from the culture plate and loaded onto the lifespan plates.  
Worms were counted and transferred to fresh plates every 2 days till post egg-laying period to 
prevent contamination by progeny and also to prevent starvation. Worms were scored as alive, 
dead or lost. Worms that failed to respond to mechanical prodding were scored as dead and 
removed from the plates. Animals that crawled off the plates and died away from the agar on 
the sides of the plate were censored from the study.  
2.14. Blinded healthspan study 
For healthspan study, the same batches of worms from the lifespan studies were scored 
concurrently for locomotor activity following the scoring framework reported by Herndon 
[287]. Briefly, all other strain of nematodes were subdivided into three groups: Class “A”, “B” 
and “C” except the CL2006 animals that were subdivided into 2 classes, class “A” and “C”,  
due to the nature of their movement where they rotate around the longitudinal axis and move 
in a circular path.  
With the exception of CL2006 animals, animals in class “A” were healthy, highly mobile, 
showed spontaneous movement, left sinusoidal tracks in the bacterial lawn through which they 
migrated. Animals in class “B” only moved in respond to prodding, left tracks that were non-
sinusoidal, reflecting uncoordinated locomotion. Class “C” animals did not move forward or 
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backward when prodded but the movement was restricted to the head and/or tail when gently 
touched.  
As for CL2006 animals, class “A” animals were healthy, highly mobile, showed constant 
movement and rotated around its longitudinal axis. Whereas, class “C” animals did not move 
the body in response to prodding but only showed head and/or tail movement.  
2.15. Relative distance travelled 
The relative distance travelled by the nematodes was measured and analysed under blinded to 
the treatment conditions and samples were randomized. Ten to twenty nematodes were used 
for each biological repeat for this experiment and the experiment was repeated three times.  
Briefly, 35 mm petri dishes filled with NGM agar, seeded with 200 µl of OP50-1 at the centre 
of the plates were used. A marking just at the border of the bacterial lawn was marked to signify 
the starting point of distance to be travelled of which the worm will be loaded on the marking.  
Using a platinum worm pick, individual nematodes were transferred onto the marking on the 
plate and allowed to travel for 15 min. Nematodes were removed and the whole of the 35 mm 
NGM agar plates was captured in a single photograph using a calibrated Leica MZ10F 
microscope (Leica, Singapore). Distance travelled by the nematodes was measured using the 
line tool provided by the Leica Application Suite software (v2.6.0 R1).  
2.16. Reactive oxygen species (ROS) measurement in C. elegans  
General ROS production in whole animal was measured using 2, 7-dichlorofluorescein 
diacetate (DCFDA) (Sigma-Aldrich, St. Louis, USA) as previously described [62, 288]. 100 
worms were transferred into each well of a black 96-well microtiter plate containing 100 µl of 
M9 buffer. To each well, 100 µl of 100 µM DCFDA dissolved in M9 buffer was added. ROS 
associated fluorescence levels were read kinetically every 2 minutes for 14 hours using a 
fluorescence plate reader (SpectraMax Gemini EM, Molecular Devices) at excitation 485 nm 
and emission 520 nm at room temperature. All samples were normalised to bacterial control in 
50 
 
separate wells on the same plate. At least four samples per condition were used and this 
experiment was repeated three times.  
2.17. Protein carbonyl content (PCC) determination  
Protein carbonyl determination was conducted as previously described in [289]. 200 worms 
were initially transferred from NGM agar plates into micro-centrifuge tubes containing 1 ml of 
M9 buffer. Samples were centrifuged at 400 g for 2 min at 4 °C. Supernatants were removed 
and 1 ml of M9 buffer was added into each tube. Samples were washed three times to remove 
bacteria and debris. Worm pellets were re-suspended in 100 µl PBS-T lysis buffer (0.1 % 
Tween-20 in phosphate-buffered saline solution (PBS) containing 1 mM phenylmethylsulfonyl 
fluoride protease inhibitor (PMSF) and 50 mM of dithiothreitol (DTT)). These sample were 
then sonicated on ice at 50 % amplitude for 2 min of 20 pulses of 5 s each, within 1 s between 
pulses.  
The lysates were then centrifuged at 15,000 g for 5 min at 4 °C. The soluble protein 
concentrations of the lysates were determined using Bradford Protein Assay (Bio-Rad 
Laboratories, USA).  A two-fold serial dilution of 2 mg/ml bovine serum albumin (BSA) with 
lysis buffer was used to generate a series of standards.  The BioRad dye reagent was diluted 
four times with de-ionized water. 10 µl of samples or standards per well were pipetted into each 
well of a 96 well plate in triplicate. 200 µl of diluted dye reagent was added into each well and 
samples were incubated for 20 min at room temperature with gentle shaking at 60 rpm. Protein 
concentration was measured using a TECAN luminometer at 595 nm.  
For each sample, 2 µg of protein (diluted to a final volume of 5 µl) was derivatised according 
to manufacturer’s protocol (OxyBlot Protein Oxidation Detection Kit).  To each sample, 5 µl 
of 12 % sodium dodecyl sulphate (SDS) was added to denature the protein. 10 µl of 20 mM 2, 
4-dinitrophenylhydrazine (DNPH) or 1 x derivatisation control solution was then added to the 
samples or control samples respectively. After 15 min incubation at room temperature to 
51 
 
derivatise the samples, 7.5 µl of neutralisation solution containing 2 M Tris and 30 % glycerol 
was added to stop the reaction.  
The Bio-Dot SF Microfiltration apparatus from BioRad was assembled with filter papers and 
nitrocellulose membrane according to the instructions from the manufacturer. 25 µl or a total 
of 2 µg of derivatised samples were loaded into each well of the slot blot apparatus. Vacuum 
pressure was used to transfer the proteins onto the nitrocellulose membrane assembled in the 
slot blot apparatus. The membranes were incubated with blocking buffer (1 x PBS solution 
containing 1 % BSA and 0.05 % Tween-20) for 1 hr at room temperature to prevent non-specific 
antibody binding. The blocked membrane was then probed with anti-DNPH primary antibody 
(1:150) diluted with blocking buffer for 1 hr at room temperature with gentle shaking, followed 
by three washes in 1 x PBS.  The membrane was then subjected to secondary detection for 1 hr 
at room temperature with an anti-rabbit HRP conjugated IgG antibody (1:300) diluted with 
blocking buffer. Antibody-bound proteins were detected by chemiluminescence using 
SuperSignal West Dura Eextended duration chemiluminescence substrate mixture (Pierce 
Biotechnology, Thermo Fisher Scientific Inc., USA). Images were taken using BioRad 
ChemiDoc XRS system and analysed using Image J.  This experiment was repeated five times.  
2.18. Adenosine-5’-triphosphate (ATP) measurement 
 The ATP assay was performed as previously described in [62]. 100 worms were collected in 
microcentrifuge tubes containing 1 ml M9 buffer. Worms were incubated at room temperature 
for 30 min to allow the nematodes to digest and clear the bacteria in the gut. The worms were 
then subjected to low speed centrifugation at 400 g for 2 min at 4 °C followed by removal of 
the supernatant. 1 ml of M9 buffer was then added to the tube. The samples were washed three 
times to remove bacteria and debris. Tubes containing worm pellet were immediately immersed 
in liquid nitrogen and stored at -80 °C until further analysis.  
For each measurement, 50 µl of ice-cold 10% trichloroacetic acid (TAC) was added. The re-
suspended worms were immediately sonicated in a water bath sonicator (SONICLEAN, 
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Thebarton) for 5 min on ice and tubes were allowed to stand on ice for an additional 15 min. 
Samples were then centrifuged at 15,000 g for 5 min at 4 °C to pellet the debris. 45 µl of 
supernatant from two samples of the same condition were pooled together into a clean 
microcentrifuge tube.  
5 µl of serial dilutions ATP standard and 5 µl of pooled samples were pipetted into the wells of 
a white 96 well microtiter plate held on ice. 150 µl of freshly prepared arsenite ATP buffer (80 
mM MgSO4, 10 mM KH2PO4 and 100 mM Na2HASO4 in a ratio of 1:1:1, pH 7.4) was added 
to each well. ATP levels were measured using a TECAN luminometer (Infinite 200, Tecan) 
pre-programmed to inject 45 µl of freshly prepared 2 mg/ml firefly lantern extract into each 
well. The luminescence signal was integrated for 10 s. This experiment was repeated three times.  
2.19. Oxygen consumption measurement  
Oxygen consumption for whole C. elegans was assayed using a Clark-type electrode 
(Hansatech oxygen electrode, Hansatech Instruments) as previously described [62]. Briefly, 
worms (approximately 1000 worms) were washed off a 94 mm plate into a 15 ml centrifuge 
tube. Excess M9 buffer was removed leaving 1 ml of M9 buffer in the tube. Worms in 1 ml M9 
buffer were placed in the chamber of the Clark-type electrode. The amount of oxygen consumed 
was monitored polarographically for 2-15 minutes. Worms in the chamber of the Clark-type 
electrode were transferred to a clean micro-centrifuge tube and allowed to settle for 5 min. 900 
µl of M9 buffer without any worms was transferred back to the electrode chamber to measure 
the oxygen consumption rate of the bacteria in the M9 buffer. The oxygen consumption rate of 
the worms was corrected against changes in oxygen concentration of the bacterial control. The 
worms were kept at -80 °C until further protein concentration analysis. The protein 
concentration of the worms was measured using Dc-protein assay kit (Bio-Rad, Hercules, USA). 
Final oxygen consumption rates were normalised to protein concentration.  This experiment 
was repeated three times.  
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2.20. Isolation of mitochondria for ETC enzymatic activity  
About 10,000 worms were washed off the plate and collected into a microcentrifuge tube with 
1 ml of medium containing 250 mM sucrose, 20 mM Hepes, 10 mM KCl, 1.5 mM MgCl2, 1 
mM EDTA and 1 mM EGTA, pH 7.4. Worms were then homogenised using a hand-held glass 
pestle and transferred to a microcentrifuge tube.  Homogenised worms were then centrifuged 
at 800 g for 10 min and the supernatant was transferred to a new microcentrifuge tube. The 
supernatant was then centrifuged at 14,000 g for 15 min. The supernatant was removed and the 
pellet was resuspended in the same medium used to wash and homogenise the worms. The 
resuspended pellet was used immediately for the measurement of ETC enzymatic activity.  
2.21. Measurement of complex IV (cytochrome c oxidase) activity of ETC 
Mitochondria were isolated as described previously[290]. Complex IV activity was measured 
using a polarographic assay modified from [291] and normalised to mtDNA copy number 
according to [62]. The assay was started by adding sequentially 65-70 µg of reduced 
cytochrome c in Mir05 buffer, 10 µg of mitochondrial protein and 5 mM azide. A high-
resolution respiratory system (Oroboros, Oxygraph-2k) was used. 
2.22. Measurement of complex I (NADH dehydrogenase) activity of ETC 
Isolation of the mitochondria was carried out as previously described [290]. The enzyme 
activity of complex I was measured by a decrease in fluorescence of NADH at Ex/Em: 352 
nm/464 nm using decylubiquinone as an electron acceptor [292] and normalised to mtDNA 
copy number according to [62]. Mitochondrial protein (10 µg) was added to a respiratory buffer 
of pH 7.2 containing 25 mM KH2PO4, 2 mM NaN3, 5 mM MgCl2, 64 mM decylubiquinone, 2 
mg/ml albumin and 25 mM NADH. Complex I activity was determined from the difference in 
NADH oxidation before and after rotenone inhibition. 
2.23. Analysis of lipids using high performance liquid chromatography mass 
spectrometry (LCMS) 
Lipid extraction was performed with modification from the Bligh and Dryer double chloroform 
extraction method [293]. Lipid analysis was performed according to [62]. Briefly, worms were 
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homogenised in chloroform:methanol (1:2; v/v) and incubated on ice with agitation for 2 h. 
Following incubation, ice-cold chloroform and ice-cold water were added and the first extract 
was collected from the lower organic layer. Ice-cold chloroform was added for re-extraction. 
The lower organic extracts were pooled and dried under a stream of N2 and stored at -80 °C. 
Lipid species were identified and quantified using a high performance liquid chromatography 
(HPLC) 1200 system coupled with an Applied Biosystem Triple Quadrupole/Ion Trap mass 
spectrometer (3200 QTrap). Lipids were quantified using spiked internal standards. PC-
14:0/14:0, PE-14:0/14:0, CL-15:0(3)/16:1 and C12-SM standards were obtained from Avanti 
Polar Lipids (Alabaster, AL, USA) 
2.24. Statistical analysis 
For statistical analysis, GraphPad Prism version 5.02 for Microsoft Windows, GraphPad 
Software, SanDiego, (USA) was used. Lifespan and healthspan curves were analysed by 
plotting Kaplan–Meier survival curves and conducting Log-rank tests. All other data were 
plotted as means±SEM, analysed using ANOVA and Bonferroni’s multiple comparisons post-









3. Results  
3.1. Selection of a good assay  
A good assay is critical in determining DNA damage. Many factors can affect the validity of a 
good assay. Essential criteria for what constitutes a good assay are accuracy, precision, 
sensitivity and robustness. Accuracy is the extent to which a value obtained from several 
replicates is found to agree with the reference value or true value if one is available (Figure 3.1).  
Thus, an accurate assay is free from experimental bias [294].  However, the wide range of basal 
DNA damage levels reported in the literature using a wide selection of methodologies makes 
this difficult to achieve as no true reference value exists [168].  
Precision is another important factor that has to be considered in validating an assay. Precision 
is the measurement of deviation around the mean value [294] (Figure 3.1).  Precision affects 
both reproducibility and repeatability. The European Standards Committee for Oxidative DNA 
Damage (ESCODD) was set up in 1997 to reach an agreement on the normal DNA damage 
level in human cells [295]. ESCODD has stated that the methods used to measure DNA damage 
should have low coefficient of variation, ideally less than 5 % [295].  
The third criterion for a good assay is sensitivity. To test the sensitivity of the DNA damage 
assay, I tested the ability of the assay to detect increases in DNA lesions by introducing artificial 
DNA damage using γ- and UV-radiation. Failure to detect these increases in DNA damage 
implies insufficient sensitivity of the assay.  
Lastly, the robustness of an assay is characterized by its ability to resist changes in assay/sample 
conditions and to remain unaffected by variations in parameters of the experimental set up. The 
robustness of an assay also affects repeatability. Robustness allows an assay to work well even 
if samples have lower purity, primers, fluorescence dyes and tubes/plates quality vary or if 























Figure 3.1. Accuracy vs. precision. The diagram shows the difference between precision and 
accuracy. Accuracy of a measurement or the correctness of the measurement is the amount by 
which the measurement deviates from the actual value. Whereas, precision is the measurement 











3.2. Comet assay  
3.2.1. Principle of comet assay 
I first explored a well-established assay for DNA damage in nuclear DNA called the comet 
assay. DNA damage assessment by comet measurement is a versatile and sensitive microscopic 
fluorescence method for quantification and analysis of damaged DNA at the level of individual 
cells. The comet assay (also known as single cell gel electrophoresis) is widely used as a reliable 
tool for assessing DNA damage and repair in samples ranging from bacteria, Drosophila and 
nematodes to human tissues [283, 296-298]. Hence, I used the comet assay to calibrate the 
gamma-radiation challenge used (to introduce additional DNA damage) and to compare the 
sensitivity of the comet assay to the sequence specific DNA damage assay that I utilized in my 
project (See section 3.3.3). 
The comet assay (Figure 3.2) is performed on single cells embedded in a thin agarose gel on a 
microscope slide. The cell is subjected to gentle lysis with detergent to remove lipids and 
proteins. The lysed cell is then treated with alkaline solution to unwind and denature the DNA. 
Following the DNA unwinding, samples are subjected to alkaline electrophoresis, stained with 
DNA intercalating dye and viewed using a fluorescence microscope. During the electrophoresis, 
fragmented DNA is drawn towards the anode. Undamaged DNA remains supercoiled, thus the 
large DNA strands do not leave the cavity of the nucleus when the electric field is applied, 
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Figure 3.2. Schematic diagram of the comet assay protocol.  C. elegans embryos were isolated from gravid adults, eggshells were digested by 
incubation in Chitinase. Dissociated embryonic cells were embedded on agarose-coated slides and subjected to gentle cell lysis with lysis buffer 
containing detergent and salts at high concentration. The cells on the slides were left in the alkaline electrophoresis buffer to allow unwinding of 




By contrast, in damaged DNA, the DNA organization with matrix proteins in the nucleus is 
disrupted, causing the DNA to lose its compact structure. When an electric field is applied, 
damaged DNA therefore expands out from the nucleoid “head” forming a “tail”, resulting in a 
comet-like appearance. The comet “head” contains intact, undamaged ( high molecular weight) 
DNA and the migrated, damaged ( low molecular weight) DNA fragments form the comet “tail” 
[283] (Figure 3.3B). Excessive DNA damage causes large numbers of DNA strand breaks and 
therefore results in much smaller DNA fragments which will move faster and migrate farther 
in the comet tail. Therefore, the measurement of DNA damage is based on the amount of DNA 
in the comet tail relative to the comet head. Features of the comet tail such as the size, shape 
and distribution of DNA can all be used as qualitative indicators for the DNA damage in the 
particular sample [299]. In general, the brighter and the longer the comet tail, the greater the 
DNA damage.  
The comet assay can be modified for use to detect various types of DNA damage, depending 
on the assay conditions. The neutral comet assay was the first to be developed and mainly 
detects DNA double strand breaks [300]. Later this assay was modified by using alkaline 
conditions during lysis to allow measurement of  both double and single strand breaks [301]. 
Although the comet assay was primarily developed to detect DNA strand breaks, it can also be 
modified to detect oxidative DNA damage. This is achieved by introducing damage-specific 
repair enzymes such as endonuclease III and Fpg following the lysis of cells. These repair 
enzymes initiate DNA repair by excising damaged bases, thereby introducing strand breaks at 
the sites of damaged DNA. This approach makes it possible to detect oxidized bases using 



























   
A. undamaged cell: Halo-like appearance 
 
 
   












Figure 3.3. Typical comet images of wild type N2 C. elegans embryonic cells obtained from 
(A) untreated control animals (undamaged DNA sample) and (B) C. elegans exposed to 40 
kRad γ-radiation (damaged DNA sample) from alkaline single-cell gel electrophoresis 
stained with Sybr Green I dye.  (A) In undamaged cells typically, the DNA remains intact 
within the highly organized structure and is confined to the nucleus when a current is applied, 
resulting a halo-like structure. (B) When DNA is damaged, the relaxed DNA expands out from 
the nucleoid and is drawn towards the anode, resulting in a structure that resembles a comet 
with a head composed of intact undamaged DNA and a tail that consists of damaged /broken 




In order to quantify the amount of DNA within the comet tail, which correlates to the extent of 
DNA damage, two approaches can be used; either semi-quantitative visual inspection or 
computer-based analysis [246, 303]. Typically, in the visual scoring approach, comets are 
assigned to one of five categories according to subjective comet appearance, with 0 representing 
undamaged cells (comets with no or barely detectable tails) and 4 representing damaged cells 
with high tail intensity (almost all DNA in tail). Although this visual scoring approach is fast 
and simple, allowing significant DNA damage to be quantified without the use of sophisticated 
image analysis software, there are limitations to using this approach: the comets must be 
selected without bias (scorers need to be blinded to the experimental conditions), visual scoring 
does not provide true quantification information of the DNA damage but only produces a score 
in arbitrary units, and there is high inter-personal variability of DNA damage levels between 
scorers. Therefore, the results obtained using the visual scoring approach can be difficult to 
interpret and typically are not comparable between experimental set ups, scorers and 
laboratories [246, 296].  
A better approach, and the one that I used to quantify the DNA damage level, is computer-
based analysis. There are a few comet parameters that are commonly used to evaluate the degree 
of damage including percentage of DNA in tail (measure of relative fluorescence intensity of 
head and tail), percentage of DNA in head, tail length ( total distance of damaged DNA 
migration), and tail moment (the product of tail length and percentage of DNA in tail, which 
takes into consideration both the migration of DNA and the amount of DNA in tail) [283]. The 
percent of DNA in the tail may be a good parameter to quantify DNA damage levels as it has 
been shown to be linearly related to DNA damage frequency [304]. It has been shown that in 
some cell types, the percentage of DNA in the tail increases with increasing dose of genotoxins 
but other parameters such as tail length do not show clear linear correlation with the dosage of 
the genotoxins [246, 303]. Another parameter, the tail length is only informative when the 
damage level is very low. It has been reported that when the damage level is high, tail length is 
not informative as the comet tail’s intensity increases with higher damaged DNA but not the 
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tail length [246, 303]. Lastly, the tail moment has been suggested to be a sensitive parameter 
but it is not linear with respect to dose increase in DNA damage [246, 303].  
3.2.2. Validation of comet assay  
The comet assay was first tested using embryonic cells from control C. elegans. The method 
used to quantify the DNA damage in individual embryonic cells is the computer-based analysis 
approach, determining the percentage of DNA in the tail. Two independent experiments 
demonstrated that the percentage of DNA in the tail obtained from embryonic cells of control, 
untreated wild type N2 C. elegans was 32.8 % ± 1.6 % and 36.5 % ± 1.5 % (mean ± SEM; 
Figure 3.4A & B and 3.4C&D, respectively). This result shows that the overall DNA damage 
in untreated control C. elegans embryonic cells, as evaluated by comet assay, appears to be 
fairly high. Furthermore, this also demonstrated the repeatability of the comet assay. The assay 
consistently detects similar level of DNA damage in control C. elegans, (Figure 3.4B and D, 
p=0.1, Student’s t-test).  
I further explored the comet assay by comparing the DNA damage in wild type N2 animals 
exposed to damaging agents: gamma (γ) radiation. 
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Figure 3.4. Comparison of comet images and analysis of percentage of DNA in tail 
obtained from embryonic cells of control, untreated C. elegans from two separate 
experimental repeats. Images of comets stained with Sybr green dye obtained from the first 
experimental repeat (A) and second experimental repeat (C). Percentage of DNA in tail 
(mean±SEM) obtained from first (B) and second experimental repeat (D). The percentage of 
DNA in tail in the first experimental repeat was 32.8 % ± 1.6, n=51. Similarly, the second 
experimental repeat showed that percentage of DNA in tail was at 36.5 % ± 1.5, n=51. These 
results are statistically insignificantly different, indicating that the comet assay consistently 
detects similar level of DNA damage, p=0.1, Student’s t-test.  
  
                     
                  












3.2.2.1. Sensitivity test for comet assay 
3.2.2.1.1. Gamma (γ) irradiation 
I exposed nematodes to γ-radiation as this radiation is known to be a potent inducer of DNA 
damage [189, 196, 305, 306]. γ-radiation is a type of ionizing radiation that is able to disrupt 
the electronic structure of molecules. As a result, γ-radiation can break chemical bonds and 
produce highly reactive ions and free radicals [8, 305].  In biological systems, the significant 
destructive effect of γ-radiation is mainly due to radiolysis of water [8, 305], the dissociation 
of water molecules into radicals H• and OH• [8, 307]. γ-radiation possesses enough energy to 
damage DNA directly, causing a variety of lesions in DNA including DNA single and double 
strand breaks, DNA protein-crosslink, alkali labile sites, oxidized bases and abasic sites [189].  
Using a cobalt-60 γ-radiation source to introduce DNA damage, I Initially explored the effect 
of various doses of γ-radiation (ranging from 0 to 250 kRad). Our pilot experiment showed that 
the control animals without any radiation treatment appeared to be healthier and travelled 
significantly more distances than most γ- irradiated animals (Figure 3.5). Animals exposed to 
5 kRad of γ-radiation also appeared healthy and travelled more than animals irradiated with 20, 
80 or 250 kRad. Animals exposed to 80 and 250 kRad γ-radiation seemed to travel significantly 
less with more severe effect at the high dose (Figure 3.5). Furthermore, γ-irradiation also caused 
sterility in animals. Animals exposed to 80 and 250 kRad generally appeared sick and produced 
no offspring. This result showed that higher doses of γ-irradiation had strong effects on the 
motility and sterility of the animals, probably due to higher damage relative to control animals. 
Therefore, in this project, I investigated DNA lesions induced by γ-irradiation at the relatively 
lower doses of 20 kRad and 40 kRad with the aim of assessing dose dependent damaging effect 
of γ-radiation on C. elegans using the comet assay. The radiation doses of 20 and 40 kRad used 
in this project have been selected to be relatively well tolerated by the nematodes with no signs 








Figure 3.5. Pilot study of various doses of γ-irradiation. Distance travelled by C. elegans exposed to 0, 5, 20, 80 and 250 kRad γ-radiation doses 
using a cobalt-60 γ-radiation source. After γ-irradiation, animals were placed at the center of the NGM agar plate seeded with bacteria and the area 
explored by the nematodes was observed overnight. Red arrows showed the extent where the nematodes explored from the center of the plate. (A) 
Untreated control animals (0 kRad) were healthy and active, travelled vigorously to the side of the plate. (B) Animals exposed to 5 kRad γ-radiation 
remained active but travelled somewhat less than untreated control animals. (C) Animals exposed to 20 kRad γ-radiation travelled even less and 
only rarely arrived at the edge of the plate. Animals exposed to (D) 80 and (E) 250 kRad γ-radiation appeared sick, moved significantly less than 





Analysis of the DNA damage induced by γ-radiation (samples were extracted immediately after 
γ-irradiation) using the comet assay revealed that the DNA damage induced by 20 and 40 kRad 
γ-irradiation was significantly higher than that of the non-irradiated control animals (P<0.01, 
One-way ANOVA)(Figure 3.6). The percentage of DNA in the comet tail of the non-irradiated 
control animals in this particular batch of animals was 36 % (Figure 3.6), similar to the 
percentage of DNA in tail showed in Figure 3.4. The percentage increase following exposure 
to 20 kRad γ-radiation dose was 4 % higher than non-irradiated control animals (Figure 3.6). 
At 40 kRad γ-radiation dose, the percentage of DNA in the comet tail was 45 % and this increase 
was significant (p<0.001, Student’s t-test) (Figure 3.6) compared to embryonic cells from 
control animals. Figure 3.6 illustrates a linear relationship between radiation dosage and DNA 














Figure 3.6. The DNA damage of day 4 wild type N2 animals exposed to 0, 20 and 40 kRad 
γ-irradiation, determined using the comet assay as the percentage of DNA in the tail. Data 
obtained from one experimental repeat. There were 36, 41 and 45 % of DNA in tail of the comet 
in control animals, 20 and 40 kRad γ-irradiated animals respectively. There was a linear 
relationship between radiation dosage and DNA in tail (R squared = 1.00). A minimum of 55 




3.3. Real Time PCR  
After having developed and validated a γ-irradiation protocol suitable to cause robust increases 
in DNA damage, I then explored several variations of sequence-specific qRT-PCR based DNA 
damage assays.  
3.3.1. Real Time PCR (RT-PCR) concepts 
Real Time PCR (RT-PCR) is a technique that enables amplification and simultaneous 
quantification of newly synthesized DNA molecules during the PCR process. Conventional 
PCR typically is an end-point detection method that can be used to quantify the amplified PCR 
products only after the PCR reaction is completed. With large cycle numbers, this is equivalent 
to only knowing the amount of DNA at the plateau phase of PCR amplification (Figure 3.7). 
PCR, unless very carefully calibrated, is typically not quantitative.  In RT-PCR, the 
incorporation of DNA binding dyes or probes makes it possible to monitor the amplification of 
PCR products in real time. Data are therefore collected throughout the PCR process, including 
the exponential phase and the plateau phase (Figure 3.7). With each PCR cycle, the increase in 
the fluorescence signal is proportional to the increase in the target amplicon. The threshold 
cycle (Ct) is the PCR cycle at which the fluorescence signal passes an arbitrary set threshold 
fluorescence level (Figure 3.7). The threshold (Figure 3.7) fluorescence level is chosen such 
that the fluorescence intensity is well above background but still within the exponential 
amplification phase of the PCR reaction.  The Ct value of a given sample depends on the starting 
copy number of target DNA. The higher the initial DNA template copy number, the sooner this 
fluorescence signal is reached and thus the smaller the Ct value (Figure 3.7).  Figure 3.7 shows 
the amplification plot from one of my RT-PCR runs. A sample with 1,000,000 copies of initial 
DNA template amplified at Ct 20, whereas for a sample with a starting DNA copy number of 
1,000 copies will give a fluorescence signal at Ct 27. 




Figure 3.7. Graphical representation of a typical Real Time PCR amplification plot of 
DNA templates with different initial copy number.  In this amplification plot, ΔRn is plotted 
against PCR cycle number. Rn is the ratio of the fluorescence signal of reporter dye normalized 
to the passive reference dye. ΔRn is the normalized reporter signal minus baseline and is used 
for determination of threshold cycle (Ct). 
Initially, the increased in fluorescence signal is not visible because it remains below background 
level (below detectable level by the Real-Time PCR machine), in this case, cycles 1-20 and 1-
27 for DNA templates with higher and lower initial DNA copy number, respectively). 
Eventually, the amplified PCR product accumulates to yield a detectable fluorescence signal. 
The cycle number at which the fluorescence signal exceeds the defined threshold (an arbitrary 
level that is set to be above baseline and sufficiently low to be within exponential phase for 
amplification plot of Rn vs cycle number) is known as Ct. ΔCt corresponds to the difference 
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3.3.2. Real-Time PCR amplification factor  
In order to interpret qRT-PCR data quantitatively, we need to understand what the amplification 
factor, k of a given PCR reaction is.  During the exponential amplification phase, the 







                                                                
n
n kXX  0                                                 Equation 3.1 
Where 
nX  , the total amount of  DNA molecules at cycle number n , depends on the initial 
number of target DNA molecules present at the beginning of the reaction (
0X ) and the 
amplification factor .   
 
 
The amplification factor reflects the fractional increase in PCR product between current and 
previous PCR product quantity in any one cycle. Under ideal conditions, each DNA molecule 
should replicate once at each replication cycle, resulting in an amplification factor of 2k , thus 
Equation 3.1 would then become   
       
n
n XX )2(0    
This would mean that the number of molecules of the PCR product doubles at each replication 
cycle during the exponential phase of the reaction. However, different samples, experimental set-
ups, reagents and fluorescence dyes can affect PCR performance and PCR reactions typically are 
not perfect. Because of this the amplification factor is 21  k . Especially for long fragments, it 






The amplification factor is related to the amplification efficiency, E, where Ek 1 .  
From Equation 3.1:  
                                                          nn EXX  10                                       Equation 3.2 
When 2k , the amplification efficiency is 100 % or 1E , indicating perfect doubling of 
PCR products in every cycle.  
To determine an accurate value of the amplification factor for each template, a standard curve 
from serial dilutions of the target template is used (Figure 3.8A) (for detailed method, refer to 
section 2.10). The slope of the standard curve is obtained by constructing a plot of Ct on the 





















Figure 3.8. (A) Real-Time PCR amplification plot and (B) standard curve of log 
concentration of DNA versus ΔCt of the DNA sample from day 4 N2 wild type animals 
using the F1R1 fragment primers. Ten-fold serial dilutions (ranging from no dilution to 106-
fold dilution) of DNA sample were used to generate a standard curve for determination of 
amplification factor for the respective primers set used. The data showed high linear correlation 
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                                  Equation 3.3 
Equation 3.1 then becomes:  




0n kXX                                   Equation 3.1A 
Similarly, for the next dilution, Equatio n 3.1 becomes:  






                              Equation 3.1B 
However, at the fluorescence threshold, every real-time PCR amplification reaction must 



































































To evaluate k  from the slope of the standard curve, we take the logarithm on both sides,  
  
CtkD  loglog  
                                                         kCtD loglog                                   Equation 3.4  
Where k  is the amplification factor, Dlog  is the logarithm of the dilution factor and ct
is the difference in Cts between dilution factors (
ii CtCt 1 ).  
In the example, the linear regression equation from Figure 3.8B for short mitochondrial DNA 
fragment that I used in my qRT-PCR assay is: 
x3113.0y   
Where the slope of the curve of serial dilutions is the log of the amplification factor k, 
therefore,  
3113.0klog   
3113.010k   
 2k   
Thus, the amplification factor per cycle for the short mitochondrial DNA fragment for this 
particular PCR run was found to be 2. While this is amplification factor for this short mtDNA 
fragment is the often assumed theoretical value of 2, this is not always the case for long 








For example, the same method was used to evaluate the amplification factor for other PCR 
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Table 3.1. Nucleotide sequences of primers, amplicon size and amplification factors for real-
time PCR. The average amplification factor for each primer set was determined from the slope of 
the linear regression of the serial dilutions of the DNA template, which was obtained by 
constructing a plot of Ct on the logarithmic scale of target template dilutions. For each primers set, 
a minimum of five RT-PCR reactions was performed and the amplification factor obtained for 




3.3.3. Principle of qRT-PCR sequence specific DNA damage assay  
The amplification of qRT-PCR can be monitored and analyzed using sequence specific 
fluorescence probes (Taqman probe) or a traditional double strand DNA fluorescence binding 
dye (SYBR Green dye). The theoretical basis of the qRT-PCR based assays for DNA damage 
relies on the fact that DNA lesions (including strand breaks, some base modifications, cross 
links and bulky DNA adducts) can inhibit primer annealing or block DNA polymerase 
progression [249, 308], but it does not efficiently detect 8-OHdG [309]. Only a DNA template 
that does not contain any such DNA lesions can amplify perfectly (Figure 3.9). Inhibition of 
annealing by DNA lesions and blocking of the progression of DNA polymerase can prevent 
amplification, resulting in an apparent drop in detectable PCR product [249, 308, 310], 
compared to an equivalent DNA sample with fewer or no such DNA lesions. Therefore, under 
identical conditions, qRT-PCR amplification of differentially damaged samples but with equal 
copy number of DNA template will result in different Ct values, since the more damaged 
sample amplifying later corresponds to a lower apparent copy number. If a particular sample 
contained on average less DNA lesions (that is the sample contained more amplifiable, 
undamaged template) (sample A), amplification will be observed in earlier cycles because 
damaged template do not amplify; whereas, for DNA templates that contained more DNA 
lesions (sample contained less amplifiable, undamaged template) (sample B), the amplification 
will be observed in later cycles (Figure 3.10). However, in any real experiment, any difference 
in the Ct between sample A and B could also be due to the difference in the starting copy 
number of DNA template. To accurately quantify the amount of relative DNA damage, qRT-
PCR therefore has to be carried out either using exactly the same copy number of DNA template 
or needs to be normalized to the copy number of template added in a particular sample (sample 
A or B). After normalizing, the difference in the Cts of sample A and B can be interpreted as 
loss of DNA template amplification of the sample B relative to sample A due to DNA damage 




Figure 3.9. Principle of qRT-PCR DNA damage assay. The qRT-PCR DNA damage assay 
is based on the principle that DNA lesions can inhibit primers annealing and block the 
progression of DNA polymerase. Only DNA template that does not have DNA lesions can 
















Figure 3.10. Principle of qRT-PCR DNA damage assay. Amplification plot of Real-Time 
PCR run from day 5 untreated control (sample A; undamaged DNA sample) nematodes and 
nematodes exposed to 20 kRad γ-irradiation (sample B; damaged DNA sample). Equal copy 
numbers of DNA templates were added into the respective well. Sample A with less DNA 
lesions amplified earlier (Ct 19.8) than sample B (Ct 21.2), which was derived from animals 
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The next step in using this approach for DNA damage determination is to convert the drop in 
Ct into a quantitative measure of DNA damage (lesions per bp). In order to quantify randomly 
distributed DNA lesion frequency in a given DNA sample, I used Poisson Equation as 
probability model.   
The probability of observing exactly q  DNA lesions in a given DNA template is then given by    









                                            Equation 3.5 
Where  underlying lesion frequency in the total fragment.  
Only undamaged templates are assumed to amplify and therefore, to quantify DNA lesion 
frequency, we need to know the probability of undamaged DNA template (no DNA lesions, 
that is 0  ). 
For instance, if we assumed that the DNA copy number in each well of the two samples, sample 
A and B are the same (Figure 3.10) and that sample A is the sample with no DNA lesions 
(undamaged DNA sample), we can use this to serve as reference sample to calculate the amount 
of DNA lesions in sample B (damaged DNA sample).  









  10Pr qA  
In other words, there is a 100 % probability of having zero lesions in a given template of sample 













 eqB )0(Pr  
In other words, the probability of finding zero lesions in a given template of sample B drops 
exponentially with the average number of lesions per template (  ) observed. The ratio of 
undamaged DNA in sample B (note that sample B is the sample with DNA lesions and only 
template without lesions will amplify, therefore I determined the amount of undamaged DNA 
in the particular sample) to sample A (undamaged DNA sample) is then exactly )0(Pr qB
and can therefore be used to calculate the average DNA lesion per DNA template,  in B.   
 Amount of undamaged            Probability of                       Total number of undamaged 
 DNA in sample B, XB         =    undamaged DNA        x        DNA in sample A, XA 
(Damaged DNA sample)          in sample B, PrB                   (undamaged reference DNA sample) 
 
Thus, ratio of amount of undamaged DNA in sample B versus sample A is  

























Therefore, average lesion frequency per DNA strand (λ) in sample B is 













ln                                            Equation 3.6  
The average lesion frequency per DNA strand obtained is then divided by the fragment length 





Finally, if the amplification factor k is known, the ratio of intact DNA template (amount of 
undamaged DNA) in sample B versus sample A can be obtained directly from the RT-PCR 
traces. I compared the observed Ct values in both sample A and B and used the ΔCt values to 
quantify the amount of undamaged DNA in both samples.  
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                                    Equation 3.7 
From the example in Figure 3.10, amplification of long mitochondrial DNA fragment with 
k=1.77, Ct value for sample A = 19.8; Ct value for sample B= 21.2. Thus, ΔCt = -1.4.  
























Therefore, relative to the reference control sample A, 45 % of mtDNA molecules are intact 
(undamaged) in sample B, while 55 % of mtDNA of the 6.3 kbp fragment in sample B has been 
damaged.  
To determine the DNA lesion frequency per template, we solve Equation 3.6,  
 45.0ln  
80.0  
On average, the DNA lesion frequency in the 6.3 kbp fragment of mtDNA is 0.80 DNA lesions per 
template molecule. To express this lesion frequency as lesions per bp, we divide 0.80 lesions per 
template molecule by the number of base pairs finding that the sample B in Figure 3.10 has          1.27 




3.3.4. Practical considerations of qRT-PCR 
Technically, the qRT-PCR DNA damage assay measures DNA lesions by comparing the 
amplification of a sample with that of an undamaged reference sample.  However, in practice, 
there is typically no available confirmed undamaged reference DNA sample. It is therefore 
impossible to perform absolute quantification directly. Instead, another way of quantifying the 
drop in apparent copy number due to DNA damage has to be used. I have utilized two different 
approaches based on PCR for this purpose.  
3.3.4.1. Fpg-qRT-PCR DNA damage assay  
The first approach is to introduce a damage-specific repair enzyme, such as Fpg enzyme that 
acts as N-glycosylase and AP-lyase. N-glycosylase selectively releases oxidatively damaged 
bases from double stranded DNA, generating apurinic sites (AP site). In addition, Fpg also 
displays AP-lyase activity that cleaves at 3’ and 5’of phosphodiester bonds of AP sites resulting 
in strand breaks that can inhibit PCR amplification [311]. Digestion with Fpg therefore converts 
8OHdG and similar lesions into single strand breaks. For quantification of oxidative damage 
using Fpg, three different samples are prepared: Fpg digest, mock digest and undigested DNA 
samples. The mock digest, without the addition of the Fpg enzyme, is done under identical 
treatment conditions as the actual Fpg digest, whereas undigested sample contains exactly the 
same amount of DNA as the mock digest sample but was incubated at 4 ˚C instead of 37 ˚C. 
DNA samples subjected to Fpg digest will have more strand breaks resulting in a lower apparent 
copy number and thus higher threshold cycles compared to mock and undigested DNA samples. 
This can be seen in Figure 3.11.  The mock digest sample serves as the undamaged reference 
control sample (sample A) for the quantification of the DNA damage in the Fpg digest sample 
(sample B). Undigested sample serves as an additional control for the Fpg digest to detect non-
specific DNA degradation due to the digest reaction. From the amplification plots, the 
percentage of intact DNA can be determined via the ratio of template after Fpg cleavage 
(sample B) relative to PCR template present in the mock digest (sample A). The amount of Fpg 
sensitive DNA lesions can then be quantified as described above (See section 3.3.3) from the 
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difference in Cts (ΔCt) between Fpg digested and mock digested samples as discussed above 
using Poisson analysis.  
  
Figure 3.11. Amplification plot of qRT-PCR on mitochondrial extract of day 4 wild type 
N2 animals that was subjected to Fpg digest. For quantification of oxidative damage using 
Fpg, three different samples are prepared: Fpg digest, mock digest and undigested DNA 
samples. To facilitate the quantification of DNA damage, the mock digest sample serves as an 
undamaged control sample. The ΔCt is the difference in Ct between the Fpg digest and mock 











Using the data obtained from my experiment for Day 4 N2 nematodes in Figure 3.11, average 












This means that relative to mock digested sample, only about 9.8 % of the mtDNA molecules 
were fully intact (undamaged with zero Fpg sensitive lesions) in the Fpg digested sample, while 
90.2 % of mtDNA had been cleaved. Thus, the drop in PCR amplifiable template concentration 
(relative to mock digest) was 90.2 %  
Equating to a DNA lesion frequency, solving Equation 3.6,  
 098.0ln  
                                          On average, 3.2  lesions per 6.3 kbp region of mtDNA 
fragment 
Therefore, in a 6.3 Kb fragment of mtDNA of Day 4 (young adult) wild type N2 nematodes that 
I utilized in this experiment, the DNA lesion frequency was 2.3 DNA lesions per 6.3 kbp or 3.7 
x 10-4 lesions per bp. Using this Fpg-qRT-PCR method, the number of Fpg sensitive oxidative 






3.3.4.1.1. Sensitivity test for Fpg-qRT-PCR DNA damage assay  
Similar to my test of the comet assay using γ-irradiated animals, the same challenge protocol 
was used to test the sensitivity of this Fpg-qRT-PCR DNA damage assay.  
As assessed by Fpg-qRT-PCR DNA damage assay, animals exposed to γ-irradiation doses of 
20 kRad had an average of 3.4 lesions per 10 kbp, while DNA damage in 40 kRad γ-irradiated 
animals was 3.5 lesions per 10 kbp (Figure 3.12A). Comparing to non-irradiated control 
animals that had 2.48 lesions per 10 kbp, the assay is unable to detect dose-dependent increase 
in the DNA damage with increasing γ-irradiation dosage (Figure 3.12A, p=0.49, One-way 
ANOVA).  
This result was disappointing since there is a significant dose-dependent increase in the DNA 
damage measured using the comet assay (Figure 3.6). I then measured the DNA damage using 
Fpg-qRT-PCR DNA damage assay in different C. elegans strains. I used the glp-1 (JK1107), 
which is an egg-laying deficient strain to reduce new mtDNA synthesis by oocytes. The DNA 
damage in non-irradiated control animals was 3.6 lesions per 10 kbp (Figure 3.12B). The 
baseline DNA damage in glp-1 animals was about 40 % more than baseline damage in wild 
type N2 animals (Figure 3.12A and B), but this difference was not statistically significant 
(p=0.30,Student’s t-test). Furthermore, 20 and 40 kRad γ-irradiation induced mtDNA damage 
in glp-1 animals, was measured as 4.2 and 4.6 lesions per 10 kbp, respectively (Figure 3.12B). 
Overall, analysis of the DNA damage in non-irradiated control, 20 and 40 kRad γ-irradiated 
animals using One-way ANOVA, again showed that this Fpg-qRT-PCR DNA damage assay 
was unable to detect significant dose-dependent increase in the DNA damage with higher γ-
irradiation dosage (Figure 3.12B, p=0.37), despite the increasing trend.  
Failure to detect dose-dependent increase in DNA damage even in different strains showed that 
the Fpg-qRT-PCR DNA damage assay lacks sensitivity.  
In addition, I also detected variations in the DNA damage measured using Fpg-qRT-PCR assay, 
even though the same sample from the same cohort of animals was used. A robust assay should 
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remain unaffected by minor variations that may occur over time. A good assay should generate 
reproducible results when run on replicates of sample both within and between runs [312, 313]. 
Therefore, robustness and repeatability are important factors that should be considered.  
 
Figure 3.12. The use of a γ-irradiation challenge protocol to test the sensitivity of Fpg-
qRT-PCR DNA damage assay. (A) There is no difference in the mtDNA damage in non-
irradiated control, 20 and 40 kRad γ-irradiated day 4 wild type N2 animals, p=0.49. (B) mtDNA 
damage in γ-irradiated day 4 glp-1 animals also does not show significant dose-dependent trend 
with increasing dosage of γ-irradiation, p=0.37. The data were analyzed using One-way 





The assay’s low sensitivity and high variability led me to address the issue relating to the use 
of Fpg enzymatic digest. It is common to have variabilities in enzymatic digest, at times, DNA 
does not appear to be digested, partially digested or unspecific degradation as shown in Figure 
3.13. I found that the mock digest and undigested DNA samples (Figure 3.13) sometimes led 
to inconsistency resulting in variable measurements of DNA lesion frequency. Mock digested 
samples without the addition of any Fpg enzyme were incubated under the same conditions as 
the Fpg digested samples.  Since there is no addition of any Fpg enzyme, the Ct of the mock 
digested and undigested DNA should be the same (Figure 3.13A).  However, this was not 
always the case (Figure 3.13) when using C. elegans mtDNA extracts. This may be due to the 
fact that it is hard to obtain pure mtDNA extract without contamination of nuclear DNA, 
proteins, free metal ions or possible endogenous DNA nucleases. I found that in some repeats, 
mock digested sample amplified significantly later than undigested samples (Figure 3.13B) 
while in some cases, they actually amplified earlier than undigested DNA samples (Figure 
3.13C). This was the case although the same batch and same amount of Fpg enzyme was used 
for every repeat of the mock, undigested and digested samples. This variability led to 
inconsistencies and it is hard to interpret data generated using this assay applied to 
mitochondrial extract.  
Furthermore, in some cases, contamination or impurity in the DNA samples may also inhibit 
the enzymatic digestion, affecting the level of DNA damage measured [314]. In the repeats, 
restriction digestion was performed for 4 hours to make sure that restriction reactions go to 
completion. However, this prolonged incubation time in turn may cause DNA degradation 
artifacts.  
In summary, the Fpg-qRT-PCR DNA damage assay lacks sensitivity, exhibits high variability 
and is subjected to possible artifacts. Therefore, this assay is not a promising tool for 





Figure 3.13. Amplification plots from two different RT-PCR runs showing inconsistencies 
of the mock and undigested sample in the restriction digest reaction. (A) Both mocked and 
undigested samples were amplified and detected at the same Cts as expected. (B) Mock digested 
DNA sample amplified later thus higher Ct compared to undigested DNA sample.  (C) Mock 
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3.3.4.2. S-XL-qRT-PCR DNA damage assay  
While the Fpg digest method is conceptually elegant in that the original, undigested samples 
can be directly served as reference sample, the problems outlined above led me to explore other 
approaches. The second approach to perform DNA lesion quantification (given that there is 
typically no available undamaged reference DNA sample) and to overcome the problems of 
using Fpg-qRT-PCR to quantify DNA damage is to avoid the digestion step altogether. 
Determination of the amount of DNA lesions in a sample is also possible by comparing the 
apparent copy number of a short and long fragment within the same sequence. This involves 
quant i fying  the  apparent  copy number  of  t he  s ame  sample  us ing  a  l a rge  
 
Figure 3.14. Schematic diagram of region amplified by S- and XL-qRT-PCR within C. 
elegans mitochondrial genome. The short amplicon (71 bp) is represented by a green arrow 







amplicon (6.3 kbp) and a small amplicon (71 bp) within the same genome and then comparing 
the apparent copy numbers (Figure 3.14). The short fragment is too short and is much less 
affected by DNA damage, therefore can be used as an approximation for the undamaged DNA  
(this is equivalent to the undamaged sample mentioned above) but the long fragment 
amplification is significantly affected by DNA damage [309, 315, 316]. The ratio between the 
apparent copy numbers of the short and long fragment is therefore a measure of DNA damage.  
In practice, two independent PCR reactions are used for this purpose: (i) a short-PCR (S-PCR) 
as quality control and internal normalization to facilitate the quantification of the actual copy 
number of DNA molecules loaded (without being affected by damage) (ii) an extra-long PCR 
(XL-PCR) is used for DNA lesion quantification. The amplification of very long genomic 
targets improves the sensitivity of this assay as the probability of the DNA lesions affecting the 
PCR within the target sequence increases with increased size of the target. A standard curve 
method is used to absolutely or relatively quantify the DNA copy number of both the small and 
large fragments using a known reference sample.   
In order to quantify DNA damage, the ratio of intact DNA templates between the small 
amplicon and large amplicon is calculated. Table 3.2 shows the average Ct values obtained 
from two independent PCRs of S-PCR and XL-PCR of a reference DNA sample. The input 
DNA copy number for the known reference sample was determined to be 10,000 copies of 
DNA per µl or 10,000 copies of DNA per well (as 1 µl of DNA reference sample was added 
into each well). To quantify DNA lesions for the DNA sample of a cohort of day 4 N2 
nematodes in Table 3.2, using the same method as discussed earlier in section 3.3.3, the number 
of the intact DNA template measured in the unknown sample using S-PCR, 
)(0 SX was 15000 
copies. By contrast, the apparent copy number of the long fragment was only 10060 molecules, 
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Table 3.2. Summary of steps to quantify DNA damage in a sample (day 4 wild type N2 
animals). Copy number of intact DNA was determined from the ΔCt of the CT value of particular 
sample from S- and XL-PCR relative to Ct of a reference sample. The copy number was then used 





Since the same DNA sample was used in both S-PCR and XL-PCR, the actual DNA copy 
number of S- and XL-PCR reaction should be the same, 15000 molecules in this case. 
However, for the long fragment (Table 3.2), the apparent copy number was lower with only 
10060 molecules. This is the number of large fragments that were undamaged and could still 
be amplified. Compared to the actual DNA copy number of 15000 molecules for both S- and 
XL-PCR, the fraction of DNA that could not amplified (that is the percentage of DNA that 
contains at least one PCR inhibitor lesion in the 6300 bp fragment), 
DX  is  
)(0)(0 XLSD XXX   
1006015000 DX  
DX 4940 
This means that there were 4940 copies or 32.9 % of DNA that contain at least one PCR 
inhibitory lesion in the 6.3 kbp fragment.  To quantify the DNA lesions frequency, the 
probability of undamaged (intact) DNA molecules needs to be calculated.  
Therefore, probability of intact DNA molecules 
               = 1-0.329 
= 0.671 
As before, DNA lesion frequency per template can be quantified using Equation 3.6:  
 671.0ln  
40.0  
Therefore, in the 6.3 kbp fragment of mtDNA of Day 4 (young adult) wild type N2 nematodes, 
the DNA lesion frequency was 0.40 DNA lesions per 6.3 kbp or 6.3 x 10-5 lesions per bp. 
Using this S-XL-qRT-PCR method, the number of such DNA lesions can be determined for 
other samples, provided that absolute copy number determination can be performed accurately 





However, this approach also has limitations. In particular, it is problematic to study specific 
types of DNA damage and the inability of the assay to distinguish between different types of 
DNA damage is a potential limitation [316-318]. However, it might be argued that the 
measurement of multiple types of DNA damage avoids misleading conclusions that might be 
drawn from the measurement of a single product [239], because a single product does not 
necessary reflect the overall DNA damage or biological relevance in the samples. However, a 
clear limitation of this approach is that this assay can only detect DNA lesions that significantly 





















3.3.4.2.1. Sensitivity test for S-XL-qRT-PCR DNA damage assay     
3.3.4.2.1.1. Gamma radiation 
After identifying the problem with the Fpg-qRT-PCR assay, I explored the same challenge 
protocol in the S-XL-qRT-PCR assay with the aim to test the sensitivity of the assay by 
comparing the DNA damage in samples exposed to varying amount of damaging agents such 
as gamma (γ) radiation and ultraviolet (UV) radiation. In contrast to the Fpg-qRT-PCR assay, 
the S-XL -qRT-PCR mtDNA assay was able to detect significantly elevated oxidative mtDNA 
damage in animals challenged with increasing doses of γ-radiation (20 and 40  kRad) (P<0.05, 
Figure 3.15). Following γ-irradiation at doses of 20, the mean mtDNA damage in young glp-1 
animals increased (Figure 3.15) to 0.8 lesions per 10 kbp, an approximately 31 % increase in 
mtDNA damage relative to untreated control young glp-1 animals (0.6 lesions per 10 kbp). γ- 
irradiation-induced mtDNA damage in animals exposed to 40 kRad dose was even higher (1.2 
lesions per 10 kbp, an approximately 98 % increase compared to untreated control animals).  
The comparison of data in Figure 3.15 (mtDNA damage frequency using S-XL-qRT-PCR assay) 
to nuclear DNA lesions obtained using the comet assay (Figure 3.6) shows that exposure to γ-
radiation indeed resulted in a consistent dose-dependent increase in mtDNA damage, which 
further validates the sequence specific S-XL-qRT-PCR assay (Figure 3.15). Analysis of the 
results from both comet assay and S-XL-qRT-PCR assay showed high correlation (Figure 3.16) 
in dose-dependent increase of DNA damage as measured by the comet assay and S-XL-qRT-
PCR assay. These dose dependent increases were best fitted by a linear regression line with R-
squared value of 0.96. This suggests that the extent of DNA damage caused by increasing doses 
of γ-irradiation measured using both comet assay and S-XL-qRT-PCR assay may be correlated 
in which the increased in the percentage of DNA damage will be the same for both assays. 





Figure 3.15. γ-irradiation dose-dependence induction of DNA damage in Day 4 young glp-
1 C. elegans. γ-irradiation dose values given to the nematodes ranging from 0 to 40 kRad. 
Increasing doses of radiation resulted in a statistically significant enhancement in the extent of 
DNA damage with 31 % and 98 % increased of DNA lesions at 20 and 40 kRad respectively, 
relative to untreated control animals. (p=0.02, One-way ANOVA), n= minimum 12 








































































Figure 3.16. Analysis of the results from both comet assay and S-XL-qRT-PCR assay 
showed high correlation. Both comet assay and S-XL-qRT-PCR DNA damage assay are 
able to detect γ-irradiation dose-dependent increases in DNA damage. Each point is a mean 
of minimum 55 comets (for data plotted on Y-axis) or minimum of 12 independent 




3.3.4.2.1.2. UV radiation 
I then tried another challenge protocol by exposing the nematodes to 400 J/m2 of ultraviolet C 
(UVC) radiation. As mentioned in the introduction, there are three main types of UV rays, 
classified according to their wavelengths.  UVA can cause DNA damage through an indirect 
mechanism by generating highly reactive radicals, thus causing DNA damage such as DNA 
base modifications, DNA strands breaks, abasic sites and DNA-proteins crosslinks [196]. 
Unlike UVA, direct UVB and UVC can directly damage DNA resulting in the formation of two 
types of DNA lesions, the cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4 
PPs) [196, 306, 319]. The high energy short wavelength UVC also results in the formation of 
double-strand breaks at the site of CPDs containing DNA [306, 320, 321]. Further, double-
strand breaks can be formed as a consequence of attempted repair of UV-induced DNA damage 
[322], likely to be detected by S-XL-qRT-PCR assay, unlike 8-OHdG from lysis of water. 
Interestingly, I observed statistically significant higher mtDNA damage in UVC-irradiated 
animals than the mtDNA damage detected in 20 and 40 kRad γ-irradiated animals (p<0.0001, 
One-way ANOVA, Figure 3.15). There were about 120 % more UVC-induced mtDNA lesions 
than γ-induced mtDNA lesions in young glp-1 animals. As seen in Figure 3.17, relative to 
untreated control animals with only 0.6 lesions per 10 kbp, there was a significant increased in 
mtDNA damage (P<0.0001) with 2.5 lesions per 10 kbp or approximately 336 % more DNA 









In addition to DNA damage assay validation, I also optimized DNA extraction, storage 
condition and type of fluorescence dyes used. (For detailed explanations, see Appendix A1, A2 
and A3). 
In conclusion, I have developed a Real Time PCR based protocol, S-XL- qRT-PCR DNA 
damage assay that is highly sensitive. This DNA damage assay is highly robust and 
reproducible, which enables precise quantification of baseline DNA damage in C.elegans. It is 
therefore a sensitive, robust and high repeatability assay for quantitative analysis of DNA 







Figure 3.17. Effect of γ- and UV-irradiation on the mtDNA of day 4 young JK1107 
nematodes.  There is a significant increase in the damaged DNA in animals exposed to γ- and 





4.  Applications  of  the  Sequence-Specific S-XL-qRT-PCR DNA 
Damage Assay  
4.1. Association of mtDNA damage to growth, development and health of the 
irradiated animals 
In order to address the biological significance of the oxidative mtDNA damage induced by γ-
radiation and UV-radiation during the challenge experiments (Figure 3.15-3.17); I investigated 
their association to lifespan, healthspan and the fitness of the nematodes.  
I conducted lifespan studies in which the samples were randomized and the observer was 
blinded to the treatment conditions. Randomization of samples and blinding when scoring 
survival minimizes observer bias [289].  Surprisingly, despite the fact that the animals had 
significantly higher mtDNA damage, I observed that young C. elegans exposed to 40 kRad of 
γ-radiation showed no significant lifespan shortening relative to untreated control animals 
(Figure 4.1A). Lifespan curve comparison, the mean and maximum (defined as the average 
lifespan of the top 10 % of the longest surviving animals) lifespan of the γ-irradiated nematodes 
were all not significantly different, as compared to non-irradiated control animals (Figure 4.1A, 
B and C, p=0.97, p=0.88 and p=0.57, respectively). The mean and maximum lifespan of γ-
irradiated animals for both conditions were 13 and 23 days, respectively (Figure 4.1B and C).  
In contrast to γ-irradiated animals, I observed that the lifespan of the animals treated with 400 
J/m2 UV-radiation was significantly shortened compared to control animals (Figure 4.1A, 
p<0.05). Mean lifespan of UV-irradiated animals was significantly shorter than control animals 
showing a 10.2 % reduction in lifespan (Figure 4.1B, p<0.05, Student’s t-test). Treatment of 
animals with 400 J/m2 UV-radiation also significantly reduced the nematodes’ maximum 
lifespan by 30.3 %, reducing it from 23.2 days to only 16.2 days (Figure 4.1C, p<0.0001, 
Student’s t-test).  
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A B C 
Figure 4.1. Survival of Day 4 glp-1 nematodes exposed to 40 kRad γ-radiation, 400 J/m2 UV- radiation and control nematodes (n=200 
worms per condition). (A) Survival curves from each condition were compared to that of the non-irradiated control animals and analyzed using 
Log-rank (Mantel-Cox) test. The survival of animals exposed to 40 kRad γ-radiation was not significantly different from non-irradiated control 
animals, while exposure to UV-radiation significantly shortened the lifespan of the nematodes, (p<0.05). (B) Mean lifespan of UV-irradiated 
animals was significantly shortened relative to control animals, (p<0.05,Student’s t-test).  (C) γ-radiation had no significant effect on the survival 




In order to judge the impact of radiation on indicators of overall health status of the muscular 
and nervous system, I further conducted blinded healthspan studies. I determined healthspan 
by measuring the animal motility as an indicator of health. Healthspan is an index of 
physiological capacity, meaning the period of time during which the animals are able to 
maintain good health [289]. The motility of the nematodes was scored daily into three classes 
of movement A, B and C [42, 45]. Class A animals are highly mobile animals that move 
constantly in response to prodding, moving away from the touch stimulus leaving sinusoidal 
tracks in the bacterial lawn through which they migrate. Class B animals move only in response 
to touch stimuli leaving non-sinusoidal tracks, reflecting uncoordinated locomotion. Lastly, 
animals in class C only move their head or tail in response to prodding.     
Healthspan curves and locomotor distribution (in percent of total animals alive on the respective 
day) were plotted to compare the animals’ relative health. Generally, animals from γ-, UV-
irradiated and non-irradiated control all showed relatively rapid age-dependent decline in terms 
of locomotor activity (Figure 4.2A and B). A-type movement was predominant at young and 
early middle age whereas B- and C-type movement became prevalent in the late-middle aged 
and old-aged nematodes, respectively. 
Interestingly, the health status of γ-irradiated and non-irradiated control animals was similar 
throughout life (Figure 4.2A and B) despite the difference in the mtDNA damage in these 
animals (Figure 3.15-3.17).  The mean healthspan of the γ-irradiated nematodes was similar to 
non-irradiated control animals (Figure 4.3A) at 13.8 days for both conditions. Surprisingly, I 
observed that the duration for which the healthiest 10 % of animals from each group were able 
to maintain good health were 23.0 and 23.8 days, respectively (Figure 4.3B). This difference 
was statistically significant (p<0.01, Student’s t-test), meaning that the maximum healthspan 
of the γ-irradiated animals was significantly improved relative to non-irradiated control animals.  
As expected from the high level of damage to mtDNA and shorter lifespan, UV-irradiated 
animals displayed a significantly lower average locomotor activity compared to the non-
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irradiated control animals (Figure 4.2A, p<0.0001, log-rank test). At early ages (from day 5 to 
day 8), there were no differences in the locomotor activity of the γ-, UV-irradiated and control 
animals. However, the detrimental effect started to take effect from day 10 where only 36 % of 
the UV-irradiated animals remained active (A-type movement) while 81 % of control animals 
still remained healthy (A-type movement) (Figure 4.2B). On the whole, UV-irradiated animals 
were the first treatment group that failed to maintain their class A health status. None of the 
UV-irradiated animals maintained class A health status beyond day 16 whereas about 38 % of 
non-irradiated control and 32 % of γ-irradiated animals were able to maintain class A health 
state at day 16 (Figure 4.2B). In addition, the average number of days that the UV-irradiated 
animals were able to maintain class A health status was only 11.3 days, which was significantly 
shorter compared to both γ-irradiated and non-irradiated animals (13.8 days for both conditions) 
of class A health state (Figure 4.3A, p<0.0001, Student’s t-test). Comparing the top 10 % 
motility phenotype of the UV-irradiated animals, I observed that the number of days that the 
UV-irradiated animals were able to retain good health was significantly shorter (by 30 %) 
relative to non-irradiated control animals (Figure 4.3B, p<0.0001, Student’s t-test).   
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Figure 4.2. . Locomotor activity of γ-, UV-irradiated and non-irradiated Day 4 glp-1 control nematodes, n=200 worms per condition. 
A. Healthspan curve from a single experiment.  Animals exposed to UV-irradiation were less active and healthy compared to non-irradiated 
control animals. The difference was statistically significant with p<0.0001, analyzed using Log-rank (Mantel-Cox) test.  B. Distribution of 
worms in percentage of total worms alive on the respective day. UV-irradiated animals showed lower locomotor activity relative to non-










Figure 4.3. Mean and maximum healthspan of the γ-, UV-irradiated and non-irradiated 
control animals. A. Mean healthspan was significantly shortened in animals exposed to UV-
radiation relative to control animals, p< 0.0001, Student’s t-test. B. UV-irradiation also 
significantly shortened the maximum healthspan of the nematodes, p<0.0001, Student’s t-test. 
Surprisingly, maximum healthspan of the γ-irradiated animals was significantly extended, 




I also investigated the fitness in terms of ability of the animals to move in a given duration, 
following γ- and UV-irradiation by measuring the average distance travelled by young 
nematodes within a 15 minutes period after transferring the animals to a fresh plate with 
bacterial lawn. All animals tested were class “A”. Distance travelled is an indicator of fitness 
of animals’ ability to explore the environment for new resources as well as escape hazardous 
environments. Surprisingly, given the lack of lifespan and healthspan effect of γ-irradiation, the 
typical distance travelled by both γ- and UV-irradiated nematodes was markedly reduced 
relative to non-irradiated control animals (Figure 4.4, p<0.0001 for both conditions, Student’s 
t-test). γ-irradiated animals travelled at an average distance of 2400 µm per minute while UV-
irradiated animals travelled about 2800 µm per minute (Figure 4.4, p=0.64, Student’s t-test). 
By comparison, non-irradiated control animals travelled about 6200 µm per minute. This means 
that γ-irradiated nematodes travelled approximately 61 % less than the control animals 
(p<0.0001, Student’s t-test). UV-irradiated animals despite being much less healthy, 
unexpectedly, travelled only approximately 56 % less than control animals (Figure 4.4). The 
difference between distance travelled by the UV-irradiated and non-irradiated animals was 
statistically significant (p<0.0001, Student’s t-test).   
Despite a significantly higher mtDNA damage in γ- and UV-irradiated animals, I observed no 
lifespan or healthspan shortening effects in γ-irradiated animals.  This is surprising as I observed 
a clear fitness impairment in γ-irradiated animals. On the other hand, UV-irradiated animals 
with extremely high mtDNA damage relative to non-irradiated and γ-irradiated animals had 
significantly shorter lifespan and healthspan as well as fitness impairment. The reason for these 
differences is unclear and it would be interesting to address this. One explanation for this is that 
the γ-irradiated animals might have used some of their metabolic energy to survive while UV-
irradiated animals with significantly higher DNA damage as measured using my S-XL-qRT-
PCR assay might have less metabolic energy declined due to the declined in mitochondrial 
function. Consequently, UV-irradiated animals are unable to compensate for the DNA damage 
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and also DNA lesions caused by UV-irradiation are more lethal than DNA lesions caused by γ-








Figure 4.4. Average distance travelled by γ- , UV-irradiated and non-irradiated day 4 
glp-1 nematodes. Both γ- and UV-irradiated animals travelled significantly less than non-
irradiated control animals, p<0.0001 for both conditions, Student’s t-test. n=10 animals per 




4.2. mtDNA Age-dependent changes  
I then applied the S-XL-qRT-PCR DNA damage assay to an ageing cohort with the aim to 
investigate age-dependent mtDNA damage in vivo. I was able to detect a trend towards higher 
mtDNA damage in older animals (Figure 4.5A). Although there was a 50 % increase in mtDNA 
damage with a maximum (at Day 14) of 0.9 lesions per 10 kbp compared to young animals 
( Day 4) with 0.6 lesions per 10 kbp, the increase was not statistically significant ( p=0.19, 
Student’s t-test) (Figure 4.5A). MtDNA damage in old animals was low, compared to mtDNA 
damage in 40 kRad γ-irradiated and 400 J/m2 UV-irradiated animals that have 1.2 and 2.5 
lesions per 10 kbp, respectively (Figure 3.17).   
In addition, I also measured the distance travelled by the animals. I found that old animals 
travelled significantly less than young animals at 3400 µm per minute compared to 6200 µm 
per minute in young animals (Figure 4.5B, p<0.0001, Student’s t-test), despite the non-
significant difference in the mtDNA damage. This phenomenon experienced by old animals 
might be similar to the γ-irradiated animals where the animals conserve their energy, in this 
case, at old age for survival. This also suggested that there might be a certain threshold of 
mtDNA damage up to which the animals use their metabolic energy to survive. Metabolic 





Figure 4.5. mtDNA damage and distance travelled measured in young and old nematodes. 
(A) Using S-XL-qRT-PCR DNA damage assay to detect the mtDNA lesions in young and old 
nematodes. mtDNA lesions in mtDNA samples of young animals (Day 4) and old animals (Day 
14). As judged by S-XL-qRT-PCR DNA assay for mtDNA damage, there was a trend towards 
more mtDNA lesions in old nematodes (P = 0.19, Student’s t-test), n=23 independent 
experiments. (B) Old animals travelled significantly less than young animals (p<0.0001, 
Student’s t-test), n=10 animals per condition.  
 
















4.3. mtDNA damage in different mutant strains 
Having established that my assay is able to detect and quantify levels of mtDNA damage even 
below the threshold for significant lifespan effects, I then applied it to investigate mtDNA 
damage in different mutant strains of C. elegans.  Strains were selected because they showed 
differences in lifespan or had modifications in ROS defences with the aim to study the 
association of mtDNA damage and lifespan.  
I first applied my assay to the glp-1 (germ line deficient-JK1107) strain, a temperature sensitive 
mutant that is sterile at 25.5 °C but fertile at 15 °C. The glp-1 gene is required for germ cells 
mitotic division. Maintenance of young adult glp-1 nematodes at restrictive temperature of 
25.5 °C inhibits germ lines proliferation and blocks cell division [323]. Therefore, at 25.5 °C, 
these mutant nematodes have post-mitotic somatic cells but few germ cells, which reduces the 
possibility of DNA from germ line cells affecting measurements of global DNA damage. At 
25.5 °C, glp-1 nematodes have shorter lifespan (with a mean lifespan of 12.3 days) [286]  
compare to wild type N2 animals at 20 °C that have a mean lifespan of 21 days [289]. Using 
my S-XL-qRT-PCR DNA damage assay, I found that there is no difference between the 
mtDNA damage in glp-1 mutant that were cultured at higher temperature and wild type N2 
animals at 20 °C (Figure 4.6, p=0.08, Student’s t-test).  MtDNA damage was measured in glp-
1 mutant (the commonly used strain) animals for the first time, which suggests that glp-1 
animals have similar DNA damage to wild type N2 animals although these glp-1 animals were 
cultivated at higher temperature and have shorter lifespan. 
I next investigated the mtDNA damage in mev-1 (a methyl viologen (paraquat)-sensitive -TK22) 
mutant strain. The mev-1 mutation results from an amino acid substitution in cytochrome b 
subunit in complex II, which results in decreased complex II activity [324] and elevated ROS 
production [325, 326]. The  mev-1 mutant is hypersensitive to both oxygen and methyl viologen 
with half the wild type C.elegans’ cytosolic SOD activity [327]. This mutant strain suffers from 
high oxidative stress [325, 326], and has shorter lifespan relative to wild type N2 animals [326, 
328]. Surprisingly, there was no elevation in mtDNA damage in mev-1 mutant relative to wild 
type N2 animals with 0.8 and 0.9 lesions per 10 kbp, respectively (Figure 4.6, p=0.67, Student’s 
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t-test). In this case, the mev-1 mutant animals have higher protein damage [326] but no 
difference in the mtDNA damage compared to wild type N2 animals, suggesting that oxidative 
damage is highly specific to the type of molecules and probably to the type of tissues. This 
illustrates the need for specific markers as clearly protein carbonyl content does not predict 
mtDNA damage and vice versa.  
Furthermore, mev-1 mutant animals have shorter lifespan but no elevation in mtDNA damage. 
This demonstrates that, lifespan shortening in mitochondrial mutant nematodes is not 







Figure 4.6. mtDNA damage of different young (Day 4) C.elegans mutant strains relative 
to young (Day 4) wild type N2 animals. Relative to wild type N2 C. elegans, glp-1 and mev-
1 mutant C. elegans strains had no significant difference in mtDNA damage as measured by S-
XL-qRT-PCR assay and expressed as lesions per 10 kbp of mtDNA (P=0.08 and 0.67, 
respectively, Student’s t-test). Compared to wild type N2 animals, sod-2/sod-3 double mutant 
animals had significantly higher mtDNA lesions (P=0.04, Student’s t-test). mpst-1 animals that 
lack the H2S synthesizing enzyme, had three-fold higher mtDNA damage relative to wild type 




Another mutant strain that I tested is the sod-2/sod-3 (GA 480) double knockout mutant strain, 
lacking both mitochondrial forms of superoxide dismutase (SOD). SOD is an antioxidant 
enzyme that detoxifies superoxide by catalyzing the dismutation of superoxide into oxygen and 
hydrogen peroxide. C. elegans has five SOD genes, of which only sod-2 and sod-3 are localized 
to mitochondria [62, 63]. Surprisingly, sod-2/sod-3 mutant animals do not exhibit lifespan 
shortening effect despite an increase in sensitivity to oxidative stress due to impairment in 
antioxidant defence [88, 329]. It has also been shown that deletion of sod-2/sod-3 genes does 
not elevate oxidative damage to protein [88]. Surprisingly, consistent with other studies, our 
lab has also found that sod-2/sod-3 mutant animals have significantly lower ROS production 
and consequently, no elevation in oxidative mtDNA damage using the Fpg-qRT-PCR as 
compared to wild type N2 animals [62]. However, using the more sensitive S-XL-qRT-PCR 
DNA damage assay, I observed a significant increase in mtDNA damage in sod-2/sod-3 mutant 
animals relative to wild type N2 animals (Figure 4.6, p=0.04, Student’s t-test).  The mtDNA 
damage in sod-2/sod-3 mutant animals represents a two-fold increase in mtDNA damage in 
comparison to wild type N2 animals. The significantly higher mtDNA damage in sod-2/sod-3 
mutant animals suggests that depleting the antioxidant defence in mitochondria causes a mild 
increase in oxidative damage. However, this mild increase does not shorten the lifespan of the 
sod-2/sod-3 mutant animals, again suggesting that mtDNA damage is not a determinant of 
lifespan in mitochondrial mutants.  
Lastly, I applied this S-XL-qRT-PCR DNA damage assay to mpst-1 (ok2040) mutant animals. 
The Mpst-1 gene codes for one of the three enzymes (namely: cystathionine γ lyase (CSE), 
cystathionine β synthetase, and 3-mercaptopyruvate transferase (MPST or 3-MST)) that 
synthesize hydrogen sulphide (H2S) naturally in C. elegans. H2S has been shown to increase 
C.elegans lifespan and healthspan by acting as antioxidant or modulator of ROS production 
[330, 331].  Loss of mpst-1 gene in C.elegans reduces endogenous H2S production, significantly 
decreasing their lifespan and healthspan with significant elevation of ROS production [331]. I 
then used my S-XL-qRT-PCR DNA damage assay to investigate the mtDNA damage and found 
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that consistent with expectation in this case, mtDNA damage was significantly elevated in mpst-
1 mutant animals (Figure 4.6, p<0.01, Student’s t-test). The damaged mtDNA in mpst-1 mutant 
animals was 3.2 fold higher than wild type N2 animals. In contrast to the mitochondrial mutants, 
these data for the mpst-1 mutant animals are in agreement with mFRTA where high ROS 
production at certain baseline threshold, elevates oxidative damage sufficiently to shorten 
lifespan in C. elegans.  
Impairment of antioxidant defence or increase hypersensitivity to oxygen may not necessarily 
shorten the lifespan or elevate oxidative damage. Even when damage is elevated through 
radiation or genetic interventions, lifespan is not necessary shortened, at least in C.elegans. The 
data above shows that the effect of oxidative damage is probably molecule-, cell- or tissue-type 
specific and mtDNA may not be a determinant of lifespan in C. elegans. Measurement of a 
single biomarker cannot be interpreted as an indicator of global oxidative stress.  
4.4. Therapeutic approaches against mtDNA damage and ageing/age-related 
diseases 
The S-XL-qRT-PCR DNA damage assay was applied successfully to different genetic strains 
of C. elegans. I next investigated the changes in mtDNA damage due to pharmacological 
interventions in ageing and age-related diseases.  
I tested a mitochondria-targeted antioxidant, MitoQ (see section 1.10.1.) in a transgenic C. 
elegans, Aβ 1-42 (CL2006) model of Alzheimer disease (AD). Aβ has been previously found 
to target the mitochondria, elevating ROS production thus causing mitochondrial dysfunction 
[232, 233]. It is believed that Aβ accumulation is closely associated with oxidative stress and 
plays an important role in AD pathogenesis [90, 225-227]. This transgenic AD model 
constitutively expresses high-levels of human Aβ under a muscle specific promoter [17],  and 
thus relates Aβ-expression and cellular toxicity to an easily visible progressive-paralytic 
phenotype thus greatly facilitates pharmacological evaluation of intervention strategies [11, 12].  
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Given the mitochondrial localization of Aβ, I first hypothesized that mtDNA damage might 
play a significant role in modulating the C. elegans’ lifespan. I therefore expected that mtDNA 
damage should be higher in Aβ-expressing transgenic nematodes relative to wild type N2 
nematodes.  
In order to examine the ability of this mitochondria-targeted antioxidant to modulate 
mitochondrial oxidative damage burden, I tested the potential of the mitochondria-targeted 
antioxidant, MitoQ in a transgenic C. elegans model of AD. I hypothesized that if MitoQ does 
modulate oxidative damage in Aβ-expressing transgenic nematodes, then administration of 
MitoQ should extend the lifespan and reduce mtDNA damage in these animals.  
4.4.1. Determining the effective dose of MitoQ in Aβ-expressing nematodes 
My first goal was to determine the effective dose of the MitoQ to be used for this study. I started 
by conducting a blinded dose-response lifespan study at MitoQ concentrations of 0.1 µM, 1 
µM and 5 µM with the aim to identify the lowest MitoQ concentration resulting in optimal 
lifespan effects. As mentioned in the introduction (see section 1.10.1.), MitoQ is produced by 
covalently attaching an ubiquinone moiety to the lipophilic decyltriphenylphosphonium (dTPP) 
cation through a 10-carbon aliphatic carbon chain [271]. Studies have shown that the lipophilic 
cation, dTPP promotes mitochondrial depolarisation at high concentration [272, 332]. 
Therefore, a dTPP-only control at the same concentrations as MitoQ was used in order to 
control for nonspecific effect of dTPP on the survival of C. elegans. In addition to the dTPP 
controls, a negative control experiment in the absence of both MitoQ and dTPP was carried out. 
The dose-response lifespan study showed that Aβ-expressing transgenic animals treated with 1 
and 5 µM MitoQ displayed significant lifespan extension effects relative to untreated control 
Aβ 1-42 mutants.  No lifespan prolonging effect was seen in 0.1 µM MitoQ treated animals 
(Table 4.1, Figure 4.7A-C). The mean lifespans for animals treated with 1 and 5 µM MitoQ 
were 15.0 and 15.2 days, respectively compared to untreated control animals with a mean 







Mean Lifespan    
(SEM) (Days) 
p-value 
Control 13.2 ± 0.4; n=145  
0.1 µM MitoQ   13.8 ± 0.4; n=148 ns 
0.1 µM dTPP 15.2 ± 0.4; n=155 ** 
1 µM MitoQ  15.0 ± 0.4; n=161 ** 
1 µM dTPP 14.7 ± 0.4; n=158 ns 
5 µM MitoQ  15.2± 0.5;  n=148 ** 







Table 4.1. Mean lifespan of transgenic Aβ-expressing C. elegans from pilot dose-response 
survival study, Lifespan study A. Lifespan study was performed under blinded conditions. 
At each concentration, mean lifespan for MitoQ and dTPP vs. untreated control animals was 
analysed using ANOVA with Bonferroni’s post-test, mean±SEM. Only 1 and 5 µM MitoQ 
treatment significantly affected the mean lifespan of the transgenic animals.   













Figure 4.7. Dose-response survival study (Lifespan study A) of Aβ-expressing transgenic C. elegans treated with different concentrations 
of MitoQ or dTPP (n=200 worms per condition). Survival curves from each condition were compared to that of the untreated control, 
analyzed using Log-rank (Mantel-Cox) test.  (A) Administration of 0.1 µM MitoQ had no significant lifespan extension benefit to the transgenic 
animals but 0.1 µM dTPP treatment significantly extended survival of the nematodes (p<0.01). (B) Nematodes treated with either 1 µM MitoQ 
or dTPP showed significant lifespan extension (p<0.01 and p<0.05 respectively) although lifespan extension in 1 µM dTPP treated nematodes 
was less significant. (C) High concentration of MitoQ (5 µM) also showed significant lifespan extension benefit but its respective control, 5 µM 




In addition to MitoQ, 1 and 5 µM dTPP showed no significant lifespan extension or reduction 
on the survival of the transgenic Aβ-expressing mutant C. elegans (Table 4.1, Figure 4.7B and 
C). The mean lifespans of 1 and 5 µM dTPP treated animals were 14.7 and 13.7 days, 
respectively, but the differences were not statistically significant relative to untreated control 
animals (Table 4.1, Figure 4.7B and C). Surprisingly, in this initial study, there appeared to be 
a significant lifespan benefit on animals treated with 0.1 µM dTPP, with treated nematodes 
showing a significantly longer mean lifespan of 15.2 days compared to untreated control 
animals (Table 4.1, Figure 4.7A). However, this observation did not reproduce in subsequent 
studies. 
The results from this initial pilot lifespan study indicated that administration of 1 and 5 µM 
MitoQ showed the most lifespan extension effects with both concentrations having similar 
lifespan benefits (p=0.63, Log-rank(Mantel-Cox)-test). This suggested that higher 
concentrations of MitoQ (5 µM and above) had no additional lifespan benefit on the transgenic 
Aβ-expressing C. elegans. I therefore chose to explore 1 µM MitoQ as it was the lowest 
concentration that displayed optimal lifespan extension effect. 
To further confirm the effective dose of MitoQ to be used for this study, I then conducted two 
further lifespan studies. Similar to the pilot survival study, only administration of 1 µM MitoQ 
showed a consistent lifespan extension effect (P<0.01 for both 2nd and 3rd lifespan studies, 














Figure 4.8. Second dose-response survival study (Lifespan study B) of Aβ-expressing transgenic C. elegans treated with 0.1 and 1 µM MitoQ 
or dTPP (n=200 worms per condition). Survival curves from each condition were compared to that of the untreated control, analyzed using 
Log-rank (Mantel-Cox) test.  (A) Administration of 0.1 µM MitoQ or dTPP did not increase the survival of the transgenic animals. (B) Treatment 





4.4.2. MitoQ decreases the mortality associated with Aβ-induced toxicity in 
transgenic C. elegans  
Combined data from three experiments showed that 1 µM MitoQ prolonged mean lifespan of 
the transgenic nematodes on average by about 14 % (Figure 4.9A and B) compared to untreated-
control animals and this effect was statistically significant (p<0.0001). The maximum lifespan 
was also significantly extended in the MitoQ-treated nematodes compared to both dTPP-treated 
and untreated control animals (Figure 4.9A and C, p<0.0001). In fact, the MitoQ-treated 
animals had a 9 % increase in the maximum lifespan. The observation that MitoQ but not dTPP, 
extended the lifespan of the Aβ-expressing transgenic nematodes supports the notion that the 
lifespan extension effect in MitoQ treated animals was dependent on the antioxidant ubiquinone 







Figure 4.9. Lifespan study C, 3rd lifespan study of Aβ- expressing transgenic animals treated with 1 µM MitoQ, dTPP or vehicle (n=200 
worms per condition). (A) Administration of 1 µM MitoQ extended the nematodes’ survival, log-rank test showed a significant difference 
between MitoQ and untreated control (p<0.01). (B) Combined data of mean lifespan from three independent experiments, analyzed using 
Bonferroni’s post-test, mean±SEM. MitoQ significantly prolonged the mean lifespan of transgenic nematodes by about 14 % relative to 
untreated control animals (p<0.0001); while dTPP did not extend the mean lifespan of the transgenic animals. (C) Maximum lifespan average 
from three independent experiments, analyzed using Bonferroni’s post-test, mean±SEM. A significant maximum lifespan prolonging of 9 % 
was observed in animals administered with MitoQ (p<0.0001) relative to untreated control animals, while dTPP did not extend the maximum 




4.4.3. MitoQ delays Aβ-induced paralysis in transgenic C. elegans 
Pharmacological interventions for promoting healthspan have recently gained much interest 
due to the fact that lifespan modulation alone is of limited interest and is not a reliable indicator 
of overall health status. Healthspan is an index of physiological capacity which is the period of 
time that the animals are able to maintain good health [289]. In addition to survival study, I 
conducted a blinded healthspan study measuring motility as an indicator of health.  
In the healthspan study of the Aβ-overexpressing transgenic animals, only two classes of 
locomotion were scored: non-paralyzed and paralyzed. This is because this strain of animals 
also carries the rol-6 gene which causes the animals to rotate around their longitudinal axis, 
having uncoordinated movement instead of the coordinated sinusoidal movement. Non-
paralyzed animals were healthy, highly mobile, showed constant movement and rotated around 
their longitudinal axis, whereas paralyzed animals only moved their head or tail in response to 
prodding. 
As expected, health status of the nematodes in all groups declined as they aged. Figure 4.10A 
shows the healthspan curve from a single experiment of nematodes treated with 1 µM MitoQ 
or dTPP alongside with untreated control. Administration of MitoQ significantly delayed the 
onset of paralysis (p<0.0001, Figure 4.10A) and the animals remained healthy for a longer 
period of time. On Day 6, 82 % of untreated-control animals were non-paralysed, while, 95 % 
of MitoQ-treated and 93 % of dTPP-treated animals were non-paralysed. At day 10, 77 %, 70 % 
and 50 % of MitoQ-treated, dTPP-treated and untreated-animals, respectively, remained 
healthy (non-paralysed). The significant healthspan advantage even in dTPP-treated animals 
illustrates that dTPP also delayed paralysis in the animals, although to a lesser degree than 
MitoQ. The mechanism of this protection remained unclear at this point (see section 4.4.9. for 
explanation).  
Overall, MitoQ treated animals were healthier (p<0.0001, Figure 4.10B). Combined data from 
three independent experiments showed that MitoQ extended the mean healthspan of the 
122 
 
transgenic animals to 15 days or by about 13 % relative to untreated control animals (p<0.0001, 
Figure 4.10B). Comparing the mean healthspan of MitoQ and dTPP-treated animals, MitoQ 
significantly extended the mean healthspan by about 8 % (Figure 4.10B).  
Even at the later stages, when only 10 % of animals remained non-paralyzed (maximum 
healthspan), MitoQ again improved health, increasing the maximum healthspan relative to 
untreated control animals (Figure 4.10C). This difference was statistically significant 
(p<0.0001, Figure 4.10C). Overall, 10 % of animals treated with MitoQ remained healthy until 
day 23 which equates to an extension of maximum healthspan by about 7% relative to untreated 
control animals (P<0.0001). Relative to dTPP-treated animals, administration of MitoQ also 
significantly extended the animals’ maximum healthspan (p<0.0001, Figure 4.10C). In addition, 
comparing to untreated control animals, administration of dTPP improved neither the mean nor 









Figure 4.10. Healthspan of the surviving Aβ-expressing transgenic animals treated with MitoQ, dTPP or vehicle (n=200 worms per 
conditions). (A) Healthspan curve from a single experiment, representative of n=3 independent experiments. Administration of MitoQ 
significantly improved the healthspan by delaying the onset of paralysis in the transgenic nematodes (p<0.0001, Log-rank (Mantel-Cox) test).  
Combined data average from 3 independent experiments of mean and maximum healthspan, analyzed using ANOVA with Bonferroni’s post-
test,mean±SEM. (B) MitoQ treatment significantly extended the mean healthspan of the transgenic animals, delayed the onset of paralysis by 
about 13 % compared to untreated control animals (p<0.0001). (C) Compared to untreated transgenic animals, administration of MitoQ 
significantly extended the maximum healthspan of the transgenic animals by about 7 % (p<0.0001) while dTPP had no significant maximum 




4.4.4. MtDNA damage in pharmacologically treated animals: MitoQ treatment 
does not affect the mtDNA damage burden 
I found that Aβ expression reduces the lifespan of the nematodes and administration of MitoQ 
extends lifespan and improves healthspan of the transgenic animals. To test the hypothesis that 
mtDNA damage was involved in the lifespan and healthspan effect, I first examined the mtDNA 
damage in wild type N2 and Aβ-expressing transgenic animals.  
Surprisingly, using my S-XL-qRT-PCR DNA damage assay, I observed that there was no 
significant difference in the mtDNA damage in untreated Aβ-expressing transgenic animals 
relative to untreated wild type N2 animals (to avoid confusion, untreated, MitoQ-and dTPP-
treated wild type N2 animals will be labelled as WT-control, WT-MitoQ and WT-dTPP, 
respectively) (Figure 4.11, p=0.07, Student’s t-test). This result is unexpected given that Aβ 
expressions shorten the lifespan of the nematodes and also studies have shown elevation of 
oxidative damage to mtDNA in AD patients [155, 333, 334] and that MitoQ is an agent that is 
specifically designed to deliver its antioxidant moiety to mitochondria. I then determined the 
efficacy of MitoQ to modulate oxidative DNA damage burden in mitochondria in the Aβ-
expressing transgenic C. elegans. Using the S-XL-qRT-PCR DNA damage assay, I found that, 
while there appeared to be a slight trend toward lower mtDNA damage in MitoQ treated Aβ-
expressing transgenic animals relative to untreated control Aβ-expressing animals (Figure 4.11), 
there was no statistically significant effect. Animals treated with dTPP also exhibited a non-
significant trend to lower mtDNA damage relative to untreated Aβ-expressing control animals 
(Figure 4.11).  
This lack of effect was unexpected as MitoQ is one of the best-characterised mitochondria-
targeted antioxidants [272]. However, in this strain, it did not attenuate mtDNA damage burden 
in Aβ-expressing transgenic animals. This could be due to the extremely low mtDNA damage 
already in these animals, which is typically 0.4 lesions per 10 kbp according to my assay, or on 
the order of one lesion (or less) per mtDNA molecule. It is possible that the mtDNA damage 
level was too low for MitoQ to significantly suppress the damage level further. While the effect 
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of MitoQ on mtDNA damage might have been below the sensitivity of the assay, it is worth 
noting that damage levels are so low as to raise the question if any further decline in DNA 
damage would be functionally or physiologically relevant. Clearly, however, neither lifespan 







Figure 4.11. mtDNA damage in wild type N2, untreated Aβ-expressing control animals, 
MitoQ and dTPP-treated Aβ-expressing animals.  mtDNA damage quantified using S-XL-
qRT-PCR DNA damage assay shows that there is no significant difference in the mtDNA 
damage in untreated wild type N2 animals relative to untreated control Aβ-expressing control 
animals (p=0.07, Student’s t-test). mtDNA damage in untreated control Aβ-expressing animals 
was 0.4 lesions per 10 kbp. Administration of MitoQ did not significantly lower the mtDNA 
damage burden in the nematodes, the DNA lesion frequencies were 0.37 and 0.33 for every 
10,000 bp in MitoQ and dTPP treated animals, respectively. Although administration of MitoQ 
or dTPP appeared to show a trend to slightly lower the mtDNA damage in the nematodes, this 
difference is not statistically significant (p=0.9, ANOVA, mean±SEM), n = minimum 3 




4.4.5. MitoQ does not affect global oxidative stress  
In order to test whether MitoQ was able to modulate other biomarkers of oxidative stress and 
damage, I employed two different additional biomarkers, ROS production and protein carbonyl 
content. 
I employed the dichlorofluorescein diacetate (DCFDA) method in whole C. elegans to explore 
the efficacy of MitoQ in modulating global ROS level. In cells, DCFDA is cleaved by 
endogenous esterases into dichlorofluorescin (DCFH) which then reacts with ROS to form the 
fluorescent dichlorofluorescein [8]. Our laboratory has found that, using this whole nematode 
DCFDA assay in intact animals, we are able to show a reproducible, mild, age-dependent 
increase in DCFDA signal in ageing cohorts [62]. Lysing worms or cells, in contrast, will cause 
the release of transition ions such as iron and these may participate in redox cycling thereby 
generating more ROS and leading to overestimation of ROS levels. When cells are not disrupted, 
iron remains sequestered avoiding this particular set of artifacts [240, 335, 336]. However, 
elevation of DCFDA level, intermediate DCF radical formation and cytochrome c, all can cause 
artefactual DCFDA fluorescence signal [8, 336]. Therefore, DCFDA is an indirect measure of 
global ROS production rather than a specific measure of ROS generation and should be 
approached with caution. 
Administration of MitoQ resulted in lower apparent ROS level relative to the untreated control 
animals; however, this was not statistically significant (Figure 4.12). In fact, the ROS level in 
the dTPP-treated animals was similar to the MitoQ-treated animals (Figure 4.12). Despite 
several well-known limitations of this assay [240, 335], these data may be taken together to 
indicate that MitoQ had no significant effect on the global ROS flux relative to untreated control 
animals.  
The presence of oxidized protein can modify key enzymes and structural proteins and has been 
suggested to be part of the neurodegenerative process in AD [337]. To compare my null result 
in term of mtDNA to a more general marker of ROS-mediated damage, I utilize the protein 
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carbonyl content assay, which is a well-established marker of protein oxidation. Consistent with 
my mtDNA results and the DCFDA results, there was no significant differences in the levels 
of protein carbonyls in MitoQ, dTPP-treated and untreated control animals (Figure 4.13A and 
B). This shows that neither MitoQ nor dTPP appeared to be able to modulate global oxidative 
damage. Despite being a well-characterized mitochondria-targeted antioxidant, MitoQ 
therefore failed to modify oxidative stress as determined by global mtDNA damage, ROS flux 












Figure 4.12. Generalized ROS production rate measured using whole-worm DCFDA 
assay in intact animals administered with MitoQ, dTPP and untreated control animals. 
MitoQ and dTPP treatment had no significant effect on the global ROS flux compared to 
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Figure 4.13. Protein carbonyl content in Aβ-expressing transgenic animals treated with 
MitoQ, dTPP or vehicle. (A) A representative oxyblot image of protein carbonyl content 
from a single experiment. Lanes 1 and 2 show protein carbonyl content of untreated control 
transgenic animals. Lanes 3 and 4 show protein carbonyl content of transgenic animals treated 
with MitoQ while lanes 5 and 6 show protein carbonyl content of transgenic animals treated 
with dTPP.  (B) Relative protein carbonyl content normalised to worm protein from 5 
independent experiments, measured by a densitometric analysis of the slot blot intensity. The 
protein carbonyl contents of the MitoQ and dTPP-treated animals were similar to the untreated 
control animals (p>0.5, ANOVA, mean±SEM.), n=20 independent replicates. 
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4.4.6. MitoQ does not alter ATP levels and oxygen consumption rates 
The lifespan and healthspan studies showed a clear ability of MitoQ to extend the lifespan and 
healthspan of the transgenic animals. This was surprising given that neither global oxidative 
damage nor mtDNA damage differs significantly between untreated control animals and MitoQ 
or dTPP-treated animals.  
In order to explore this discrepancy further and to test the efficacy of MitoQ, in altering the 
global energy metabolic parameter, I next measured oxygen consumption rate and steady-state 
ATP content of Aβ-expressing transgenic animals. MitoQ administration did not alter the ATP 
content of the Aβ-expressing transgenic animals relative to untreated control animals (Figure 
4.14). I found that dTPP-treated animals had a trend toward lower ATP content (about 19 % 
less ATP content than untreated control animals) but the difference was not statistically 
significant (Figure 4.14).  
Aβ has been found to cause mitochondrial dysfunction as determined by impaired oxygen 
consumption. The determination of oxygen uptake rate is also a measure of mitochondrial 
function. Compared to untreated control animals, there were no significant changes in the 
oxygen uptake of MitoQ- and dTPP-treated animals (Figure 4.15). In fact, the oxygen uptake 
rates of untreated control, MitoQ- and dTPP-treated animals were similar. The untreated control 
animals consumed 0.36 µmol of oxygen per hour per mg of worm protein whereas oxygen 
uptake rate for both MitoQ- and dTPP-treated animals were 0.37 µmol per hour per mg of worm 
protein (Figure 4.15).  
Overall, MitoQ treatment did not alter the steady-state ATP content and oxygen consumption 
rate of the three treatment groups, suggesting that MitoQ was not able to modulate the 











Figure 4.15. Administration of MitoQ did not modulate the oxygen uptake of the Aβ-
expressing transgenic animals. Average oxygen consumption normalized to worm protein. 
Neither MitoQ nor dTPP had any significant effect on the oxygen consumption rate of the 




Figure 4.14. MitoQ treatment did not alter steady-state ATP level. There were no significant 
difference in the steady state ATP levels of Day 6 untreated-control, MitoQ- and dTPP-treated 




4.4.7. MitoQ protects complex IV of ETC 
My experiments up to this point, demonstrated that MitoQ did not modulate mtDNA damage 
burden, global oxidative stress nor alter global energy metabolism. This is surprising as MitoQ 
is an antioxidant that was designed to accumulate within mitochondria in order to protect 
mitochondrial membrane against oxidative damage. However, it did not show any positive 
effects in protecting mitochondria. I then investigated the efficacy of MitoQ to protect 
mitochondria and mitochondrial function more locally in the mitochondrial membrane by 
examining the function of the ETC protein complexes, complex IV and complex I. 
Complex IV is a large and terminal trans-membrane protein complex of the ETC. Complex IV 
receives electrons from cytochrome c and transfers the electrons to oxygen, converting oxygen 
to water [113]. Numerous studies have reported that complex IV activity is reduced in AD 
tissues [236, 338-340]. Therefore, we used a sensitive polarographic complex IV activity assay 
that measured complex IV activity in mitochondrial extracts. Complex IV activity was 
significantly higher in MitoQ-treated animals only (p<0.01, Figure 4.16) relative to untreated 
control animals and dTPP-treated animals. Compared to untreated control animals, there was a 
60 % increase in the complex IV activity in the MitoQ-treated animals (Figure 4.16). In contrast, 
no significant changes of the complex IV activity were detected in dTPP-treated animals 
relative to untreated control animals (Figure 4.16).  
In order to test for any direct artefactual effect of MitoQ on complex IV activity, a spiking assay 
was conducted using several concentrations of MitoQ. Figure 4.17 shows that spiking with 
different MitoQ concentrations did not change the complex IV activity detected. This confirms 
that MitoQ did not directly interfere with the complex IV activity measurement. Therefore, the 
elevation in complex IV activity detected in MitoQ-treated animals was most likely due to a 









Figure 4.16. Effect of MitoQ and dTPP on complex IV activity. A polarographic complex 
IV activity assay was conducted and normalised to the mtDNA copy number of the respective 
mitochondria extract. Administration of MitoQ significantly elevated the complex IV activity 
in Aβ-expressing transgenic animals (p<0.01, ANOVA with Bonferroni’s post-test, 
mean±SEM.) but there were no significant changes of complex IV activity in dTPP-treated 







































































































































































































Figure 4.17. Spiking assay: sample of traces of the Oxygraph-2K using water, MitoQ or 
dTPP. The blue line indicates the oxygen concentration in the sample. The red line indicates its 
derivative (control (water only), MitoQ or dTPP), the oxygen consumed by the sample. Spiking 
assay using different MitoQ or dTPP concentrations showed that neither MitoQ nor dTPP had 
any direct effect on the complex IV activity measurement.   
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4.4.8. MitoQ also protects complex I of ETC 
We further explored the efficacy of MitoQ in modulating another ETC key enzyme complex, 
complex I. This is because complex I is the first enzyme in the mitochondrial ETC that catalyzes 
the transfer of electrons from NADH to coenzyme Q10 and is the primary site of superoxide 
generation in the ETC, releasing superoxide to the mitochondrial matrix [8, 74, 119].  
Administration of MitoQ as well as dTPP significantly increased complex I activity in Aβ-
expressing transgenic animals relative to the untreated control animals (p<0.01, Figure 4.18).  
There were 42 and 54 % increases in the complex I activity in MitoQ- and dTPP-treated animals 
respectively (P<0.05 and p<0.01 respectively, Figure 4.18). In fact, dTPP-treated animals had 
a trend towards higher (about 9 %) complex I activity compared to MitoQ-treated animals and 
this is not statistically significant. This implies that the increase in complex I activity in MitoQ- 
and dTPP-treated animals could be due to a mild uncoupling effect of the dTPP moiety, not due 
to the antioxidant ubiquinone moiety.  
A spiking assay with different MitoQ or dTPP concentrations was also conducted and this 
verified that neither treatment of MitoQ nor dTPP interfered directly with complex I activity 
measurement (Figure 4.19).  
In summary, only MitoQ but not dTPP was able to elevate the complex IV activity in Aβ-
expressing transgenic animals, whereas, both MitoQ and dTPP significantly increased complex 
I activity in this strain. This suggests that MitoQ treatment either protected ETC enzymes 











Figure 4.18. Effect of MitoQ and dTPP on complex I activity. Rotenone sensitive complex 
I activity was measured based on decrease in fluorescence of NADH and normalized to mtDNA 
copy number of the respective mitochondrial extract. Administration of MitoQ and dTPP 
significantly elevated (p<0.01, ANOVA with Bonferroni’s post-test, mean±SEM) the complex 
I activity of the Aβ-expressing transgenic animals relative to untreated control animals. n=9 

















        


























Figure 4.19. Representative traces of fluorescence of NADH at ex/em wavelength 352/464 
nm (for MitoQ, dTPP and positive control). Addition of MitoQ or dTPP did not interfere 
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4.4.9. MitoQ increases cardiolipin content of mitochondrial membranes 
Changes in enzyme activity of the mitochondrial ETC can be secondary to changes in 
mitochondrial lipid, particularly to decreases in cardiolipin content in the mitochondria [339]. 
Cardiolipin is an inner mitochondrial membrane phospholipid [137, 138]. It is one of the lipid 
components of the ETC that interacts with ETC proteins to regulate a wide range of 
mitochondrial functions [341]. Cardiolipin is highly vulnerable to peroxidation due to its high 
polyunsaturated fatty acid content and its location near ROS production sites [137]. Therefore, 
loss of cardiolipin may be one of the factors that contribute to mitochondrial dysfunction in 
ageing and neurodegenerative diseases. To investigate MitoQ’s potential as a targeted 
antioxidant and its possible protective effect on mitochondrial lipids (MitoQ was specifically 
design to prevent lipid peroxidation), we employed a lipidomics method [62] to characterise 
mitochondrial cardiolipin species and determine the level of each cardiolipin species in 
untreated-control, MitoQ- and dTPP-treated animals. 
In general, MitoQ- and dTPP-treated animals showed a trend towards higher global cardiolipin 
levels relative to untreated control animals but this trend was not statistically significant (Figure 
4.20). We further employed a more detailed lipidomic analysis of individual cardiolipin species 
to evaluate the effect of MitoQ treatment on changes in mitochondrial lipids. We found that 
MitoQ treatment tended to increase the amount of cardiolipin in most cardiolipin species that 
we examined, particularly CL78, CL79 and CL80 (Figure 4.21). Interestingly, within the 
cardiolipin species, the highly unsaturated forms of cardiolipin (20:4) were significantly 
increased in MitoQ-treated animals (Figure 4.21), compared to relatively less unsaturated forms 
of cardiolipin (20:3). Among these unsaturated cardiolipin species, we consistently detected a 
significant, at least 16 % elevation (CL80:16, CL79:14, CL78:15 (p<0.05, p<0.01, p<0.01 
respectively). As highly unsaturated cardiolipin is more vulnerable to oxidative damage due to 
its polyunsaturated fatty acids structures [339], these data are consistent with the notion that 
MitoQ administration may protect the mitochondrial membrane, specifically highly unsaturated 
cardiolipin species from oxidative damage. Moreover, the increase in cardiolipin content is 
139 
 
consistent with the higher ETC activity that we observed in complex IV and I in MitoQ treated 








Figure 4.20. Effect of MitoQ administration on the content of the mitochondrial specific 
lipid cardiolipin. (A) MitoQ and dTPP treatment increased total cardiolipin content of 
mitochondrial membranes in the Aβ-expressing transgenic animals, but the difference was not 











Figure 4.21.A more detailed lipidomics method was used to characterize different cardiolipin species in the nematodes. Higher level of 
unsaturated cardiolipin (20:4) species were detected in MitoQ-treated animals relative to untreated-control nematodes (comparison: control vs. 




4.4.10. MitoQ does not modulate lifespan and healthspan of wild type N2 
nematodes 
My experiments up to this point show that MitoQ did not attenuate mtDNA oxidative damage 
nor reduce DCFDA fluorescence or protein carbonyl levels or modulate steady state ATP levels 
or oxygen consumption rate. However, I resolved that the protective effect on lifespan and 
healthspan might be due to the mode of action of MitoQ to ameliorate depletion of the 
mitochondrial lipid cardiolipin and protection of complex IV and I of the ETC, in particularly 
the protection to complex IV that is pathologically reduced in AD. MitoQ is predominantly 
localized to mitochondrial membrane thus protecting the ETC complexes and mitochondrial 
lipid. I therefore conducted a lifespan experiment in wild type N2 animals, expecting that 
MitoQ would not have any effect on the lifespan or healthspan of the wild type animals. 
Consistent with my hypothesis, no lifespan prolonging effect was seen in wild type N2 animals 
treated with MitoQ or dTPP compared to untreated control wild type N2 animals (Figure 4.22).  
Similar to the lifespan study, administration of MitoQ did not improve the healthspan of the 
wild type N2 animals (Figure 4.23). There are no differences in the motility of the MitoQ, 
dTPP-treated as well as untreated control animals (Figure 4.23). Hence, MitoQ may be an 


















Figure 4.23. Survival curve of wild type N2 C. elegans in the presence of 1 µM MitoQ, 
dTPP or vehicle (n=200 worms per condition). Neither MitoQ nor dTPP treated animals 
significantly extended the lifespan of the wild type N2 animals 
 
Figure 4.22. Healthspan curve of wild type N2 C. elegans administered with MitoQ, 
dTPP or untreated control wild type animals (n=200 worms per condition). Neither 






5.1. Consequences of ROS perturbation in C. elegans  
Damage due to mitochondrial ROS has been suggested to be a main cause of ageing. However, 
even if this is true, mitochondrial ROS production alone is not sufficient to explain longevity 
as living systems are protected by antioxidant defense systems. These systems are responsible 
to safeguard cells from ROS-mediated oxidative damage and steady state damage levels, 
therefore, are complex functions of ROS production, ROS detoxification and damage repair. 
These antioxidant systems provide a popular avenue for testing the mFRTA. This is because, if 
the mFRTA is correct, impaired expression of, for instance, mitochondrial SOD enzymes might 
be expected to increase oxidative damage and shorten lifespan. I found that mtDNA damage as 
evaluated by my S-XL-qRT-PCR DNA damage assay was indeed significantly elevated in 
MnSOD mutant nematodes. However, in contrast to expectation from the FRTA, the lifespan 
of these nematodes, although devoid of all mitochondrial MnSOD and suffering from elevated 
oxidative damage, was not shortened [88, 213]. Surprisingly, we further found that impairment 
of mitochondrial SOD detoxification capacity does not appear to elevate total ROS, at least as 
measured by DCFDA fluorescence dye, but instead dramatically decreases the generalized ROS 
production [62]. This surprising result can likely be explained as part of a broad set of 
compensation strategies found in C. elegans that sacrifice mitochondrial energy for reduced 
ROS production, especially during situations where ROS detoxification is impaired. In the case 
of the SOD mutants, the reduction of ROS production was probably due to repression of flux 
through the ETC by direct mitochondrial ETC inhibition [62]. In support of this hypothesis, 
deletion of mitochondrial MnSOD resulting in phenotypes with reduced energy production, 
such as reduction in the number of progeny that survive and smaller size [88, 213].   
This example illustrates two important insights that I encountered several times during my work 
on this project. First, the phenotypes of the SOD mutant strains reveal features of a complex 
regulatory system where unexpected effects and even counter-intuitive effects in response to 
perturbation are typical features. Such complexity can be observed relatively common in the 
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free radical feedback systems that control lifespan. Secondly, given this degree of complexity, 
the SOD mutants are another example for the need for carefully validated biomarkers of damage, 
ROS production and metabolism. Given that on ROS homodynamic systems are complex, it is 
difficult or impossible to guess what the consequences of a given perturbation might be in terms 
of damage, unless damage is actually measured and measured well.  
5.1.1. Complexity in antioxidant perturbations in C. elegans  
I already discussed the unexpected results in terms of ROS production and metabolism when 
mitochondrial SODs are knocked out. Unexpected consequences also occur not only with 
knockout nematodes but also with overexpression of the same mitochondrial SODs, in C. 
elegans. As expected by FRTA, overexpression of mitochondrial sod-2 does increase the 
lifespan (by about 25 %) without however, reducing oxidative damage accumulation, at least 
in C. elegans as assessed by protein carbonyl accumulation [342]. Similar complexity also 
became apparent when we repressed another antioxidant enzymes , mitochondrial prdx-3 [342]. 
In nematodes, this intervention, again, neither shortens nematodes’ lifespan nor elevates 
oxidative damage to proteins. Instead, loss of prdx-3, similar to the case of SOD knock out, 
reduces total energy availability, manifesting in reducing motility and brood size. However, in 
this case, we showed that the compensatory mechanism involves mitochondrial uncoupling 
instead of mitochondrial ETC inhibition [343].  
5.1.2. Complexity in mutation that alters mitochondrial function in C.elegans  
I have also found similar complexity in regulatory mechanism in nematodes harbouring a 
mutation of the ETC, mev-1. Mev-1 encodes a subunit of the enzyme succinate dehydrogenase 
cytochrome b, which is part of the mitochondrial ETC complex II. Nematodes with mev-1 
mutation, lack functional complex II and produce excess ROS [324, 328]. These mev-1 mutants 
are known to suffer from high oxidative stress and short lifespan [324, 328]. Instead mev-1 
mutants have specifically been reported to suffer from high accumulation of protein damage at 
old age [326]. I investigated mtDNA damage in this strain, expecting it to be high as well. 
Surprisingly, I instead found low mtDNA damage (in the level of less than one lesion per 
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mitochondrial molecule) as measured using my S-XL-qRT-PCR DNA damage assay. In fact, 
mtDNA damage in this mev-1 mutant is even lower than mtDNA damage in wild type N2 
animals as discussed in section 4.3. This is surprising as mev-1 lies in the mitochondrial inner 
membrane in succinate dehydrogenase cytochrome b of complex II facing the mitochondrial 
matrix [344]. While mtDNA is housed in the mitochondrial matrix, it is anticipated that mev-1 
mutation may increase the ROS production at the mitochondrial matrix, thus mtDNA that is 
located in matrix would be expected to be damaged. However, for unknown reasons, this 
apparently is not the case.  
Another example of this complexity due to regulatory mechanisms in nematodes are short-lived 
mpst-1 (3-mercaptopyruvate sulfurtransferase (3- MST) orthologues) mutants. These mutants 
do not have the ability to produce endogenous H2S, suffer from elevated ROS and short lifespan. 
These animals also have high mtDNA damage but there was no elevation in protein 
carbonylation [331]. Interestingly, ROS production is elevated in this mpst-1 mutant as 
determined using both DCFDA and MitoSOX dye. Again, I observed surprising results in C. 
elegans when I attempted to confirm one mutant with another in a short-lived strain. It is unclear 
why damage levels are inconsistent between different macromolecules, while lifespan is 
shortened in some cases.   
5.1.3. Complexity in non-genetic perturbations: γ-irradiation response in C. 
elegans  
As shown above, perturbation of antioxidant system and endogenous ROS in C. elegans results 
in complex processes that are often difficult to interpret. In order to more directly test the 
relevance of mtDNA in the context of lifespan determination, I used γ- irradiation to artificially 
introduce additional damage to mtDNA directly in C. elegans. Strikingly, I found that lifespan 
of nematodes exposed even to 40 kRad γ-radiation was not shortened, despite a significant 
increase in the mtDNA damage. This lack of lifespan shortening in C. elegans after 40 kRad γ-
irradiation was surprising because lifespan has previously reported to be significantly shortened 
in C. elegans even exposed to γ-irradiation as low as 5 kRad [345]. For example, Ye et al. 
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reported that 5 and 20 kRad γ-irradiation were both able to shorten the mean lifespan of C. 
elegans by 41 and 69 %, respectively [345]. A likely explanation for these discrepancies is that 
Ye et al. exposed nematodes to γ-radiation during first larvae stage while in my experiment, 
nematodes were only treated with γ-radiation after they had reached adulthood. During the 
larvae stage, C. elegans somatic blast cells undergo cell divisions, while no cell divisions take 
place during adult stage [346]. Damaged DNA is passed on to the new cells during the larvae 
stage cell division which impacts the survivorship of the nematodes. Furthermore, dividing cells 
are generally more susceptible to DNA damage and more likely to undergo apoptosis. 
Unfortunately, no data on oxidative biomarkers were reported in the nematodes exposed to γ-
radiation at larvae stage. This is another example where nematodes are able to survive for a 
long period of time (normal lifespan) despite having high oxidative mtDNA damage. However, 
similar to the case of the antioxidant system perturbations discussed above, these animals again 
exhibit a low energy phenotype. They do not have normal healthspan and move significantly 
less.   
5.2. The need for good biomarkers?  
As discussed above, given these complexities in terms of lifespan, healthspan and damage 
response, it is difficult to understand the consequences of genetic, physical and pharmacological 
perturbations and mechanism of ageing in the absence of carefully validated markers of 
oxidative damage. Therefore, good biomarkers with stable oxidation products that reflect 
oxidation status at specific site at macromolecules are needed. Previously, no such marker was 
available for mtDNA in nematodes.  
Using a previous marker, we had found that mtDNA damage was not significantly elevated in 
the MnSOD mutant nematodes [62]. However, as mentioned earlier in section 3.3.4., the basic 
Fpg-qRT-PCR DNA damage assay lacks sensitivity, exhibits high variability and is subjected 
to possible artifacts. Therefore, I developed a new S-XL-qRT-PCR DNA damage assay in order 
to overcome the limitations of the Fpg-qRT-PCR DNA damage assay. Using this new assay, I 
was able to detect statistically significant increases in damage to mtDNA in the SOD mutants. 
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These animals now therefore pose a stronger challenge to mFRTA, at least in C. elegans, 
because the damage level to mtDNA is higher but lifespan is normal.  
We should be aware that we cannot make the assumption that oxidative damage in one set of 
macromolecules is necessarily correlated closely to elevated damage in other macromolecules. 
For example, in the case of both the mev-1 and mpst-1 mutant nematodes, not all 
macromolecules showed high oxidative damage. Unexpected results were also observed in the 
aforementioned study, where overexpression of sod-1 increases the level of H2O2 [347].  
However, overexpression of sod-1 increases the levels of protein oxidation but does not alter 
the levels of lipid oxidation. This is an example illustrating that animals suffer from high 
oxidative damage in one macromolecules do not necessary also suffer from high damage in 
another macromolecule and vice versa. Our data are consistent with this view in the case of 
mpst-1 mutant nematodes, where we initially expected that high ROS level in mpst-1 mutant 
nematodes would equally elevate damage to all macromolecules. However, this is not the case. 
We have observed that the mpst-1 mutant has increased mtDNA damage but normal level of 
protein damage. Good biomarkers are clearly required to determine if oxidative damage to a 
given target is actually elevated.  
Many studies attempted to test the mFRTA either by modulating antioxidant defenses or 
pharmacological interventions, however, often only lifespan studies are reported and data on 
oxidative damage accumulation is usually missing [88, 275, 328, 348-350]. For example, 
original study of the SOD mutants, the authors concluded that the superoxide radical is not a 
major determinant of ageing [88]. However, this conclusion was uncertain without any data on 
oxidative damage. This is because in the absence of oxidative damage data, the underlying 
mechanisms that determined the lifespan, whether these data challenge the mFRTA was unclear.   
In the context of pharmacological interventions, reliable oxidative biomarkers are also needed 
in order to answer the questions concerning interventions that can attenuate oxidative stress. 
For example, I found that mitoQ, a mitochondrially-targeted antioxidant not only prolongs the 
lifespan of transgenic Aβ overexpressing nematodes but also improves their healthspan. 
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However, we cannot assume that the observed beneficial effects on lifespan and healthspan in 
response to exposure to MitoQ are due to a global antioxidant effects without confirmation of 
this expectation through the use of appropriate biomarkers. Attempting to do so, I found that 
MitoQ did not in fact decrease ROS levels as measured by DCFDA fluorescence dye, and did 
not reduce protein carbonyl levels or modulate levels of oxidative damage in mtDNA in the 
transgenic Aβ overexpressing nematodes despite its clear efficacy in ameliorating the 
phenotype of early death. This is surprising as MitoQ is an antioxidant that is specifically 
designed to selectively absorb and accumulate within mitochondria, making it reasonable to 
expect that MitoQ might exert its effects through modulation of oxidative stress. However, I 
found that administration of MitoQ instead specifically increases or protects mitochondrial 
lipids (cardiolipin) and associated lipid bound ETC complexes (Complex I and IV), suggesting 
that MitoQ may be effective specifically in protecting the mitochondrial inner membrane. 
Based on the results, I expected that MitoQ might improve mitochondrial general metabolic 
energy availability. However, when I measured ATP content and oxygen consumption rate, I 
found that administration of MitoQ did not in fact affect the global energy availability, despite 
an improvement in mitochondrial ETC activities.  
These data illustrate that not all antioxidants reduce oxidative damage to all macromolecules, 
even when they show efficacy in treatment conditions associated with elevated oxidative 
damage. Relationships between lifespan and oxidative damage accumulation should be 
carefully examined. Oxidative and metabolic biomarkers are important tools to investigate 
antioxidant activity of compounds in order to study how and where the interventions work. 
Furthermore, an ideal oxidative biomarker should be molecule, cell and tissue-specific to 
overcome some of the complexity of free radical metabolism and stress response system in the 
context of the process of ageing. It may be not surprising that I also found that MitoQ does not 




5.3. Mitochondrial DNA is not a determinant of ageing in C. elegans  
 
With the establishment of appropriate biomarkers, it is possible to test prediction of the mFRTA 
directly. Mitochondria are often believed to be the major site of ROS production as well as a 
major target of oxidative damage.  
 5.3.1. mFRTA: Mitochondrial DNA damage and ageing  
If the accumulation of oxidative damage as a consequence of inadequate detoxification of ROS 
by antioxidants controls ageing rate, modulating the expression of antioxidant enzymes should 
increase or decrease the lifespan. Similarly, according to mFRTA, long-lived mutants should 
show low levels of oxidative damage, such as low level of mtDNA damage, lipid peroxidation 
and protein carbonylation. MtDNA damage in particular, is of interest because among different 
types of ROS-mediated molecular damage, damaged to mtDNA can lead to irreversible loss or 
alteration of mitochondrial coding sequences, thus changing its genetic information.  
Using my S-XL-qRT-PCR assay, I found that there is some age-associated mtDNA damage 
pattern in C. elegans with a trend toward more mtDNA lesions in old nematodes.  This is 
somewhat consistent with the expectations of mFRTA and studies in humans that also show 
mtDNA damage accumulation with age, at least when determined using a HPLC method [207, 
351]. Using a HPLC-ECD method, the most commonly measured DNA lesion, 8-OHdG is 
shown to accumulate with age in human heart [207]. However, it is still unclear whether this 
accumulation of mtDNA damage is related to ageing given the small change in the level of 
mtDNA damage, so it is difficult to know what the important functional consequences are.  
Normal lifespan in MnSOD mutant nematodes might be attributable to reduced general ROS 
production and decreased energy metabolism, delaying development and reproduction [62, 88, 
213], which is the phenotypic characteristics of long-lived animals. This lack of effect on 
lifespan can be explained by mechanisms that alter mitochondrial function in these SOD 
mutants. As suggested by Van Raamsdonk et al., none of the sod genes are responsible for 
lifespan effect in these sod deleted mutants and genetic manipulations that affect mitochondrial 
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functions and lifespan in a number of mutants in C. elegans show phenotypes of long-lived 
mutants [63]. This indicates that deletion of MnSOD in C. elegans does not decrease the 
survival of the nematodes possibly due to alteration of mitochondrial function where 
generalized ROS production as measured by DCFDA fluorescence dye was reduced, although 
the mtDNA damage is clearly higher but lifespan was unchanged. However, while the level of 
damaged mtDNA in the MnSOD mutant is significantly higher than in wild type nematodes, 
the absolute level remains low (1.9 lesions per mtDNA molecule, see section 4.3, Table 5.1) 
and this absolute level might be too low to suppress functional mitochondria and too low to 





















1 Wild type N2 0.9 NA Normal #[213] 
2 MnSOD 
knockout 
1.9 * Normal #[213] 





3.0 ** Decreased 
(15.4 %) 
#[331] 
5 glp-1 0.6 NA Normal  
6 γ-irradiated 1.2 ** Normal  
7 UV-irradiated 2.5 *** Decreased 
(10.5%) 
 
# denotes lifespan data obtained from journal papers.  
Table 5.1.  Levels of mtDNA damage and lifespan. 2 to 4: mtDNA damage and lifespan of 
mutants were compared wild type N2 nematodes. 6-7: mtDNA damage and lifespan for mutants 





While data in MnSOD and mev-1 mutants imply that small variations in mtDNA damage may 
not be a determinant of ageing rate, the levels of damaged mtDNA in these mutants are well 
below three lesions per mtDNA molecule (Table 5.1). In fact, the level of mtDNA damage in 
mev-1 mutant is even lower than wild type N2 nematodes (Table 5.1). One interpretation of the 
data therefore is that for the mtDNA damage to significantly affect and thus shorten the lifespan 
of the nematodes, the level of mtDNA damage has to be higher than some threshold.  As 
previously mentioned, I found that short-lived mpst-1 mutant nematodes suffer from higher 
(more than three lesions per mtDNA molecule) mtDNA damage compared to wild type C. 
elegans and these animals are short-lived [331]. However, while some have reported 
association of mitochondrial function and mtDNA damage [352, 353], there are also 
suggestions that H2S production by mitochondrial 3-MST controls mitochondrial function 
directly, e.g. by serving as electron donor to enhance mitochondrial electron transport [353].  It 
is thus still unclear whether the shortening of the mpst-1 mutants’ lifespan is due to the elevation 
of the mtDNA damage or dysfunctioned mitochondria by some other mechanisms.  
To investigate the idea that mtDNA damage may affect lifespan only above certain thresholds, 
I compared the levels of mtDNA damage in nematodes exposed to γ- and UV-irradiation. I 
found that exposure to γ-radiation elevates damaged mtDNA but lifespan is not shortened, 
possibly because the level of mtDNA damage is still below the threshold level that is sufficient 
to decrease lifespan. However, interestingly, γ-irradiated nematodes move significantly less 
than non-irradiated nematodes. The decrease in the distance travelled in γ-irradiated nematodes 
may suggest that these animals, similar to the SOD and PRDX mutants, may sacrifice energy 
for survival.  
Also, using my S-XL-qRT-PCR DNA damage assay, I found that 400 J/m2 UV-irradiation 
increases mtDNA damage to a significantly higher degree, reaching about three lesions per 
mtDNA molecule. Using a similar approach, Leung et al. have also shown that mtDNA damage 
is elevated in larvae of UV-irradiated C. elegans [354]. These UV-irradiated larvae also 
consume less oxygen while maintaining a normal level of steady state ATP [354]. Thus, 
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consistent with my idea, the lifespan shortening effect in UV-irradiated animals could also be 
due to failing mitochondria. While the γ- and UV irradiation experiments were initially 
designed only to test the damage detection method, the lack of lifespan result in γ-irradiated 
animals is surprising.  Therefore it would be interesting to titrate the mtDNA damage over a 
wider range, so as to identify more clearly whether a threshold of mtDNA damage that affects 
lifespan exists.  
Mitochondria do clearly fail in ageing nematodes and whether these dysfunctional 
mitochondria are a cause of ageing, remains to be studied. Also, one would expect that the 
shortest-lived animal, for instance, C. elegans has higher damage than other longer-lived 
species. However, this not the case as the total DNA damage levels are comparable between 
humans, mice and C. elegans [355-357].  
In some cases where C. elegans were used as a model, the mFRTA seems to be supported by 
the notion that lifespan was reduced in the animals (mpst-1 mutant nematodes or UV-irradiated 
nematodes) with high mtDNA damage. However, we should be aware that these are mutants of 
antioxidant perturbations or oxidative damage perturbations. The lifespan effects do not reflect 
the actual natural ageing process, but may in fact be pathology due to excessive high oxidative 
damage to mtDNA or other molecules. 
Previously, it has been reported that protein carbonyl contents in long-lived mutants such as 
daf-2 and age-1 mutant nematodes were low [326, 358]. The authors concluded that oxidative 
damage is the major determinant of ageing in C. elegans by determining the oxidative damage 
to protein only. This is an area that needs to be addressed to determine the consistency of the 
levels of oxidative damage to other macromolecules.  I have yet to apply my new assay to these 




5.4. C. elegans as a model system for studying human ageing/ diseases  
5.4.1. Relevance of the C. elegans system to mammals systems 
Despite its evolutionary distance from mammals, C. elegans has become a prominent model 
organism for studying aging. C. elegans shares 60-80 % homologues of genes identified in 
humans  [259]. Several age-related changes associated with ageing are similar in worms, flies 
and humans [359]. For example, as nematodes age, they gradually slow in their movement and 
display uncoordinated movement activity [257]. This reduction in physical activity is consistent 
with flies, mice and humans where old age is associated with poorer movement skill [360-362]. 
In C. elegans, these age-related changes in the patterns of movement are due to deterioration in 
muscle cells [287].  We and others have also shown that mitochondrial function, oxygen 
consumption and metabolic rate in nematodes decline with ageing, which also happens in other 
animals, including human beings.  
Another area in ageing where nematodes are increasingly used, are age-dependent diseases. An 
example to study human age-related diseases is the study of Alzheimer disease, where 
transgenic animals were engineered to overexpress human Aβ. I showed that in C. elegans, 
transgenic Aβ overexpressing nematodes have deficiency in mitochondrial ETC complex IV 
activity. This finding is in line with several studies conducted in humans’ brain and transgenic 
AD mouse model, where complex IV activity is also significantly reduced in AD tissues [236, 
338-340].  
However, C. elegans is obviously not appropriate in all regards as a model for human biology. 
For example, I exposed C. elegans to 40 kRad γ-radiation and measured the mtDNA damage 
and physical changes caused by this γ-radiation dose.  40 kRad γ-radiation is 100 times higher 
than the 0.4 kRad radiation dose that is expected to cause a 50 % death rate in humans [363]. 
This dosage is needed to observe significant effect in nematodes because fully developed adult 
C. elegans consist of non-dividing somatic cells with no cellular replication [364]. This non-
proliferative property of adult C. elegans somatic cells is important when considering radiation 
responses. Irradiation of nematodes during post-egg laying period involves only somatic cells 
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that can tolerate higher levels of damaged DNA and therefore much more resistance to radiation 
damage [365].  
Like mammals, C. elegans possesses all the typical antioxidant genes such as SOD and PRDX. 
However, one difficulty in using C. elegans as a model to study mammalian ageing are the 
significant differences in the response of nematodes to perturbations between C. elegans and 
mammals.  
Numerous studies have been done to characterize the effect of impaired SOD on lifespan and 
oxidative stress resistance in different model systems. As previously discussed in sections 5.1. 
and 5.1.1., mitochondrial MnSOD knockout  mutants nematodes suffer from increased mtDNA 
damage but the lifespan of the nematodes is not altered [88, 213]. Unlike nematodes, mice 
lacking mitochondrial SOD die at very early ages and also suffer from high accumulation of 
lipid peroxidation products and reduced mitochondrial ETC function [366, 367]. Overall, 
deletion of mitochondrial SOD in both C. elegans and mice models results in dramatically 
different consequences in terms of lifespan and healthspan.  
Similarly, deletion of mitochondrial PRDX, prdx-3 in C. elegans, neither shortens lifespan nor 
elevates oxidative protein damage. Instead, loss of prdx-3 reduces total energy available by 
reducing motility and brood size. We believe this to be due to mitochondrial uncoupling as a 
compensatory changes in response to lack of prdx-3 [343]. Unlike the effect of repression of 
PRDX in mitochondria in nematodes, knocking out of mitochondrial PRDX in mice does 
increase ROS generation and elevates DNA and protein oxidative damage [368]. However, at 
present it is unclear whether mice lacking mitochondrial PRDX suffer from early death or 
elevated mtDNA damage. This is another example that shows differences between mice and 
nematodes. Overall, antioxidant enzymes are conserved throughout all the biological kingdom, 
but the regulatory mechanisms and damage responses in C. elegans are different from 
mammalian systems. In the case of SOD, C. elegans contains more homologues of SOD than 
mice with an additional mitochondrial SOD, sod-3 that exists in C. elegans. It seems that, at 
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least in C.elegans, mitochondrial ETC inhibition and mitochondrial uncoupling are the 
response for the repression of SOD and PRDX, respectively.  
Finally, as discussed above, using my DNA damage assay, I found no elevation of mtDNA 
damage in mev-1 mutant nematodes, despite the fact that the animals are short-lived.  Similar 
to mev-1 C. elegans, mouse embryonic fibroblast cells with equivalent mutation suffer from 
high cell death and accumulate high oxidized protein [324, 369]. By contrast to my DNA 
damage results, studies in young mouse fibroblast cells showed two-fold higher accumulation 
of 8-OHdG, a DNA damage marker, in  the mev-1 cells than control cells [324, 369].  
It is obvious from these results that in many ways C. elegans are not like mice. It seems that 
some of the compensatory mechanisms are private to the nematodes.  
5.5 Conclusions    
It is becoming increasingly apparent that mitochondria are involved in ageing. As the major 
producer and target of ROS, oxidative damage accumulation in mitochondria has been 
implicated to be the major cause of ageing. However, it is still unknown as to what type of 
oxidative damage, if any, is a determinant of ageing rate.  
Many studies have attempted to test the mFRTA by perturbing oxidative damage through 
various genetic, pharmacology and physical interventions. Changes in lifespan have often been 
reported together with only sparse data on oxidative damage. It is usually assumed that 
perturbation of antioxidants system will affect oxidative damage and that this, in turn, will 
affect lifespan; however, this is clearly an oversimplified view and consequently results are 
conflicting. I found features of a complex regulatory system in C. elegans. There is complexity 
in terms of lifespan and damage response and several compensatory mechanisms that alter 
mitochondrial activity have evolved to maintain ROS homeostasis in nematodes.  
My data also show that it is possible for the nematodes to be long-lived with high oxidative 
damage (eg. MnSOD mutant and γ-irradiated nematodes) or short-lived with low mtDNA 
damage (eg. mev-1 mutant nematodes). While, in some cases, I indeed found nematodes to be 
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short-lived with high oxidative damage, for example, in the case of short-lived UV-irradiated 
nematodes and mpst-1 mutant nematodes with high levels of damaged mtDNA. This may not 
be a causal relationship and may not be due to accelerated ageing.  Furthermore, one should not 
expect high oxidative damage in all macromolecules of a given short-lived nematode. For 
example, damage to protein and to mtDNA were inconsistent in antioxidant perturbation in 
both mpst-1 and mev-1 mutant nematodes. Short-lived mpst-1 mutant animals suffer from high 
mtDNA damage but, surprisingly, do not suffer from elevated oxidative damage to protein. 
Given these complexity, results of perturbation are often difficult to interpret. Therefore, well 
validated markers of oxidative damage are needed in order to test the relevance of oxidative 
damage to macromolecules, particularly, mtDNA to the survival of nematodes.  
I found evidence that a level of mtDNA damage below a certain threshold does not affect the 
nematodes survival. However, when mtDNA damage is sufficient to cause variations in lifespan, 
this appears as pathological and this lifespan shortening may not be a determinant of ageing 
either. Finally, pharmacological intervention using MitoQ improves the lifespan and healthspan 
of the transgenic Aβ-expressing nematodes but does not ameliorate damaged mtDNA and 
protein. MitoQ also does not affect lifespan of wild type N2 nematodes.  
Comparing this to mice, I found that regulatory mechanisms in C. elegans are quite different 
from mice.  In nematodes, antioxidant perturbations results in compensatory mechanisms 
involving mitochondrial uncoupling or mitochondrial ETC inhibitions and resulting in 
significant metabolic suppression. In mice, perturbations of antioxidants appear to elevate 
oxidative damage and shorten lifespan. It is therefore unsurprising that reported data in 
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7. Appendix  
7.A.1. DNA extraction 
The development and validation of good assays is important to measure and report the true level 
of DNA damage.  
Careful DNA extraction for DNA damage assays is essential. A good DNA extraction technique 
should optimize DNA yield while minimizing DNA degradation and artifacts. Special care 
should be taken to avoid nicking, shearing or introducing additional oxidative DNA damage 
during the DNA extraction and purification process. DNA extraction protocols should also 
result in reproducible yield and generate DNA samples that can be stored without DNA 
degradation.  In order to obtain a DNA extraction method that met these criteria, I tested DNA 
samples obtained from total genomic DNA and compared these to nuclear/mitochondrial DNA 
obtained by organelle separation. The mitochondrial and nuclear fractions were obtained from 
differential centrifugation (a method that allows the isolation of nuclei and mitochondria from 
homogenates) of worm lysate. Mitochondrial and nuclear fractions were then cleaned up using 
the Prepman Ultra sample preparation reagent, whereas the total genomic DNA was cleaned up 
using a spin column-based nucleic acid purification method according to the manufacturer’s 
protocol.  
I tested the quality of DNA from these different extraction methods early in the method 
development using the Fpg-qRT-PCR approach, which I based on the method demonstrated by 
Lu et al. [248]. I found that the mtDNA damage in DNA samples obtained from mitochondrial 
fractions were not significantly different from mtDNA damage in total genomic DNA, with 
2.5±1.7 and 1.1±0.3 lesions per 10 kbp respectively (Figure 7.1A). Similarly, nuclear DNA 
damage in DNA samples extracted from nuclear fractionswas not significantly different from 
nuclear DNA damage measured in total genomic DNA with 1.0±0.3 and 1.2±0.3 lesions per 10 
kbp respectively (Figure 7.1B). Furthermore, statistical analysis showed that there was no 
significant different in the DNA damage between mitochondrial and nuclear DNA (Figure 
7.1C). Taking these data together, Figure 7.1 shows that there is no significant difference in the 
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DNA damage levels obtained from different DNA extraction methods at least for baseline 
damage. 
 
The extraction of total genomic DNA requires a relatively large quantity of worms due to the 
small size of C. elegans and loss of sample using the spin column-based DNA purification 
method. Therefore, all subsequent assay optimization for the DNA damage assay was 
performed using mtDNA or nuclear DNA extract obtained using differential centrifugation 


















































         
 
Figure 7.1. DNA damage level of different DNA extracts of Day 4 wild type N2 animals 
determined using Fpg-qRT-PCR approach. (A) DNA damage in mitochondrial DNA and 
total DNA extracts determined using mitochondria primers set. There was no statistically 
significant difference in the DNA damage per base pairs in mtDNA obtained using differential 
centrifugation and total genomic DNA, (p=0.3, Student’s t-test).  (B) DNA damage level of 
nuclear DNA and total DNA extracts determined using nuclear primers set. There was no 
statistically significant difference in the DNA damage using the nuclear DNA obtained by 
differential centrifugation, (p=0.4, Student’s t-test). (C) The DNA damage in the mtDNA 
extract was not statistically significant higher than DNA damage level in nuclear DNA extract.  
MtDNA damage 
Nuclear DNA damage 
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Using the comet assay, I had earlier shown that there was a significant dose-dependence 
increase in nuclear DNA damage in γ-irradiated animals (Figure 3.6). At this stage, all the 
different DNA extraction methods appeared to be similar. I therefore, used the Fpg-qRT-PCR 
approach to further assess which DNA extraction protocols were able to detect elevation of 
DNA damage with increasing γ-radiation dosage. However, using the Fpg-qRT-PCR DNA 
damage assay, DNA damage in the mitochondrial fraction, nuclear fraction and total genomic 
DNA amplified using mitochondrial or nuclear primers set, did not show a statistically 
significant dose-response increased of γ-irradiated DNA damage (Figure 7.2A).  Although the 
samples from mitochondria, nuclear fraction and total genomic DNA amplified using nuclear 
primers set, showed increasing trends, these were not statistically significant (Figure 7.2A, C 
and D).  
Furthermore, the large variations in oxidative DNA damage values demonstrated that this Fpg-
qRT-PCR approach lacks robustness and the fact that this assay cannot detect the dose-
dependence increase in the level DNA damage in γ-irradiated animals, irrespective of the DNA 
extraction methods used, indicates that this Fpg-qRT-PCR assay lacks sensitivity; therefore, I 
decided to explore the alternative short versus long fragments of S-XL-qRT-PCR DNA damage 





















Figure 7.2 .DNA damage level of Day 4 wild type nematodes exposed to 0, 20 and 40 kRad γ-radiation, determined using Fpg-qRT-
PCR approach in different DNA extracts. (A) Mitochondrial DNA extract.  There were slightly more (not significant) DNA lesions 
detected in the mitochondrial DNA fraction of 20 and 40 kRad γ-irradiated animals relative to untreated control animals. The increase was 
not statistically significant. (B) qRT-PCR of total genomic DNA using mitochondria primers set. DNA lesions frequency in the animals 
exposed to the higher dosage of γ-irradiation (40 kRad) appeared lower than control and 20 kRad γ-irradiated animals. There was no dose-
dependent increased in the level of mt DNA damage determined using the total genomic DNA. (C) Nuclear DNA extracts. (D) qRT-PCR 
of total genomic DNA using nuclear primers set. There were no significant dose-dependent increased in the level of nuclear DNA damage 
determined using nuclear DNA obtained from differential centrifugation and total genomic DNA.  The observed trends were not statistically 





7.A.2. Determination of Real-Time chemistry (intercalation dye Vs fluorogenic 
probe) for S-XL-qRT-PCR assay 
To overcome the limitations in Fpg-qRT-PCR methodology (see section 3.3.4), I optimized the 
sequence specific S-XL-qRT-PCR DNA damage assay.  
In my S-XL-qRT-PCR method, the amplifications of the short and large fragments were 
initially monitored and analyzed using the same PCR amplification temperature profile by the 
intercalation of the fluorescence dye, SYBR Green I to double-stranded DNA. The amount of 
fluorescence emitted is proportional to the amount of double-stranded PCR product generated, 
thus, PCR products can be detected as these products accumulate during PCR amplification 
(Figure 7.3A). Using the same sample and copy number, the samples were detected using 
SYBR Green I dye and amplified using long and short amplicon primers set (XL and S 
respectively). Samples amplified using XL primers were detected earlier than sample amplified 
using S primers (Figure 7.3A). This demonstrates the detection limit of long and short fragment.  
However, the primary disadvantage of SYBR Green I dye is that the dye binds all double-
stranded DNAs, including non-specific reaction products. I further analyzed the samples using 
gel electrophoresis and found that some non-specific amplification in PCR reactions using both 
XL and S primers set (Figure 7.3B). However, the gel photo showed that the true signal (actual 
band intensity) for the long amplicons is higher than the signal from non-specific bands. In 
contrast, the actual band intensity for the short amplicons is comparable to the band intensity 
for the amplification of non-specific fragments suggesting significant artifacts. This 
demonstrated that short fragment is much more sensitive towards non-specific amplification 
and SYBR green I dye may not be ideal to detect short amplicon.  Therefore, I chose to instead 
detect short fragments using Taqman probes. The Taqman system utilizes a fluorogenic-labeled 
probe that contains a reporter molecule attached to a nucleotide probe. This fluorogenic probe 
is specific to the target gene and has a reporter dye and quencher dye attached to it. When the 
probe is intact, the quencher dye signal blocks the fluorescence signal emitted by reporter dye. 
In contrast, during PCR primer extension, DNA polymerase cleaved the probes thus separating 
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the reporter dye from the quencher dye.  This results in the increase in the fluorescence signal 
of the reporter dye which is proportional to the molecule of amplified template.  
To improve PCR specificity of my S-XL-qRT-PCR damage assay for all subsequent 
experiments, the amplification of short PCR products was monitored using the Taqman system 
while the amplification of long PCR product was monitored using SYBR Green I dye. The 
product specificity of the long PCR fragment that uses SYBR Green I dye was tested by 


























































Figure 7.3. A. qRT-PCR amplification plots of short and long PCR fragments detected 
using intercalation dye (SYBR Green I dye). Mitochondrial extract of day 4 young JK1107 
was used and RT-PCR was amplified using mitochondria primers sets, F1 (short amplicon) 
and L1 (large amplicon). The yellow amplification plots represent the sample amplified using 
long amplicon primers set while the blue amplification plots represent sample amplified using 
short amplicon primers set. ΔCt shows the difference in the detection limit of long and short 
amplicon although the same copy number was used. B. PCR products of short and long PCR 
fragments detected using intercalation dye (SYBR Green I dye) evaluated using agarose gel 
electrophoresis. PCR products electrophoresed in agarose gel shows non-specific 




7. A.3. Sample storage conditions  
After identifying the problem with the Fpg-qRT-PCR assay, I then explored the sample storage 
conditions using the S-XL-qRT-PCR DNA damage assay. I found that DNA degradation 
occasionally happened when samples were stored for extended periods of time. The effects of 
different storage conditions are important as the quality of starting material and method of DNA 
sample storage conditions prior to PCR analysis can affect PCR amplification efficiency.   
The extraction of a single sample requires 2 hours and there are at least three different samples 
to be extracted for each experimental repeat.  Therefore, it is not feasible to routinely run the 
qRT-PCR on the same day as extraction. Moreover, a good storage protocol enables the 
comparison of samples, for example, samples from animals at different ages, time points or 
cohorts. DNA samples were resuspended and stored in TE buffer (alkaline conditions) to inhibit 
DNA depyrimination, deamination, depurination and hydrolytic cleavage during DNA storage 
thus preserving the DNA integrity [370].  
In our laboratory, DNA samples are most commonly stored at 4 °C, -20 °C, or -80 °C. The four 
DNA storage conditions that I have tested are stored aliquoted DNA sample at 4 °C, -20 °C, -
80 °C or stored DNA at -80 °C with or without multiple freeze-thaws. Using the S-XL-qRT-
PCR method, the amount of DNA was determined. Comparing the intact DNA in both S- and 
XL-qRT-PCR, artefactual degradation and damage due to different storage conditions can then 
be quantified.  
Using this approach, DNA damage for DNA samples stored at -80 ˚C, 4 °C, -20 °C or multiple 
freeze thaw at -80 °C were 0.49, 0.57, 3.90 and 3.36 lesions per 10 kbp respectively (Table 7.1). 
It should be noted that the sample used for this experiment is not an undamaged control sample; 
thus, a certain background level of DNA lesions is expected. In appropriately stored DNA 
samples (DNA samples stored at -80 ˚C), the DNA damage level quantified was the lowest 
(Table 7.1) with no change in DNA damage comparing the DNA damage among the DNA 
samples from the same batch of animals but stored at 4 °C  and measured immediately after 
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DNA extraction. Therefore, this DNA lesions frequency is the DNA lesions that represent the 
actual damage existing in the sample, not the level of DNA damage due to additional damage 
caused by storing the samples under different conditions.    
Furthermore, short term (up to 3 days) storage of DNA pellets at 4 ˚C did not impact the PCR 
analysis. The DNA damage for samples stored at 4 ˚C was closer to DNA damage level for 
DNA samples stored at -80 ˚C (Table 7.1). The DNA samples stored at -20 ˚C and -80 ˚C with 
multiple freeze-thaws had the highest artifacts, resulted in higher DNA damage relative to DNA 
sample stored at -80 ˚C (Table 7.1).  
These results clearly demonstrated that repeated freeze thaw of DNA samples should be 
avoided as this will lead to loss of intact undamaged DNA and artifacts that will result in 
increased DNA lesions frequency as determined by this approach. Furthermore, DNA samples 
stored at 4 and -80 °C do not cause any measurable artifacts. Quantification using S-XL-qRT-
PCR also showed that long term storage in -20 ˚C may also decrease the amount of intact, 
undamaged DNA. DNA pellets used in this project were either analyzed within 3 days and 
stored at 4 ˚C to reduce the impact of freeze-thaw, or if long term storage was required, DNA 













DNA lesions ( per 
10 kbp) 
Fold change in additional DNA 
lesions produced  relative to 
DNA sample stored at -80 °C 
4 °C 0.57 0.2 
- 20 °C 3.90 7.0 
- 80 °C 0.49 - 
Stored at – 80 °C 











Table 7.1. Different DNA storage conditions affect PCR amplification.  mtDNA damage in 
day 4 glp-1 animals  assessed using  S-XL-qRT-PCR approach.  DNA samples stored for a week 
at 4 °C and -80 °C degraded less than DNA samples kept at -20 °C and multiple freeze thaws at 
-80 °C. Higher DNA lesions frequencies were detected in samples stored at -20 °C and with 
multiple freeze-thaw at -80 °C.  
